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Summary 
 
This thesis describes initial efforts towards the conjugation of biomolecules onto 
supramolecular self-assembled coordination cages in order to render the system biocompatible. 
Firstly, the compatibility and influence of coordination cages on a simple biomaterial was 
studied by the incorporation of tetrahedral cages in a peptide-based supramolecular gel. 
Secondly, bioconjugation of single amino acids and a tripeptide gelator onto coordination cages 
were investigated, showing that the properties of the peptide such as chirality and gelation were 
transferred to the whole system. Finally, a water-soluble cage was synthesised using N-
acetylatedgalactoamine building blocks to allow ligation of the cage onto the 
asialoglycoprotein receptor of hepatocytes. 
Deciphering the self-assembly rules within complex self-assembled libraries involves new 
characterisation challenges. In a second section of this thesis the potential to assess individual 
outcomes of self-sorting experiments by mass spectrometric techniques was investigated in 
three case-studies. The relative energies of heteroleptic structures compared to the more stable 
homoleptic as well as the effect of anion binding on a dynamic library of self-assembled 
tetrahedra was investigated. Furthermore, quantitative information on speciation within 
mixtures was obtained for a complex system of self-assembled scalenohedra and pseudo-
octahedra. 
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Le vrai point d'honneur n'est pas d'être toujours dans le vrai. Il est d'oser, de proposer des 
idées neuves, et ensuite de les vérifier. 
 
The real point is not to always be right. It is to dare, to propose new ideas, and then to 
validate them. 
 
PIERRE-GILES DE GENNES 
 
from La Science des Rêves, 2007 
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Abstract 
Coordination cages formed by supramolecular self-assembly are excellent candidates for the 
selective encapsulation of molecules and sheltering these guests from their environment after 
uptake. The easily tuneable nature of these 3D-structures can make them versatile carriers in 
applications such as drug delivery. However, to achieve this, the capsules need to be converted 
into biocompatible vehicles by the conjugation of biomolecules onto the cages’ surface for 
example. This thesis describes initial efforts towards this goal. Firstly, the compatibility and 
influence of coordination cages on a simple biomaterial was studied by the incorporation of 
tetrahedral cages in a peptide-based supramolecular gel. Rheological changes of the 
macroscopic material were observed while the host-guest properties of the cages remained 
unchanged, enabling the chemical segregation of guests. Secondly, bioconjugation of single 
amino acids and a tripeptide gelator onto coordination cages were investigated, showing that 
the properties of the peptide such as chirality and gelation were transferred to the whole system. 
Addition of a photoacid generator to the organo-gel formed triggered the reversible gel-sol 
transition of the material under alternating cycles of light irradiation and darkness. Finally, a 
water-soluble cage was synthesised using N-acetylatedgalactoamine building blocks. The 
geometry and organisation of the sugar biotags were engineered to allow ligation of the cage 
onto the asialoglycoprotein receptor of hepatocytes with the goal of realising the cellular 
internalisation of the complex and its cargo. 
In synthetic supramolecular systems, molecules can interact in different ways to yield complex 
self-assembled libraries. Multiple components combined can result in the integrative formation 
of single products or, most often, multiple self-assembled products. Deciphering the self-
assembly rules within such systems involves new characterisation challenges: dynamic, low-
symmetry products are difficult to detect and identify by NMR spectroscopy and labile species 
can re-equilibrate after chromatographic separation. Hence, in this thesis the potential to assess 
individual outcomes of self-sorting experiments by mass spectrometric techniques was 
investigated in three case-studies. A new methodology to calculate the relative energies of 
heteroleptic structures compared to the more stable homoleptic was developed, allowing for 
the quantification of each ligand’s structural preferences. Following a similar approach, the 
effect of anion binding on a dynamic library of self-assembled tetrahedra was probed. Finally, 
quantitative information on speciation within mixtures was obtained for a complex system of 
self-assembled scalenohedra and pseudo-octahedra.
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1.1 Understanding self-assembled coordination cages 
Supramolecular chemistry focuses on the synergistic combination of discrete molecular 
subunits into systems via intermolecular interactions. Mixtures of compounds are led into 
defined products during self-assembly, driven by the formation of non-covalent interactions. 
Weaker than their covalent counterpart, H-bonds, π-π (and other electrostatic) interactions and 
metal-ligand coordinative bonds are key elements to achieve the reversibility necessary to form 
the thermodynamic product from a starting library.  
 
1.1.1 General guidelines for design  
Self-assembled coordination cages rely on the formation of dative bonds between metals and 
ligands, for the construction of 3D structures able to delimit the space between the outside or 
inside of the framework formed.  The strong, yet labile, bonds formed along with the chelate 
effect, allow the system to rearrange into stable assemblies under thermodynamic control.  
Combining this versatile type of interaction with specially designed organic ligands has led to 
a rapid increase in the number and type of architectures synthesized.[1-2] The interplay between 
the symmetry, the number of coordination sites and the size of the ligand along with the 
coordination geometry of the metal cation and the overall stoichiometry of the system 
influences the outcome of the reaction, yielding the most stable product. Highly tailorable 
assemblies are therefore formed following simple geometric rules of complementarity between 
the organic and inorganic molecular components of the system.  
The reaction between the components of a chemical library will produce the most entropically 
and enthalpically stable architecture that satisfies both the coordination geometry of the metal 
and the coordinate vector of the organic molecule.[3] The ligands can only bind to the metal 
centre if their denticity and angle matches the metal coordination sphere.[4] The design of 
organic ligands and the metal chosen to occupy the edges and vertices are both paramount to 
obtain the desired shape (Figure 1.1).[5-6] The ligand can be mono or multi-dentate, singly or 
multi-branched, straight, bent or even concave or convex for multitopic molecules.  
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For example, Fujita et al. demonstrated the importance of the bend angle of a ditopic ligand in 
determining the final structure.[7] By iterative synthesis leading to ligands with subtly different 
curvatures, increasingly larger structures were self-assembled, from simple octahedron 1.1,[8] 
to more complex cuboctahedron 1.2,[9] rhombicuboctahedron 1.3[10] and finally 
icosidodecahedron 1.4 (Figure 1.2).[11] 
With these rules in hand, supramolecular chemists have been able to gain a better understanding 
in the self-assembly process, leading to rational design of ligands and subunits to obtain the 
desired structure, slowly moving away from serendipity. 
 
Figure 1.1│Geometric complementarity of subunits in self-assembly of coordination cages. a) 2D convex 
polygons and canonical polyhedral are obtained from ditopic building blocks and b) 3D architectures are obtained 
from ditopic and tritopic blocks. Figures adapted with permission from reference 6. 
 
 
Figure 1.2│Capsules of formulae MxL2x obtained by variation of the ligand bend from 90° to 150° leading to 
changes in the structure stoichiometry and therefore diameter.[8-11]  
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1.1.2 Imine chemistry and subcomponent self-assembly 
Subcomponent self-assembly relies on the formation of both covalent bonds and metal-organic 
dative bonds through a metal-templation process. First investigated by Busch et al.,[12] this 
strategy was further developed by Hannon et al.[13] and later by Nitschke et al.[14] Used to 
stabilise copper mononuclear complexes,[14-15] the method has evolved to incorporate complex 
polydentate ligands[16-17] in a bottom-up approach, reacting separate organic subcomponents 
around a metal template instead of coordinating preformed ligands. Coordination leads to 
stabilisation of the covalent bond formed, but also of the metal, preventing its oxidat ion or 
reduction once coordinated.  
Imine bonds may be reversibly cleaved and reformed, making them an ideal dynamic covalent 
bond to use in subcomponent self-assembly. As a product of the condensation of an aldehyde 
with an amine (mainly anilines and picolinaldehydes in this thesis), the imine bond formed is 
reversible through hydrolysis. However, once coordinated to a metal via its nitrogen donor 
atoms, the complex formed renders the imine bond stable, even in water in selected cases 
(Figure 1.3).[15]  
 
Figure 1.3│Formation of an imine between an amine and an aldehyde. a) General case and b) specific case of the 
metal templated imine formation between a picolinaldehyde and an aniline.   
 
This design allows building blocks to be readily switched, making it extremely versatile. The 
morphology and the resulting properties of a structure can be influenced by slight variations in 
the starting library. The structures yielded are thus varied and include helicates,[18] 
tetrahedra,[19] octahedra,[20] cubes,[21] prisms,[22] polymers[23] and many more.[24-25] 
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Furthermore, only one component of the library (pyridine, amine, metal or anion) needs to be 
changed to modify the behaviour of the whole system, limiting the synthetic effort required. 
For example, the amine used in the self-assembly process can undergo metathesis as another 
amine is added to solution.[26]  This strategy has been applied by Nitschke et al. to generate a 
library of tetrahedra in a “cascade” manner by consecutive substitution of p-chloroaniline by 
p-toluidine and p-anisidine.[27] The Hammett parameter of the aniline was also shown to 
infuence the size of the architecture formed, going from smaller M8L12 1.5 to the larger M10L15 
1.6 or M12L18 prisms
[28] or to influence the rate of reaction at a site on the coordination cage’s 
ligand (Figure 1.4).[29]  
 
Figure 1.4│Influence of the aniline’s Hammett parameter on self-assembled cages displaying the pyridyl-imine 
coordination motif. a) The equilibrium between two structures 1.5 and 1.6 or b) the rate of conversion of 1.7 into 
1.8 is affected, showing a linear free-energy relationship between log(K) and σp+ or σp respectively.[28-29]  
 
The power of subcomponent self-assembly can be illustrated by another example: the use of 
different metals and counter-ions. Recently, the role of the metals on the coordination cages 
stability in water has been unravelled in work by Nitschke et al. The authors showed that the 
half-life of structures could be increased from minutes to months by changing the metal from 
CdII  to FeII  or NiII.[30] The role of the counter-anion was also deciphered, where the 
hydrophobicity of the anion was shown to be paramount for the solubility of the coordination 
cage in different phases, bringing water solubility[31] or phase transfer ability to cages.[32]  
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1.1.3 Geometry and chirality 
Transition metals are extensively used in supramolecular chemistry due to their fixed, 
well-defined coordination geometries, making them good templates for self-assembly and 
rational design. The metal d-orbital occupancy dictates the lability of the metal and the 
geometry of the coordination sphere. Most commonly tetrahedral, square planar and octahedral 
metals are chosen for the formation of coordination cages.[6] For octahedral coordination which 
is our focus in this thesis, either six monodentate, three bidentate or two tridentate ligands bind 
to the metal centre via dative interactions.  
Bidentate ligands, if asymmetric, can bind in two different fashions, and will, if no other 
parameters influence the binding, yield a statistical mixture of meridional and facial geometries 
in a 3:1 ratio. The facial (fac) coordination is defined by the geometry in which the three imine 
nitrogen atoms define one triangular face of the octahedral coordination sphere, as opposed to 
the meridional (mer) coordination where the three imine nitrogen atoms define a plane that 
includes the metal centre (Figure 1.5 a).[33] The formation of fac or mer vertices therefore has 
a strong influence on the resulting structure. The “wider” opening in the angle between ligands 
in the case of mer vertices as opposed to fac allows for larger structures with higher nuclearity 
to form like prisms[22, 34] or icosahedra[25] for example.  
In addition two different optical isomers exist (Δ and Λ) contributing to the complexity of 
structures that can be achieved using the same ligand and transition metal (Figure 1.5 b). 
Usually both isomers are present in solution if no influencing factors are present. Otherwise, 
when one optical isomer is present in larger proportions than the other, chiral induction is 
observed which can be partial or complete. In the latter case, enantiopure cages are obtained, 
most often resulting from the use of chiral ligands in self-assembly.[35-37]  
 
Figure 1.5│a) fac and mer geometries and b) Λ and Δ stereochemistry obtained for an octahedral metal centre 
when reacted with three bidentate ligands. 
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Coordination cages can also present both optical isomers of the metal vertices in the same 
structure. For example, for tetrahedral cages with edge-bridging ligands (where the organic 
component of the coordination cage lies along the edge of the polyhedron formed, as opposed 
to face-capped cages where the organic component closes the faces of the structure), three 
different isomers can exist. When the same optical isomer is present at all four vertices (ΔΔΔΔ 
or ΛΛΛΛ), the overall structure displays T-symmetry. When one vertex presents the opposite 
isomer (ΔΔΔΛ or ΛΛΛΔ) the structure has C3-symmetry. Finally when two vertices are Δ and 
the other two are Λ the structure has S4-symmetry (Figure 1.6 a).[38] However, most edge-
bridged tetrahedra reported form the T-symmetric isomer only. 
Face-capped tetrahedra are also usually T-symmetric, due to the propeller shape of their tritopic 
ligands enforcing homochirality between all metal vertices.  The overall symmetry of the 
structure can nonetheless be changed by employing either ligands that can be present in 2 
conformations (endo and exo for example) or by employing two different types of ligand. 
Similarly to edge-bridged tetrahedra, the coordination cages obtained can be defined as T-
symmetric, C3-symmetric or C2-symmetric (Figure 1.6 b). 
 
 
Figure 1.6│a) Different optical isomers for edge-bridged tetrahedra, the blue and yellow balls representing Λ and 
Δ vertices respectively. b) Face-capped tetrahedra of different symmetry based on the type of ligand employed. 
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1.1.4 Complexity in systems: mixed ligands and self-sorting 
The complexity of biological macromolecular systems arise from the assembly of multiple 
molecular components arranged in a careful and controlled way. The variety of functionalities 
achieved by these systems such as catalysis or molecular recognition, to cite only a few, are 
tailored by the properties of the components used. Similarly, in coordination-driven self-
assembly, complexity and an increase in functionality of the 3D structures formed can be 
obtained by using a combination of organic building blocks.  
When multiple components are used in self-assembly, a library is formed. Self-sorting occurs 
in the system if there is a degree of recognition between the molecules in the library. If the 
building blocks have an affinity for themselves only, the process is referred to as narcissistic 
self-sorting, whereas social self-sorting occurs if building blocks of a different nature get 
incorporated into the final products (Figure 1.7 a-b).[39] Cooperation between the building 
blocks can be complete, in which case a single product is formed, referred to as integrative 
sorting (Figure 1.7 c). In the cases where the socialisation is not complete, multiple products 
are formed during non-integrative processes.[40] 
 
 
Figure 1.7│Scheme of the different self-sorting regimes possible, where components of the library sort a) 
narcissistically, b) socially and c) integratively. 
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Because heteroleptic systems (made of different ligands, as opposed to homoleptic) are built 
through self-sorting, new properties emerge from these,[41] one of which can be the formation 
of new, unexpected architectures.  
For example, Fujita et al. employed a combination of two similarly shaped ligands, but varying 
in size, to generate a Pd12L12L
’
12 pseudocantellated tetrahedra 1.9 (Figure 1.8). The system 
underwent integrative self-sorting, with a single highly desymmetrised product formed.[42] 
Another example is the formation of a triple-decker ZnII4L4L
’
2 sandwich 1.10 when both NDI- 
and pyrene-based ligands were employed, as described by Nitschke et al. (Figure 1.8).[43] 
 
Figure 1.8│Crystal structures of heteroleptic coordination structures formed from two different organic ligands. 
a) Pd12L12L’12 pseudocantellated tetrahedra 1.9 and b) triple-decker ZnII4L4L’2 sandwich complex 1.10.[42-43] 
 
Incorporating a variety of ligands carrying more than a single functionality can confer new 
properties to the heteroleptic cages formed,  such as catalysis[44] or new host guest properties.[45] 
A well-known example is the formation of stable mono- and di-nucleotide duplexes in the 
cavity of self-assembled heteroleptic prisms as demonstrated by Fujita et al.[46] Recent 
unpublished work from the Nitschke group showed the formation of a triangular prism from 
porphyrin-based tetratopic and triazine-based tritopic ligands presenting both the right cavity 
shape as well as electronic interior to encapsulate a series of steroids.[47]  
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1.2 Host-guest chemistry in coordination cages  
One of the features of molecular cages or containers, as their name indicates, is the presence of 
a well-defined internal void capable of accommodating guests. The conditions for guest 
binding within the cavity of cages are diverse and the rules governing the specificity of 
molecular interactions between host and guest are complex.[48] However, thanks to their high 
tuneability, coordination cages are good candidates for the study of host-guest recognition. 
With a few rules in hand, it is possible to engineer molecular recognition by rationally 
designing the appropriate cage. 
 
1.2.1 General rules for encapsulation  
The thermodynamic process of guest encapsulation within the cavity of a cage relies on both 
entropic and enthalpic contributions. Most often, the major entropic driving force results from 
the solvent being both expelled from the cavity and desolvated from the guest, whereas 
enthalpic gains are generated by positive cooperative interactions. The predominant factor for 
successful encapsulation lies in the size and shape match between the host and the guest. It was 
shown that optimal binding could be achieved when approximately 55% of the available cavity 
is occupied, leading to the so called “55% rule”.[49] This trend was investigated experimentally 
by Hunter, Ward et al., in a coordination cage giving an experimental value of ca. 50% for 
cavity occupancy before the binding strength started to decrease.[50]  
Quite often the cavity of coordination cages presents a different environment from the bulk 
solution, such that complementary interactions increase the binding affinity. These strong 
intermolecular forces include hydrophobic interactions,[51] hydrogen bonding[52] and π-
stacking[53] amongst others. The ability of a cage to adapt its cavity to match a guest is a good 
example. Velders, Severin et al. reported cage 1.11, able to expand its cavity in order to bind 
two coronene molecules, thus increasing intermolecular interactions (Figure 1.9).[54]  Closing 
off the faces of the cage is another common strategy to increase enthalpically-favourable 
interactions. Nitschke et al. elegantly demonstrated that increasing the size of the aromatic 
panel situated on FeII4L6 tetrahedra 1.12-X was directly related to changes in guest binding 
strength, with more enclosed cages encapsulating a larger range of guests (Figure 1.10).[55] 
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Figure 1.9│Crystal structures of RuII6L2L’6 1.11 before and after encapsulation of two coronene (purple) which 
resulted in a conformational switch from a collapsed to an extended trigonal prismatic structure.[54] 
 
Figure 1.10│Scheme for tetrahedron 1.12-X with X representing the different panels on the centre of the ligand 
(yellow stick) and crystal structure of 1.12-Anthracene after encapsulation of two pyrene molecule. Table 
showing the relation between the binding of different guests and the type of aromatic panel with more enclosed 
cages leading to stronger binding.[55] Figures adapted with permission from reference 55. 
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Finally, charge complementarity between coordination cages (often positively charged) and 
guests (often negatively charged) must also be accounted for to assess guest binding.[56-57] Poor 
size-match between host and guest can be overcome thanks to Coulombic attraction, with the 
caveat of overcoming electrostatic interactions such as ion pairing between the anionic guest 
and its counter-cation.  
 
1.2.2 Templates, an essential type of guest  
Binding of guests, mainly anionic in cationic cages, is commonly used to direct the formation 
of architectures. The templation process can lead to the formation of unexpected, new 
geometries instead of the otherwise obtained discrete structure without a template. More 
importantly, the use of a template in self-assembly has been shown to sometimes be necessary 
to direct the subcomponents from a dynamic library to the formation of a single or multiple 
discrete species.  
Nitschke et al. have extensively exploited this strategy to induce the reconfiguration of cages 
upon addition of a template[58] or to drive structural adaptation[59] for example. In one case 
different anions were used to form a series of discrete architectures from a dynamic library 
obtained when NTf2
– was employed (Figure 1.11).[60] Upon binding of OTf –, tetrahedron 1.13 
and grid 1.14 were formed, whereas BF4
– drove the mixture towards tetrahedron 1.13 and grid 
1.14 as the kinetic product which then reconverted into pentagonal prism 1.15, inferred to be 
the thermodynamic product. When ClO4
– or NO3
– were used, single products were formed, 
respectively pentagonal prism 1.15 or cuboid 1.16. Similarly, Ward et al. used ClO4
– and BF4
– 
to drive the formation of CoII4L6 tetrahedral capsules as opposed to the Co
II
2L3 helicate 
previously obtained.[61]   
Ureas can strongly coordinate to anions and, as such, have been incorporated in a multitude of 
ligands used in self-assembly. For example, Hay et al. have used this motif to generate M4L6 
cages forming exclusively around oxoanions EO4
n– (E = S, Se, Cr, Mo, W, P) by binding of 
four urea-based ligands around a single anion.[62] 
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Figure 1.11│A series of four discrete NiIIxLy supramolecular coordination architectures were obtained from the 
same ligand and metal, by varying the anion used as a template. NTf2– gave a non-discrete dynamic library, OTf – 
gave tetrahedron 1.13 and grid 1.14, BF4– gave tetrahedron 1.13 and grid 1.14 as the kinetic product which then 
reconverted into the thermodynamically stable pentagonal prism 1.15, ClO4– gave pentagonal prism 1.15 solely 
when traces of Cl– were present and NO3– gave cuboid 1.16 and precipitate.[60] 
 
1.2.3 Chemical separation  
Separation of molecular compounds is a challenge which chemists have been working on for 
decades, developing techniques ranging from simple extractions to more sophisticated 
approaches such as chromatography.  More recently, the use of molecular hosts able to bind 
compounds of interest has emerged as a new strategy to separate mixtures of molecules or to 
recover precious compounds. Small organic receptors able to strongly bind anions have been 
extensively employed to extract harmful anions from the environment (TcO4
–, CN– or AsO4
– 
amongst others)[63] or to recover gold[64] for example. Metal-organic frameworks (MOFs) have 
also shown great potential for chemical separation of a wide range of molecules (gases, anions, 
enantiomers, structural isomers etc).[65] 
Similarly to MOFs, one could imagine that the high selectivity of a discrete coordination cage 
for a certain class of compound could be used towards chemical separation. However their use 
in this context is still embryonic. One of the main challenges to overcome in order to enable 
the use of coordination cages as chemical separation tools is the extraction of the cage from the 
bulk solution and the subsequent recovery of the compound of interest. To do so, phase transfer 
has been explored as a strategy.  
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Nitschke et al. demonstrated that changing the anion associated with a cationic cage allows, 
based on their hydrophobicity, the selective transfer of one cage over another between phases, 
thus transporting and separating their encapsulated molecular cargoes.[32] The chemical 
separation and recovery of ReO4
– from other anions was achieved via this method.[66]  FeII4L4 
molecular cage 1.17 capable of anion recognition in water was employed.[59] When dissolved 
in CH3NO2, 1.17 was shown to selectively encapsulate ReO4
–. After removing the water layer 
and evaporating the organic solvent, transfer to EtOAc led to the decomposition of 1.17 over 
time, thus releasing the guest in a clean water phase. Finally, evaporation of the EtOAc and 
suspension of the subcomponents from 1.17 in CH3CN allowed the reassembly and recovery 
of 1.17 (Figure 1.12).  
 
Figure 1.12│a) Scheme depicting the cyclic extraction and recovery of ReO4– from a mixture of anions in water 
by 1.17. b) Crystal structure of ReO4– ⊂ 1.17.[66] Figures adapted with permission from reference 66. 
 
Instead of employing the cage cavity as a means to separate molecules, Sun et al. recently 
exploited self-assembly to selectively coordinate specific ions from a mixture of lanthanides.[67] 
A pyridyl-diamide ligand was shown to self-assemble with a range of lanthanide metal ions 
(LaIII, CeIII, PrIII, NdIII, SmIII, YbIII, LuIII, or YIII) to give cage 1.18-a, with higher affinity for 
some of these ions. Addition of alkyl chains at the periphery of the ligand allowed transfer of 
the cage formed from water to chloroform. Assembling cage 1.18-b in the presence of a mixture 
of LaIII cations and partitioning the mixture between chloroform and water resulted in the 
extraction of the metal preferentially bound, which could then be recovered by disassembling 
cage 1.18-b in CH3CN (Figure 1.13). 
Chapter 1 
 
- 15 - 
 
Figure 1.13│a) Self-assembly of pyridyl-diamide ligands bearing two different groups (a or b) and a series of 
lanthanide metal ions gave tetrahedral cage 1.18. The crystal structure of cage 1.18-a is given here. b) 1.18-b 
could be extracted in CHCl3 while the uncomplexed lanthanide cations remained in the water phase. c) Separation 
factors obtained from lanthanide solvent extraction.[67] Figures adapted with permission from reference 67. 
 
1.2.4 Applications to drug delivery  
Currently, medical treatments rely mostly on small drug molecules administered orally or 
injected directly into in the patient’s bloodstream, often leading to severe toxicity or the 
development of multi-drug resistance. The use of nanocarriers building on the enhanced 
permeability and retention effect has been explored to improve drug efficiency.[68] However, 
poor tissue penetration of nanomedicines and lack of selectivity have been highlighted as the 
major issues encountered, resulting from poor solubility, low stability of the drugs and carriers, 
or conflicting charge interactions.[69]  
Coordination cages have recently been investigated as candidates for drug delivery, based on 
their potential to protect the drug in the body. The molecular recognition and unique 
environment found inside the coordination cage can lead to selective encapsulation of 
biologically relevant molecules. For example, Yoshizawa et al. have demonstrated the ability 
of PdII2L4 capsule 1.19 to encapsulate lactic acid derivatives
[70] while Fujita et al. have shown 
the sequence selective uptake of peptides into PdII6L4 octahedral cage 1.21
[71] (Figure 1.14 a 
and c).  
Cisplatin is one of the major chemotherapy medicines, and as such, its encapsulation or that of 
cisplatin derivatives has been frequently investigated in cages. Clever, Shionoya et al. have 
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successfully incorporated Magnus Salt derivatives (alternating stacks of positively and 
negatively charged square-planar Pt complexes)[72] into PtII2L4 cage 1.20 (Figure 1.14 b).
[73]   
 
Figure 1.14│Different coordination cages encapsulate biologically relevant molecules such as lactic acid 
derivatives (a),[70] platinum complexes (b)[73] or peptides (c).[71] 
 
Furthermore, as a result of their generally hydrophobic cavity, cages have the ability to increase 
the solubility of molecules that would otherwise be insoluble in aqueous media. As an example, 
the co-encapsulation of otherwise water-insoluble Ir and Rh‐Cp‐type metal complexes along 
with aromatic compounds has been achieved in water thanks to the stabilisation effect of an 
M6L4 metallacage.
[74] Therrien et al. have shown the encapsulation and solubilisation of 
pyrenylcycloplatinate complexes in water soluble Ru6L2L’3 cages 1.22, demonstrating the 
increased solubility of guests.[75] They have also focused on the incorporation of either 
(acac)2Pt or (acac)2Pd complexes in 1.22, which can be toxic to cancerous cells (Figure 1.15). 
The cytotoxicities of the drug-in-cage complexes were compared to the drugs by themselves, 
showing acute toxicity of the complexes which were described to acts as a “Trojan horse”, 
facilitating the uptake of the drug in cells.[76]  
The positive charges induced by metal ions or positive groups on coordination cages can also 
balance out negative charges common in drug molecules, leading to higher levels of 
encapsulation. This strategy has been successfully implemented to improve the penetration of 
compounds in cells. In two cases, Mascarenas et al. used a fully organic positively charged 
cage to facilitate the internalisation of both pyranine containing peptides[77] and gold-
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nanoparticles in cells.[78] Combining the benefits of both increased overall charge and increased 
solubility, Lippard et al. used a Pt6L4 cage to bind four platinum prodrugs that could then 
penetrate cells and later be activated by ascorbic acid.[79]  
 
 
Figure 1.15│a) Crystal structure of (acac)2Pt ⊂ Ru6L2L’3 cage 1.22, where the black stick can be either of ligands 
dioxydo-1,4-naphthoquinonato or 2,5‐dihydroxy‐1,4‐benzoquinonato (b). Cage 1.22 binds the various Pt 
complexes shown in c.[76] 
 
Another important factor for drug delivery is the potential to release the encapsulated drug-
molecule. To do so, triggers are commonly used to disassemble the cage or render the host-
guest complex unfavourable. Light has largely been explored as a way to release guests by 
incorporating a photoswitching moiety in the cage ligands’ backbone. Upon light irradiation, 
the change of conformation imposed on the cage leads to contraction of the cavity and the 
expulsion of the guest.[80]  
Changing the pH of the bulk solution has also been a popular approach for guest release. 
Severin et al. used a photoacid generator to induce protonation of a range of pyridyl-containing 
ligands, leading to disassembly of the cages.[81] On the other hand, Hunter, Ward et al. exploited 
protonation of the guest molecules to induce release.[82] A collection of guest molecules bearing 
acidic or basic groups were encapsulated in Co8L12 cage 1.23 which was stable over a range of 
pH. Depending on the pKa of the guest, protonation of the guest occurred at different pH 
values, leading to their decomplexation from the cage’s cavity (Figure 1.16).  
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Figure 1.16│a) Crystal structure of 1-adamantane-carboxylic acid ⊂ Co8L12 1.23. b) Chemical shift of one of the 
signals of 1-adamantane-carboxylic acid (blue curve) and occupancy of the cavity of 1.23 (red curve) as a function 
of pH. c) Association constants for guests in neutral and charged states.[82] Figures adapted with permission from 
reference 82. 
 
1.3 Biomolecules and self-assembly 
Initial work by E. Fisher in the late 19th century described the “lock and key” principle between 
an enzyme and a substrate,[83] setting the platform for the study of weak interactions, molecular 
recognition, and host-guest chemistry from which supramolecular chemistry emerged. Natural 
molecules like peptides, proteins, nucleotides, carbohydrates and the interactions that allow 
these to cooperate and form higher ordered structures have been inspirational to chemists. Since 
then, chemists have tried to imitate the confined space found in enzymes to perform chemical 
reactions or reproduce host-guests interactions. Combining biomolecules and man-made 
supramolecular architectures represent the next logical step to better mimic and understand nature’s 
marvels.  
 
1.3.1 Supramolecular cages and biological systems  
Supramolecular architectures are bridging the gap between small molecules and larger complex 
biomolecules (or assemblies of biomolecules) such as proteins or membranes. As such, the 
study of the interactions between supramolecular coordination cages and biological systems 
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and the potential of relatively small cages to impact larger biomolecular assemblies has 
expanded recently.  
One of the main focuses has been the use of supramolecular metal complexes in biology as 
imaging agents[84-85] and therapeutics.[79] To this end, Hannon et al. have extensively 
investigated the interaction of M2L3 helicates with DNA,
[86] RNA[87] and proteins.[88] They 
demonstrated that coordination cages can bind specifically within the grove of certain DNA 
and RNA architectures like three-way junctions (Figure 1.17). Building on these results, the 
versatile helicate 1.24 was shown to act as a potential anti-cancer drug[89] or inhibitor for viral 
replication in HIV by binding to the TAT protein.[90]  
 
Figure 1.17Crystal structure of FeII2L3 1.24, and 1.24 bound within a RNA three-way junction (view from the 
side and the top).[87] 
 
Others have investigated the binding of coordination cages to transmembrane nanopores[91] or 
even the potential to use them as transmembrane pores.[92] The binding of single molecules to 
a tetrahedral coordination cage could be detected by monitoring the ion current through a α-
hemolysin transmembrane protein which the cage interacted with, extending the scope for 
nanopore‐detection strategies.[93]  
 
1.3.2 Biomolecular cages  
Incorporating biomolecules as building blocks into supramolecular cages has proven a 
successful strategy to render these biocompatible. In this context, the field of DNA nanocages 
has expanded recently, thanks to the increased control gained in DNA synthesis. The nanocages 
formed have good programmability and responsiveness and thus represent advantageous 
Chapter 1 
 
- 20 - 
carriers in applications like cargo delivery or biosensing and bioimaging.[94] Forming cages out 
of proteins and peptides has also been a popular approach.[95] The different polar and non-polar 
environments found on a peptide backbone provides great host-guest properties and 
recognition. Furthermore, the peptide cages’ ability to mimic their biological compartments is 
now providing a way towards protocells for example.[96]  
Although cages made of proteins,[97] peptides[98] or DNA[99] are common, small synthetic 
coordination cages incorporating biomolecules in their framework are rare. One of the few 
examples is the formation of a β-barrel demonstrated by Fujita et al. through metal directed 
self-assembly leading to folding of the peptide-based ligand.[100] An octapeptide combining 
both a β-strand and a loop-forming sequence was designed and self-assembled with either ZnI2, 
ZnCl2 or ZnBr2, forming a pore bearing barrel made of three Zn2L2 macrocyles (Figure 1.18). 
The design employed here mimics the tertiary and quaternary structures only found in nature 
so far.  
 
Figure 1.18│a) Crystal structure (top view) of β-barrel 1.25 made from three macrocyclic ZnII2L2 units and b) the 
cartoon representation with each ZnII2L2 unit in a different colour. c) Structure of the components used: 
octapeptide highlighting the barrel forming sequence (green arrow, F-V-F-V) and the loop forming sequence (blue 
string, P-G-P) and ZnII (purple sphere). d) Side view of schematic representation of 1.25 with β-strands highlighted 
in green.[100] Figures adapted with permission from reference 100. 
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Coordination has also been used in supramolecular structures as a way to stabilize the 
architecture formed from biomolecules. The incorporation of glycol based pyridine ligands into 
oligonucleotide strands was investigated by Clever et al. as a way to stabilize DNA 
quadruplexes for example. More precisely, when a pyridyl ligand was integrated into telomeric 
DNA sequences (repeating TTAGGG units), a G-quadruplex was formed with one of the tetrad 
replaced by the ligand. Upon binding of Cu, the folding of the quadruplex was enhanced by 
thermal stabilization.[101]  
 
1.3.3 Bioconjugated self-assembled cages  
Since the formation of synthetic coordination structures from biomolecules remains quite 
challenging, a simpler approach relies on tagging biomolecules at the surface of cages, while 
maintaining the original, better understood framework of the supramolecular cage. This 
strategy can potentially transform the coordination cage into a biocompatible vehicle without 
modifying the central cavity and therefore the host-guest properties of the cage. 
Pioneering work in this field was carried out by Fujita et al. as early as the mid-2000s when he 
functionalised the inner cavity of a Pd12L24 capsule with peptides through amide coupling, 
leading to the generation of a chiral environment within the cavity.[102] A similar strategy was 
used to graft the outside of a self-assembled coordination cage with mono-, di-, tri- or poly-
saccharides (Figure 1.19 a) which could undergo further higher order assembly by aggregation, 
mediated by either proteins[103] or  Ca+ ions.[104] Bioconjugation of DNA fragments was also 
achieved, showing the overall structure could bind complementary oligonucleotides at its 
periphery.[105] 
More recently, Casini et al. investigated two strategies for attaching peptides to M2L4 
supramolecular cages. Bioconjugation of the peptide pre-assembly to the cage was shown to 
be a more successful strategy than post-assembly modification of the cage.[106] This method 
was used to perform the exo-biofunctionalisation of PdII2L4 1.27 with four different integrin 
binding ligands (Figure 1.19 b).[107] After encapsulation of cisplatin in the cage’s cavity, both 
increased anticancer activity and decreased toxicity on healthy cells were observed. 
However, only a few examples describing biotagged supramolecular coordination containers 
are reported to date. Despite the advantages of coordination cages, their application to the 
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biomedical field has been far less explored than other systems such as MOFs,[108] 
nanoparticles[109] or liposomes.[110]  
 
Figure 1.19│Examples of bioconjugated coordination cages 1.26 and 1.27 functionalised respectively with a) 
saccharides, here a Lewis X type sugar,[104] or b) peptides, here integrin ligands.[107] Figures adapted with 
permission from references 104 and 107. 
 
1.4 Supramolecular self-assembled gels 
Supramolecular interactions have played a fundamental role in the development of molecule-
based soft-materials. Amongst those, self-assembled gels have gained an increasing popularity 
over the years, with applications in fields as diverse as biomaterials, environmental remediation 
or self-healing materials to cite only a few.[111] 
 
1.4.1 Low Molecular Weight Gels 
Unlike the more common gels formed by polymeric compounds, most supramolecular gels are 
made of smaller molecules, known as low molecular weight gelators (LMWG), which are held 
together by non-covalent linkages. A high level of control can be gained thanks to the ease of 
design of the small molecules used to form the gels, leading to new properties on the 
macroscopic scale.  
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The gelation process of LMWG relies on the self-association of molecules to form long, 
polymer-like fibrous aggregates, which get entangled forming a matrix which traps the solvent, 
forming the bulk material (Figure 1.20).[112] As a consequence, supramolecular gels must be 
studied at all scales, using a wide range of methods such as NMR or UV-vis spectroscopy on 
the molecular level, microscopy (TEM, SEM, confocal) on the fibril level (nanostructures) or 
rheology on the macroscopic level.  
 
Figure 1.20│Supramolecular gels form from assembly occurring at different scales, from molecular interactions 
to fibres, to network and finally bulk material.  
 
The desired physical properties can be enforced on the bulk material by fine-tuning of the 
molecular gelator properties. For example, changes of the gel aspect have been observed upon 
application of an external stimulus such as UV light. Jung, Lee, Kim et al. have shown the 
possibility to perform reversible lithography (write and erase) on a gel made of tris(4-((E)-
phenyldiazenyl)phenyl)-benzene-1,3,5-tricarboxamide by localised melting of the fibres.[113] 
As a popular trigger, UV light was also employed by Smith et al. to promote the formation of 
patterned gel domains made of DBS-gly 1.29 (DBS=1,3:2,4-dibenzylidene-D-sorbitol, opaque 
gel) within a preformed gel matrix made of DBS-CO2H 1.28 (translucent gel).
[114]  Due to the 
differences in pH of these molecules (pKa = 5.4 for 1.28 and pKa = 4.3 for 1.29), the selective 
gelation of 1.29 could be obtained by pH change initiated by UV irradiation of 
diphenyliodonium nitrate (DPIN, Figure 1.21).  
Furthermore, the reversible nature of the interactions holding the gel together most often render 
the crosslinking and the gelation reversible as well. Self-healing can therefore be easily 
achieved by LMWG, as demonstrated by the multitude of examples in the literature.[115] Stimuli 
responsiveness is aided by the reversible nature of the bonds in the gel. A sol-gel transition[116] 
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in LMWG was shown to be obtained via redox,[117] light,[118] heat,[119] sound[120] or combination 
of these stimuli.[121] 
 
Figure 1.21│Photo-patterning of a multi-domain gel containing DBS-CO2H (1.28) and a DBS-gly (1.29). First a 
gel forms made of fibrils containing exclusively 1.28. Following acidification by UV irradiation through a mask, 
a pattern is imprinted via formation of gel domains rich in 1.29.[114] Figures adapted with permission from 
reference 114. 
 
1.4.2 Self-assembled gels from short peptides 
Naturally occurring small molecules, peptides have versatile biological properties and have 
been used widely to form peptide-based materials. Their propensity to aggregate and form 
stacks or fibrils makes small peptides ideal candidates for the formation of supramolecular gels. 
Easily obtained by solid-phase synthesis, a wide variety of peptides ranging from only a few 
amino acids (our focus here) to longer sequences up to dozens of amino acids have been studied 
for their gel-forming ability and biocompatibility.[122-124] 
Very small peptides were discovered to aggregate into defined nano-structures, the simplest to 
date being the tube-forming diphenylalanine (Phe-Phe).[125] Other dipeptides have been shown 
to form gels, but only when the N-terminus was protected by an Fmoc 
(fluorenylmethyloxycarbonyl) moiety.[126] Fmoc-dipeptides and mainly Fmoc-Phe-Phe are 
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amongst the most extensively studied LMWG due to their excellent mechanical properties. 
However, identifying natural, non-substituted peptides able to form gels is of great interest. 
 With this objective in mind, Ulijn, Tuttle et al. carried out a computational study screening 
8000 tri-peptide combinations (Figure 1.22).[127] A set of design rules that promote aggregation 
were drawn from the systematic study, showing that aromatic amino acids (with apolar groups 
in blue in the MARTINI code, Figure 1.22 a) are most favourable in the middle or end of a 
tripeptide, while positive and hydrogen-bonding (yellow or orange) residues should be placed 
at the N-terminus and negative (red) residues in position at the C-terminus. 
 
Figure 1.22│Screening for self-assembling tripeptides. a) Representation of amino acids in the MARTINI force 
field. b) Simulation showing the aggregation for four tripeptides: KYF, KFD, PFF and GGG. c) Aggregation 
propensity (AP) as a function of hydrophobicity for 8,000 tripeptides. Tripeptides with AP > 2 are denoted in red, 
the top 400 tripeptides from the APH score (APH = hydrophobicity-corrected AP, taking into account the 
solubility of the peptide as well) are given in green with the overlapping candidates shown in orange. Arrows 
point to data points for KYF, KFD, PFF and GGG.[127] Figures adapted with permission from reference 126. 
 
Formation of nano-structures designed to favour the stacking of tripeptides was achieved by 
incorporating amino acids of alternating chirality. The first example dates back to 1993 when 
nanotubes were obtained from octapeptides of alternating L and D residues.[128] Subsequently, 
Marchesan et al. have applied this strategy to the formation of gels from heterochiral 
tripeptides.[129] 
Hydrophobic peptides of general structure Phe-DXxx-Phe, with Xxx being valine or leucine 
isomers, were shown to assemble into fibrils, unlike the less hydrophobic sequences tested.[130] 
The nanostructures observed were diverse in terms of rigidity, branching or tendency to form 
bundles, as shown by TEM and cryo-TEM (Figure 1.23). The assembly into structures was 
explained by bending of the heterochiral tripeptide backbones to maximize non-covalent 
interactions and exclude water from specific regions, resulting in zipping of the amino-acids 
and aggregation. 
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Figure 1.23│Photograph, TEM and cryo-TEM images of hydrogels obtained from alternating chirality tripeptide 
Phe-DXxx-Phe, with DXxx = valine, norvaline, isoleucine, leucine or norleucine.[130] Figures adapted with 
permission from reference 129. 
 
1.4.3 Coordination cages in gels  
Metal coordination has been widely used to promote the crosslinking of polymeric strands, 
forming the matrix of gels.[131] The same principle applies to the incorporation of coordination 
cages in gels with the advantage that the higher nuclearity of the cage allows for increased 
branching of the polymer network.  
The most common approach to obtaining gels containing cages is to append cage-forming 
building blocks onto soluble polymer strands. Upon coordination with metal ions, the cages 
assemble, acting as the nodes of the gel matrix. A typical example of this strategy was reported 
by Johnson et al. Bent di-pyridyl ligands were connected by PEG linkers, which upon addition 
of Pd(NO3)2 and heating at 80 °C formed the polymer/cage system.
[132] Based on the ligand 
used (Figure 1.24 f), either small M2L4 cages, or larger M12L24 cages were formed (Figure 1.24 
a), leading to various degrees of crosslinking and therefore changes in the mechanical 
properties of the material. However, in the case where the large cage was formed, a high 
number of loop-defects, where the linker connected two points on the same cage, were 
observed (shown in red in Figure 1.24). This effect was limited by lengthening the linker, thus 
decreasing the amount of loop obtained (Figure 1.24 e).[133]  
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Figure 1.24│a) Representation of the complexes used as linkers, here a metal corner, a M2L4 or a M12L24 cage. 
Schematic representation of the polymeric networks obtained upon formation of metal complexes (b), small M2L4 
cages (c), or larger M12L24 cages with either short (d) or long (e) linkers. f) Polymeric linker used with variable 
length PEG chain and variable cage-forming building blocks.[132-133] Figures adapted with permission from 
reference 131 and 132. 
 
High levels of control over the gel properties directly results from the shape and size of the 
cage chosen, leading to well defined polymers with regular cavities and intrinsic 
microporosity.[134] The incorporation of coordination cages into gels also allows the 
combination of both the properties of the cage and gel, yielding extremely versatile 
materials.[135] For example, Stang et al. demonstrated the formation of a fluorescent 
supramolecular gel. The fluorescence was induced by a tetraphenylethene bearing ligand while 
the gel network was formed via host-guest interactions between the crown ether grafted on the 
cage’s framework and bis-ammonium linkers.[136]  
The very sought after self-healing property is facilitated in self-assembled coordination gels 
due to the reversible nature of the chemical bonds present. Fujita et al. described a M12L14 cage, 
grafted with mesogenic arms which self-assembled into spherical liquid crystals. When 
combined with 1) the same cage-core grafted with aldehydes and 2) a diamine crosslinker, 
formation of a hybrid liquid crystal-gel with self-healing properties was triggered.[137] Stimuli-
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responsive self-healing was demonstrated by Johnson et al.[138] Light-responsive cages which 
switch between M3L6 and M24L48
[139] were crosslinked by PEG chains. Due to the difference 
in kinetics of the ligand exchange, the gel formed by the M3L6 linkage proved to be self-
healable, while that made of the M24L48 cage was not. 
However, the geometry of the cage is not the only important factor. The properties of gels can 
also be controlled based on the shape of the linker. Maji et al. nicely demonstrated the 
importance of this parameter by gaining control over the gel nano-structures through the linker 
binding between cubic M8L12 cages 1.30 (Figure 1.25 a).
[140] When combined with either N-
(2-aminoethyl)-1,3-propanediamine, guanidine.HCl or β-alanine, cage 1.30 assembled to form 
nanobouquets, nanosheets or nanocubes respectively, thus tuning the properties of the hydrogel 
on the nano-, micro- and macroscopic scale (Figure 1.25 d-g). 
 
Figure 1.25│a) Crystal structure of cage 1.30 interacting with multiple Me2NH2+ cations. b) Portion of the crystal 
structure showing ligands from two different cages connected via intermolecular H-bonding with four Me2NH2+ 
cations. Gels (d) formed when 1.30 was combined with different binders (c) and the FESEM and TEM images, 
revealing the gel nanostructures (e).[140] 
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1.5 Aims and overview  
The combination of coordination cages with biomolecules could lead to new properties arising 
either from each component – cage and biomolecules – separately, or emerging from the 
synergy of the two systems. This thesis will present a series of investigations into the 
interactions of sub-component self-assembled cages and biomolecules. More precisely, cages 
will be tested as a way to influence the structure of peptide LMWG and as a way to increase 
the gel selectivity towards guests.  Functionalisation of coordination cages by direct covalent 
attachment of biomolecules, tri-peptides and sugars, will also be probed, showing new 
properties arising from this unique combination. 
With the rise of more complex, biologically relevant chemical systems, the study of 
multicomponent supramolecular self-sorting is a necessity. Understanding the driving forces 
which lead molecules to sort into precise well defined structures will enable the design of 
composite synthetic systems closer in performance to those of nature. However, the 
investigation of complex systems has been challenging and limited by current analytical 
methods. With this goal in mind, part of this thesis will be dedicated to the investigation of 
mass-spectrometry as a quantitative tool for the study of self-sorted systems. Three different 
chemical systems were assessed, showing that quantitative information on the structural 
preferences of the systems could be gained from simple MS analysis.  
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2.1 General 
All reagents and solvents, unless stated otherwise, were purchased from commercial suppliers 
and were used without purification. Commercially supplied pararosaniline base 6.I was found 
to contain impurities (including fuchsin). The material supplied by Aldrich was found to 
contain the least amount of this contaminant and could be obtained in satisfactory purity after 
multiple washes with CH3CN. Trialdehyde 3.A,
[1] trianiline 3.B,[2] dialdehyde 6.C,[3]  
perfluorinated dialdehyde 6.D,[4] iron(II)bis(trifluoromethane)sulfonimide,[5] and 
iron(II)hexafluorophosphate,[5] were prepared following literature procedures. 
Cobalt(II)bis(trifluoromethane)sulfonimide[6] and cobalt(II)(trifluoromethane)sulfonate,[6] 2-
formylphenantroline 6.G,[7] and trianline 6.J[8] were synthesised by Felix Rizzuto following 
literature procedures. Trianiline 5.N was synthesised by Dawei Zhang following a literature 
procedure.[9] 
 
2.2 Mass spectrometry (MS) 
Low resolution electrospray ionisation mass spectrometry (LR-ESI-MS) was carried out on a 
Micromass Quattro LC mass spectrometer (cone voltage 15-25 eV, desolvation temp. 313 K, 
ionization temp. 313 K) infused from a Harvard Syringe Pump at a rate of 10 µL min–1. High 
resolution electrospray ionisation mass spectrometry (HR-ESI-MS) was undetaken on a 
Thermofisher LTQ Orbitrap XL hybrid ion trap mass spectrometer. Travelling Wave Ion 
Mobility Quadrupole Time-of-Flight mass spectra (IM-MS) were collected on a Waters Vion 
IMS QTof mass spectrometer equipped with XS Ion Optics and the QuanTof2 detection 
system. 
 
2.3 Nuclear Magnetic Resonance (NMR) spectroscopy 
NMR spectra were recorded at 298 K on a Bruker Avance III HD 400 MHz Smart Probe 
Spectrometer, a Bruker 500 MHz DCH Cryoprobe Spectrometer, a Bruker Avance III 
HD 500MHz Smart Probe Spectrometer or a Bruker Avance 500 MHz TCI Cryoprobe 
Spectrometer. Chemical shift (δ) values are reported in ppm relative to the residual solvent 
peaks for 1H and 13C and relative to an internal standard of C6F6 in CD3CN (δ = −164.90 ppm) 
for 19F. Coupling constants (J) are reported in hertz (Hz) and the signal multiplicities are 
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described as s (singlet), d (doublet), dd (doublet of doublets), t (triplet), dt (doublet of triplets), 
m (multiplet) and b (broad).  
Wide sweep paramagnetic NMR spectra were recorded in the analogue digitisation mode with 
a spectral width (SW) of 407.42 ppm, a transmitter frequency offset (O1P) of 130.00 ppm and 
an acquisition time of 0.1 sec. Due to the experimental difficulties associated with collecting 
NMR data for 1H nuclei with vastly different relaxation times, differences between measured 
and theoretical integration values were in some cases observed. While the paramagnetic nature 
of the complex precluded complete assignment of the proton environments, we propose that 
through-bond proximity of the proton environment to each CoII centres dictates the extent of 
downfield shifting of each signal, as observed in previous reports.[6, 10] 
DOSY NMR experiments were performed on a Bruker Avance 500 MHz TCI Cryoprobe 
Spectrometer. Maximum gradient strength was 5.3 G/cm A with a gradient highest current of 
10 A. Gradient amplitudes ranged from 5 to 95%.  The standard Bruker pulse program, 
ledbpgp2s, employing a stimulated echo and longitudinal eddy-current delay (LED) using 
bipolar gradient pulses for diffusion using 2 spoil gradients was utilised. The diffusion delay 
(d20) was set to 0.80 s and the diffusion gradient length (p30) to 500 µs.  
 
2.4 UV-Vis spectroscopy  
UV-Visible absorption spectroscopy was performed using an Agilent Cary 5000 UV-Vis-NIR 
spectrophotometer at 298 K. Measurements were background subtracted from blank solvent in 
an identical cuvette. Samples were analysed using quartz cuvettes with optical path lengths of 
1, 10 or 50 mm. 
 
2.5 Molecular modelling 
Molecular model simulations (MM2 and MM3 force fields) of supramolecular complexes were 
performed using SCIGRESS version FJ 2.6 (EU 3.1.9) Build 5996.8255.20141202. 
 
2.6 Fluorescence spectroscopy 
Fluorescence measurements were performed on a Cary Eclipse Fluorescence 
spectrophotometer with a 10 mm path length quartz cuvette at 295 K. 
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2.7 Circular Dichroism (CD) spectroscopy 
Circular Dichroism spectroscopy was performed on an Applied-Photophysics Chirascan qCD 
spectrometer using a 1 mm path-length quartz cuvette. Experiments were recorded at 298 K, 
maintained with a Peltier temperature control. Measurements were background subtracted from 
blank solvent in an identical cuvette. The sample concentrations were adjusted to maintain a 
HV below 700 Volts. A minimum sample integration time of 1 second was used. The data was 
smoothed using a 10 pts Savitzky-Golay algorithm and the residuals checked for distortions. 
CD spectra were acquired by Jake Greenfield. 
 
2.8 Oscillatory rheometry  
Dynamic time sweep rheological analyses were performed on a Malvern Kinexus Ultra Plus 
Rheometer with a 20 mm stainless steel parallel plate geometry. Experiments were recorded at 
298 K, maintained with a Peltier temperature control. Each sample was prepared in situ and 
immediately analyzed with a gap of 1 mm. Time sweeps were recorded for 1 h, using a 
frequency of 2 Hz and a controlled stress of 2 Pa. After 1 h, frequency sweeps were recorded 
from 0.1 to 10 Hz using a controlled stress of 2 Pa. Finally, stress sweeps were recorded using 
a frequency of 2 Hz until the breaking point for every gel. Rheometry data was acquired by 
Ana García Fernández. 
 
2.9 Transmission electron microscopy (TEM) and energy-
dispersive X-ray (EDX) spectroscopy  
TEM analyses were performed on JEM 2100 equipped with an Oxford Instruments INCS 
energy-dispersive X-ray spectroscopy (EDXS) detector operated at 100 kV. TEM grids 
(copper-grid-supported lacey carbon film) were first exposed to the UV-ozone cleaner (UV-
Ozone Procleaner Plus) for 10 min. After deposition on the TEM grid, the samples were dried 
for 15 min at 298 K, and contrasted by aqueous tungsten phosphate solution (pH=7.4). TEM 
images and EDX spectra were acquired by Slavko Kralj. 
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3.1 Introduction 
Systems relying on supramolecular interactions have generally been investigated in the solution 
state. However, some challenges such as chemical separation by supramolecular hosts would 
be better approached if bulk materials were to be used. Gels are materials that share properties 
of solids and liquids, and exhibit stimuli-responsiveness,[1] which enables applications that 
include environmental remediation[2] and cargo delivery.[3] The incorporation of metal 
complexes and hollow metal-organic cages into gels[4] can alter the responsiveness of the 
material to stimuli, thus endowing it with useful properties comprising fluorescence and self-
healing. [5-6] Chemically-modified coordination cages have been reported to act as nodes within 
gels and polymers, with linkages between cages formed by polymeric chains or binders.[7-8] 
The ability of cages to selectively encapsulate molecular cargoes led to materials with high 
affinities for one compound or a family of compounds specifically.[9-10] However, synthetic 
challenges often arise from this approach due to the high degree of modifications necessary to 
obtain gels from molecular cages.  
The identification of a suitable gel matrix, compatible with metalorganic cages could enable 
the immobilization of cages within the gel, without any chemical modification. Under the 
condition that the gel pores are small enough, the large 3D molecular cages could be entrapped 
in the matrix. Short peptides[11] are readily obtained, biocompatible materials[12] that form gels 
under a wide variety of conditions. More specifically, tripeptides of alternating L-D-L 
stereochemistry have recently been shown to adopt a conformation with side chains in an 
isotactic configuration that enables their long-range self-organization into gel-forming fibres 
(Figure 3.1).[13] 
 
Figure 3.1│ L-Phe-D-Ile-L-Phe tripeptide generates fibres, wherein hydrophobic side chains (orange) are 
localised on the opposite side of the hydrophilic peptide backbone (blue).[14] Figure reproduced with permission 
from reference 14.  
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In this chapter, gels made from a new tripeptide LMWG (low molecular weight gelator) were 
prepared and used to separate and immobilize different cages within distinct regions, but within 
a single solvent phase. The peptide gel was assembled in the presence of existing self-
assembled coordination cages, embedding these in its matrix formed from peptide fibrils. The 
hybrid gel material contained a homogenous array of cage cavities with functional guest-
binding capabilities. The spatially-separated cages were shown to bind distinct small molecule 
guests, allowing these guests to be segregated within defined parts of the gel and thus separated 
from a mixture by selective encapsulation. 
 
3.2 Immobilisation of cages in a tripeptide gel – Stability and 
properties of the material 
The subcomponents 3.A and 3.B were synthesized according to literature procedures.[15-16] 
Self-assembly of Fe(NTf2)2 and either p-toluidine and 3.A or picolinaldehyde and 3.B yielded 
cages 3.1 and 3.2 respectively (Figure 3.2).[15, 17]  
 
Figure 3.2│Self-assembly of a) cage 3.1 from p-toluidine, 3.A and Fe(NTf2)2 and b) cage 3.2 from 
picolinaldehyde, 3.B and Fe(NTf2)2. c) and d) single crystal X-ray structures of 3.1 and 3.2 with the linkages 
between FeII centres (blue or pink spheres) added to highlight the frame. e) and f) schematic representations of 
3.1 and 3.2 and their ligands. 
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Cage 3.1 encapsulated trifluoroacetate (TFA–) in slow exchange, as evidenced by the changes 
observed in 1H and 19F NMR upon addition of 20 eq. of KTFA (notably a new signal 
corresponding to the encapsulated TFA– appeared at –79.8 ppm in the 19F NMR spectrum). 
Further addition of 1 eq. of TBAReO4 resulted in the displacement of the encapsulated TFA
–, 
indicative of the stronger affinity between 3.1 and ReO4
– compared to TFA– (Figure 3.3 b and 
c). Cage 3.2 encapsulated NTf2
– very weakly as evidence by the small second set of peaks 
observed in the 1H NMR. As previously reported, 3.2 encapsulated fluoroadamantane (FA) 
sufficiently strongly to displace the encapsulated NTf2
– (Figure 3.3 e and f).[18] 
 
 
Figure 3.3│Host-guest properties of a) 3.1 and d) 3.2. b) and c) 1H NMR spectra (400 MHz, 298 K, CD3CN) and 
19F NMR spectra (376 MHz, 298K, CD3CN) of 3.1 before and after the addition of 20 eq. of KTFA followed by 
1 eq. of TBAReO4. e) and f) 1H NMR spectra (400 MHz, 298 K, CD3CN) and 19F NMR spectrum (376 MHz, 
298K, CD3CN) of 3.2 and FA⊂3.2. 
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Work in the Marchesan group is focused on the synthesis of small syndiotactic L-D-L tripeptide 
gelators. Recently, rules were unravelled explaining the mechanism of gelation for these small 
peptides, based on their hydrophobicity and alternating chirality.[14] The peptide L-Phe-D-Ala-
L-Phe was an exception to the design rules established. It was hypothesized that the 
hydrophobicity and steric hindrance of this molecule were not sufficient to trigger gel 
formation. The addition of a p-aminobenzoyl moiety at the N-terminus was hypothesized to 
solve both issues. Furthermore, this approach removed the undesirable free primary aliphatic 
amine (N-terminus of the peptide) which could otherwise lead to substitution of the cage aniline 
subcomponents thus reducing the cage stability. The newly designed gelator instead possessed 
an aniline substituted with an electron-deficient amide group which should not interfere with 
the residues from the cage.  
The tripeptide (p-aminobenzoyl)-L-Phe-D-Ala-L-Phe-NH2 3.C was thus synthesized by Ana 
García Fernández (Figure 3.4). Gelation occurred in CH3CN at 30 mM after 3 h and at 50 mM 
within seconds after sonication of the sample. 19F NMR spectrum of 3.C revealed the presence 
of two TFA– anions per molecule of 3.C. When combined with either cage 3.1 or 3.2, the 
tripeptide 3.C formed gels in CH3CN. For a peptide concentration of 50 mM, various cage 
concentrations could be used, ranging from 0.1 mM to 5 mM. The cages imparted a visible 
color to the gel even at concentrations as low as 0.1 mM (Figure 3.5 b and e).  
 
Figure 3.4│Peptide 3.C formed a gel at concentrations above 30 mM in CH3CN. 
 
Oscillatory rheometry was performed on the hybrid materials by Ana García Fernández. Time 
sweeps showed that the elastic modulus (G’) was superior to the viscous modulus (G”) for the 
hybrid materials 3.1⊂Gel and 3.2⊂Gel, confirming the gel nature of the materials (Figure 3.5 
c and f). Values for the G’ and G” are given in Table 3.1.  
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Figure 3.5│Combining peptide 3.C at 50 mM and either a) cage 3.1 or d) cage 3.2 at different concentrations 
gave the hybrid materials b) 3.1⊂Gel and e) 3.2⊂Gel, here pictured at 0.1 mM cage concentration. c) and f) 
Rheology data for the two hybrid materials at 5 mM cage concentration, showing that G’ (dark blue or dark pink) 
is superior to G” (light blue or light pink) for both gels. 
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Table 3.1│Elastic (G’) and viscous (G”) moduli for the gel from 3.C and the hybrid materials ([3.C] = 50 mM). 
Average and standard deviation of three independent experiments performed using three different samples. 
Sample G’ / kPa G” / kPa 
Gel from 3.C (50 mM) 46.4 ± 4.0 1.8 ± 0.7 
3.1⊂Gel ([3.1] = 1 mM) 18.4 ± 1.4 0.7 ± 0.3 
3.2⊂Gel ([3.2] = 1 mM) 18.1 ± 0.5 0.9 ± 0.1 
3.1⊂Gel ([3.1] = 5 mM) 12.3 ± 0.3 0.2 ± 0.1 
3.2⊂Gel ([3.2] = 5 mM) 6.1 ±1.7 0.3 ± 0.1 
 
The morphologies of the different gels were investigated by transmission electron microscopy 
(TEM). The images were acquired by Slavko Kralj. The peptide 3.C gelled to give a colorless, 
transparent material containing a matrix of homogeneous thin fibrils of average diameter 
9.8 ± 1.7 nm (Figure 3.6 a-b). When cage 3.1 or 3.2 were incorporated at a concentration of 
1 mM, no significant changes to the fibril diameter were observed (8.9 ± 1.9 nm for 3.1⊂Gel 
and 9.0 ± 2.1 nm for 2⊂Gel respectively, Figure 3.6 d, e, g, h). At higher concentration (5 mM), 
the cages appeared to alter the fibrils’ structures. The hybrid material 1⊂Gel displayed thinner 
fibrils (6.5 ± 2.0 nm in diameter, Figure 3.6 j, k) than observed at lower concentrations. In 
contrast, 2⊂Gel displayed thicker, shorter fibrils (11.7 ± 1.9 nm in diameter) in addition to 
amorphous aggregates, evidencing the disruptive effect of the cage on fibril formation (Figure 
3.6 l, m).  
The homogenous distribution of the cage within the material was probed by energy-dispersive 
X-ray (EDX) spectra which evidenced the presence of iron across all hybrid gel samples, with 
increasing amounts as the concentration of cage was increased (Figure 3.6 c, f, i, l, o).  
Both the oscillatory rheometric data and the TEM data revealed that the cages affected the gel 
properties. The incorporation of cages into the gel, in addition to increasing the selectivity for 
guest encapsulation, was thus shown to provide a means to fine-tune gelation kinetics, stiffness 
and response to stress. Differences in properties were obtained when different cages were used 
(3.1 or 3.2), introducing an additional level of control over the viscoelasticity of the material.  
For all further experiments, the cages were used at 5 mM to maximise their impact on the gel 
properties and increase the amount of guest which can be encapsulated, thus facilitating 
detection in the NMR experiments. 
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Figure 3.6│TEM micrographs at high (left) and low (middle) magnification and corresponding EDX spectra 
(arrow highlighting the signal for Fe) for the gel from a-c) 3.C and hybrid gels d-f) 3.1⊂Gel at 1 mM, g-i) 3.2⊂Gel 
at 1 mM, j-l) 3.1⊂Gel at 5 mM and m-o) 3.2⊂Gel at 5 mM. 
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The stability of cages in solution and in gels was probed by 1H and 19F NMR measurements. 
In solution, KTFA (20 eq.) was added to cages 3.1 and FA⊂3.2 (5 mM) as peptide 3.C contains 
two residual TFA– anions (ratio obtained for hybrid gels at 50 mM peptide and 5 mM cages). 
Gels incorporating 3.1 or FA⊂3.2, were prepared and monitored over time. The degree of 
decomposition of each cage was inferred from the changes in the percentage of encapsulated 
guest. The signals for the encapsulated guest peak (either TFA– for 3.1 or FA for 3.2) in the 19F 
NMR spectra were integrated against the NTf2
– peak. The values were normalised so that the 
highest points were equal to 100% as only the host-guest complexes were observed at this 
stages. The integrals obtained for 3.1 and 3.2 in solution and 3.1⊂Gel and 3.2⊂Gel were 
plotted as a function of the time (Figure 3.7). The errors on the values of the integrals (reading 
error) were assumed to be 5%. 
 
Figure 3.7│Plots of the percentage of encapsulated guest for a) 3.1 and b) 3.2 in solution and c) 3.1⊂Gel and d) 
3.2⊂Gel. 
 
In both gel and solution, 3.1 encapsulated TFA– quickly to become TFA–⊂3.1. In solution, no 
precipitate, nor significant decrease of the intensity of the encapsulated TFA– peak was 
observed over time for 3.1 (Figure 3.7 a). Similarly, the percentage of encapsulated guest did 
not decrease for TFA–⊂3.1⊂Gel after maximum encapsulation was reached (Figure 3.7 c). 
Cage 3.1 was thus inferred to be stable both in solution and in the hybrid gel in the presence of 
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KTFA (20 eq.). Interestingly, the encapsulation of TFA– in 3.1⊂Gel was observed to follow 
slower kinetics than in solution. This was tentatively explained by competitive interactions 
between the TFA– and the peptide fibrils, making the anion less available for encapsulation in 
3.1. This interaction between anions and fibrils was evidenced by broadening of the 19F NMR 
signals corresponding to the free TFA− in the gel, as compared to the solutions containing either 
3.1 or 3.2 and KTFA. The peak corresponding to the encapsulated TFA– was still sharp 
however, which was explained by the single environment found within the cage’s cavity. 
The percentage of FA⊂3.2 in solution decreased steadily over long periods and a precipitate 
formed gradually, which was attributed to the formation of the salt FA⊂3.2(TFA)8, expected 
to be insoluble in CH3CN (Figure 3.7 b). Additionally, small amounts of free FA were observed 
after 2 weeks, which was attributed to a slight decomposition of 3.2, further evidenced by the 
appearance of signals for subcomponent 3.B in the 1H NMR spectra after 2 weeks (Section 3.6, 
Figure 3.29). Upon formation of FA⊂3.2⊂Gel, small amounts of encapsulated FA were 
released (approximatively 7%) but no further decrease of the percentage of encapsulated guest 
was observed, indicative of the stability of 3.2⊂Gel (Figure 3.7 d). While 3.2 did not appear to 
be stable in solution in the presence of KTFA (20 eq.), 3.2⊂Gel was relatively stable after the 
initial slight decomposition. Once more, this could be explained by the TFA– interacting with 
the gel fibrils, thus preventing association with 3.2 and further precipitation.  
Additionally, in both 3.1⊂Gel and 3.2⊂Gel, the cage integrity was evidenced by the absence 
of NMR resonances associated with free cage subcomponents such as the aldehyde peak around 
10 ppm. The stability of the cages was also probed by ESI-MS. After dilution and filtration of 
3.1⊂Gel and 3.2⊂Gel, the spectra of the solutions obtained were acquired, showing signals for 
intact 3.1 and 3.2 (Figure 3.32). The spectrum for 3.1 showed a high number of peaks, some of 
which were assigned to the cage associated with TFA– anions instead of NTf2
– (see section 
3.6.3). 
 
3.3 Host-guest chemistry of cages in the gel state 
The host–guest properties of 3.1⊂Gel and 3.2⊂Gel were studied by 1H and 19F NMR over time 
and compared against those of 3.1 and 3.2 in solution. Following the layering of a solution of 
TBAReO4 or FA (1 eq.) in CD3CN on top of 3.1⊂Gel or 3.2⊂Gel, the resonances assigned to 
free and encapsulated guests were integrated against the NTf2
– signal in the 19F NMR spectra. 
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Similarly, a solution of TBAReO4 or FA (1 eq.) in CD3CN was added to a solution of 3.1 or 
3.2 respectively containing KTFA (20 eq.) which were previously equilibrated for 2 h, allowing 
for the formation of the host-guest complex TFA−⊂3.1. As ReO4− could not be tracked by 
NMR directly, the displacement of the encapsulated TFA– from TFA−⊂3.1 or TFA−⊂3.1⊂Gel 
as a consequence of the encapsulation of ReO4
– was monitored instead. The amount of 
encapsulated ReO4
– was assumed to complement the amount of released TFA–. The integrals 
obtained for 3.1 in solution and 3.1⊂Gel were normalised so that the value for the encapsulated 
TFA– is equal to 100% before the addition of TBA ReO4 as only the host-guest complex TFA
–
⊂3.1 or TFA–⊂3.1⊂Gel were observed at this stage. The amount of free FA and encapsulated 
FA⊂3.2 were normalised so that the sum of the signals was equal to 100% at its maximum. All 
values obtained were plotted as a function of time (Figure 3.8 and Figure 3.9). The errors on 
the values of the integrals (reading error) were assumed to be 5%. 
 
Figure 3.8│Plots of the amount of a) encapsulated ReO4– for 3.1 and b) encapsulated (dark pink diamonds) and 
free FA (light pink triangles) for 3.2 in solution and after addition of guest (1 eq.). 
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The guest uptake curves in the gel state were fitted to an asymptotic exponential model 
(Equation 3.1) which allowed calculation of the initial rate of guest uptake and quantitative 
comparison between samples. In solution, the processes followed the same trends but were too 
fast to allow calculation of a rate of encapsulation. Similar calculations have been made in the 
past by Gale et al. to study the kinetics of anion transport through membranes.[19]  
Equation 3.1:   % 𝑒𝑛𝑐𝑎𝑝𝑠. 𝑔𝑢𝑒𝑠𝑡 = 𝑎 − 𝑏 ∗ 𝑐𝑥 
where x refers to the time, a relates to the maximum encapsulation of a guest and b and c relate 
to the initial rate of encapsulation by the following formulae (Equation 3.2):  
Equation 3.2:     𝑘𝑖𝑛𝑖 =  −𝑏 ∗ 𝑙𝑛(𝑐) 
 
 
Figure 3.9│Plots of the amount of a) encapsulated ReO4– for 3.1⊂Gel and b) encapsulated NTf2– (light pink 
triangles), encapsulated FA (dark pink diamonds) and free FA (dark pink circles) for 3.2⊂Gel after addition of 
guest (1 eq.). The grey dotted lines represent the fitting from the parameters given in the insert table. 
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In solution, the maximum encapsulation of ReO4
− in 3.1 (86% ± 4) was reached after four days 
(Figure 3.8 a) whereas the maximum encapsulation of FA in 3.2 (69% ± 3) was reached within 
2 h of guest addition (Figure 3.8 b). The subsequent decrease in FA⊂3.2 followed the same 
trend previously observed for the stability tests in solution and was attributed to precipitation 
of 3.2. The complete encapsulation of ReO4
− in 3.1⊂Gel was reached after 12 days (Figure 3.9 
a). For 3.2⊂Gel, the signal for the encapsulated NTf2− dropped rapidly, with no trace of 
encapsulation for this compound after 48 h and the maximum encapsulation of FA (59% ± 3) 
was reached after 72 h (Figure 3.9 a). More ReO4
− was encapsulated in 3.1⊂Gel relative to 3.1 
in solution, which was hypothesized to result from the binding of TFA− anions by the gel fibrils, 
thus reducing the TFA– availability for competitive encapsulation.  
Comparison of the rates of guest uptake between solution and gel state clearly highlighted the 
slower kinetics in the gels (Figure 3.10). It was thus inferred that the rate of guest uptake by 
cages in the gel only partially resulted from the rate of guest encapsulation and that other effects 
were involved as well. Based on the striking difference observed between 3.1⊂Gel and 
3.2⊂Gel and the known difference in their properties on the material level, the rate of guest 
uptake was hypothesized to be dependent of the kinetics of diffusion through the sample in 
addition to that of guest encapsulation.  
 
Figure 3.10│Overlap of the plots showing the amount of encapsulated guest in 3.1 in solution (light blue squares), 
3.2 in solution (light pink triangles), 3.1⊂Gel (dark blue circles) and 3.1⊂Gel (dark pink diamonds) after addition 
of guest (1 eq.). The grey dotted lines represent the fitted model. 
 
The diffusion of TBAReO4 was gauged by monitoring the signals for TBA
+ in the 1H NMR 
spectra and the diffusion of FA was gauged by monitoring the signals for both free and 
encapsulated FA in the 19F NMR spectra (Figure 3.11). 
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Figure 3.11│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) of 3.1⊂Gel after addition of TBAReO4 (1 eq.) 
showing the signals for TBA+ over time and 19F NMR spectra (471 MHz, 298K, CD3CN) of b) 3.2⊂Gel and c) 
3.1⊂Gel after addition of FA (1 eq.). Time elapsed from guest addition is given on the spectra.  
 
The diffusion curves were fitted to the same asymptotic exponential model as previously 
(Equation 3.1) and the initial rates of diffusion were calculated. In 3.1⊂Gel, the rates of 
diffusion for ReO4
− (5.44 ± 0.20 % h-1) and FA (6.30 ± 0.22 % h-1) were similar whereas the 
rate of diffusion of FA in 3.2⊂Gel (14.61 ± 0.28 % h-1) was faster than in 3.1⊂Gel (Figure 
3.12). These observations suggest that the rate of diffusion of small molecules within the hybrid 
gels is mainly influenced by the structure of the gel network, rather than by the chemical 
structure of the diffusing species. Indeed, the higher storage modulus G’ of 3.1⊂Gel relative 
to 3.2⊂Gel indicates that the first gel is more “robust” and hence harder to diffuse through. 
Furthermore, it was inferred that the difference in nanostructures between gels, such as thinner 
fibrils with higher surface area, lead to greater physisorption of guest molecules and therefore 
slower diffusion. 
Overall, a five-fold difference between the initial rate of guest uptake for 3.1⊂Gel and 3.2⊂Gel 
(1.60 ± 0.05 % h-1 and 7.23 ± 0.15 % h-1 respectively) was obtained due to the different 
properties of the hybrid materials (Figure 3.13). The difference resulted primarily from the 
microscopic structure of the material and the kinetic of guest encapsulation within the cage to 
a lesser extent. Temporal control of the encapsulation of small guest molecules could thus be 
achieved for this system.  
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Figure 3.12│Plots of the diffusion of a) TBAReO4 in 3.1⊂Gel, b) FA in 3.2⊂Gel and c) FA in 3.1⊂Gel. The 
grey dotted lines represent the fitting from the parameters given in the insert tables. 
 
 
Figure 3.13│Overlap of the plots showing the diffusion of TBAReO4 in 3.1⊂Gel (dark blue), FA in 3.2⊂Gel 
(dark pink) and FA in 3.1⊂Gel (light blue) highlighting the similarity in diffusion kinetics between TBAReO4 
and FA in 3.1⊂Gel and the difference between diffusion of FA in 3.1⊂Gel and 3.2⊂Gel. 
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Finally, the diffusion of cages through the hybrid gels was investigated. A solution of 
TFA–-⊂3.1 or FA⊂3.2 (1 mM, 50 µL) was layered on top of hybrid gels 3.2⊂Gel or 3.1⊂Gel 
respectively. The diffusion was monitored via the integrals of the encapsulated TFA– peak for 
3.2⊂Gel and the encapsulated FA for 3.1⊂Gel in the 19F NMR spectra. 
 
 
Figure 3.14│Plots of the diffusion of a) FA⊂3.2 in 3.1⊂Gel and b) TFA–⊂3.1 in 3.2⊂Gel. The grey dotted lines 
represent the fitting from the parameters given in the insert tables. 
 
As expected, the diffusion of the cages was slower than that of the smaller molecular guests 
(Figure 3.14). The initial rate of diffusion of 3.1 was seven times slower compared to FA in 
3.2⊂Gel (Figure 3.15, solid vs. dash-dot line). The initial rate of diffusion of 3.2 was four times 
slower compared to ReO4
– in 3.1⊂Gel (Figure 3.15, dashed vs. dotted line). This implies that 
the cages remain localized in the gel matrix on a timescale that allowed the smaller guests to 
diffuse through the sample. The hybrid gel system was therefore suitable for cage segregation 
in separate layers and selective guest encapsulation. All values obtained for guest uptake and 
diffusion are summarised in Table 3.2. 
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Table 3.2│Summary of the initial rate of uptake and diffusion for ReO4−, FA, 3.1 and 3.2 in 3.1⊂Gel and 3.2⊂Gel 
derived from kinetic 1H and 19F NMR experiments. 
 Initial rate of uptake (% h-1) Initial rate of diffusion (% h-1) 
 ReO4− FA ReO4− FA 3.1 3.2 
3.1⊂Gel 1.60 ± 0.05  5.44 ± 0.20 6.30 ± 0.22  1.31 ± 0.20 
3.2⊂Gel  7.23 ± 0.15  14.61 ± 0.28 2.11 ± 0.11  
 
 
 
Figure 3.15│Overlap of the plots showing the diffusion of TBAReO4 in 3.1⊂Gel (dark blue diamonds, dashed 
grey line), FA in 3.2⊂Gel (dark pink circles, solid grey line), FA⊂3.2 in 3.1⊂Gel (light blue squares, grey 
dotted line) and TFA–⊂3.1 in 3.2⊂Gel (light pink triangles, dash-dot grey line). 
 
3.4 Chemical separation within a tri-layered system 
With guest separation in mind, a tri-layered system composed of 3.1⊂Gel and 3.2⊂Gel, 
separated by a buffer layer of peptide gel devoid of cages (3.C only) was designed (Figure 
3.16). A solution of cage 3.1 in CD3CN (5 mM, 0.12 mL) was combined with 3.C (4.4 mg, 
6.0 µmol, 10 eq.). The solution was transferred in a 5 mm NMR tube and was sonicated for 10 
min to promote the formation of the gel. After 2 h of equilibration, a solution of 3.C in CD3CN 
(50 mM, 0.09 mL) was layered on top of the gel containing 3.1. The sample was sonicated for 
10 min to promote the formation of the gel (Figure 3.16 a). This layer served as a buffer 
between the two cages. A solution of cage 3.2 in CD3CN (5 mM, 0.12 mL) was combined with 
3.C (4.4 mg, 6.0 µmol, 10 eq.). The solution was layered on top of the sample and was 
sonicated for 10 min to promote the formation of the gel (Figure 3.16 b).  
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Figure 3.16│Composition of the tri-layered system. a) Photo of 3.1⊂Gel (dark blue) and the buffer (light blue). 
b) Photo of the complete tri-layered system with 3.1⊂Gel (dark blue), buffer (light blue/purple) and 3.2⊂Gel 
(dark purple). c) Schematic representation of the tri-layered system. 
 
The sample was studied by slice-selective 1H NMR.[20-21] 1H NMR 2D mapping was done by 
acquiring 20 slices of approximately 1 mm thickness to obtain a high resolution spatial 
representation of the sample. The ‘map’ of the sample produced allowed the selection of the 
slices with the best homogeneity and signal intensity for the monitoring of the process. 
The presence of 3.1 and 3.2 in their respective layers was confirmed by spatial mapping of the 
sample (Figure 3.17). The grey regions indicate the spatial partitioning of the proton signals 
corresponding to cages 3.1 and 3.2 within the gel matrix. 1H NMR signals assigned to 3.1 (blue 
spectrum) were only found in layer 1, and signals for 3.2 (purple spectrum) were only found in 
layer 2. The observation of color leaching into the buffer layer was attributed to the strong 
visible absorbance of MOCs even at low concentrations (Figure 3.5 b and e). 1H NMR signals 
of the peptide only were detected there, indicating that the MOCs remained segregated mostly 
in their original layers and were not present at concentrations above the NMR detection 
threshold in the buffer layer.  
After the tri-layered gel formation, a solution of TBAReO4 and FA in CD3CN (1 eq., 0.02 mL) 
was added on top of the sample, and the encapsulation of the guests in the different gel layers 
was followed by slice-selective 19F NMR (Figure 3.18 and Figure 3.19). Two regions of the 
19F NMR (−135 to − 115 ppm and −88 to − 68 ppm) were monitored over time for layer 1 and 
layer 2. 
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Figure 3.17│a) Photo of the sample and b) 2D mapping of the 1H NMR spectra for the three-layered gel, showing 
the presence of 3.1 in layer 1 (3.1⊂Gel), the peptide alone in the buffer gel layer, and 3.2 in layer 2 (3.2⊂Gel). 
The 1H NMR spectra of 3.1⊂Gel (blue) and 3.2⊂Gel (pink) obtained by slice-selective NMR are overlapped for 
clarity. 
 
The signal corresponding to encapsulated FA was observed in layer 2, with maximum 
encapsulation reached after 12 h (Figure 3.18 b). Free FA was observed in both layer 1 (Figure 
3.19 b) and layer 2 (Figure 3.18 b), which was explained by the weaker binding of this guest 
in 3.2. It is important to note that no comparisons between the intensity of the signals observed 
in both layers could be made as the performance of the detection greatly varied from one layer 
to another, as evidenced by the higher signal/noise ratio in layer 2 compared to layer 1. Layer 
2 additionally presented signals for FA⊂3.2, which were only observed at later stages (t > 24h) 
in layer 1 due to leaching of FA⊂3.2. Despite the lack of absolute separation of FA between 
layers, an enrichment of this compound was achieved in layer 2.  
The disappearance of the encapsulated TFA− peak, indicative of ReO4
− encapsulation was 
observed in layer 1 (Figure 3.19 a). Approximately 80% of ReO4
– was observed to be 
encapsulated in 3.1 (by integration against the triflimide peak) after 62 h. The remaining 20% 
was inferred to be entrapped in the gel and spread evenly through the sample. Even though 
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complete segregation of the ReO4
– in layer 1 was not achieved, an enrichment of up to 9:1 ratio 
in layer 1 compared to layer 2 was obtained. The potential of this system for chemical 
separation was thus demonstrated. 
 
 
Figure 3.18│a and b) 19F NMR spectra (471 MHz, 298 K, CD3CN) of layer 2 containing 3.2⊂Gel in the two 
regions where the guests signals are detected after addition of a mixture of FA and ReO4– (1eq.).  Time elapsed 
from guest addition is given on the spectra. c) Cartoon representation of the chemical process.  
 
 
Figure 3.19│a and b) 19F NMR spectra (471 MHz, 298 K, CD3CN) of  layer 1 containing 3.1⊂Gel in the two 
regions where the guests signals are detected after addition of a mixture of FA and ReO4–  (1eq.).  Time elapsed 
from guest addition is given on the spectra. c) Cartoon representation of the chemical process.  
 
                                                                                                                                                                    Chapter 3 
 
- 65 - 
3.5 Conclusions and future work 
In conclusion, the formation of hybrid cage⊂gel nanostructured materials made of a self-
assembled tripeptide and one of two distinct FeII4L4 cages was achieved. Once embedded in 
the gel, the cavities of the cages were still available for guest uptake and either ReO4
– or FA 
could be encapsulated. The gel nanostructure was shown to be influenced by the presence of 
the cages, thus influencing the rate of diffusion of different compounds through the material 
based on their size. This provided new means for the control of diffusion kinetics and, as a 
consequence, the uptake of small molecules. These hybrid gels allowed for the creation of 
spatially separated, chemically-distinct phases within one-solvent systems. After embedding 
two different cages in distinct areas of the gel, the supramolecular assemblies allowed for 
chemical segregation of molecules from a mixture by means of guest encapsulation.  
The chemical platform established in this chapter could be extended in the future to create 
biocompatible materials. Recently, Nitschke et al. reported a blueprint for the formation of 
water soluble self-assembled cages.[22] Combined with peptide LMWGs that can assemble in 
water, these water soluble cages could generate new, easily accessible materials able to perform 
guest uptake and release under biological conditions. Potential uses in drug delivery could thus 
be envisioned. 
 
3.6 Experimental section 
3.6.1 Synthesis of 3.C, 3.1 and 3.2 
Peptide p-aminobenzoyl-L-Phe-D-Ala-L-Phe-NH2  3.C 
 
p-aminobenzoyl-L-Phe-D-Ala-L-Phe-NH2 3.C was 
synthesized by AMG following Fmoc-based solid phase 
peptide synthesis under a dry and inert atmosphere. The 
resin 2-chlorotrytil chloride (10 g) was swollen in DCM 
(40 mL). SOCl2 (1 mL) was added and the reaction was 
shaken under an argon for 1 h. The resin was washed with DMF (2 × 30 mL) and DCM (2 × 
30 mL). A solution of Fmoc-Rink amide linker (5.4 g, 10 mmol) and DIPEA (9 mL) in 
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DMF/DCM (2:1) was added to the resin, and the mixture was stirred for 1.5 h. MeOH (4 mL) 
was added and the reaction mixture was shaken for 5 min and then washed with DMF (3 × 30 
mL) and dicloromethane (3 × 30 mL). Piperidine 20% in DMF (10 mL) was added to the 
reactor and was stirred at room temperature (2 × 10 minutes) for deprotection. The reaction 
mixture was washed with DMF and DCM. A mixture of Fmoc-L-Phe-OH (7.3 g, 18.8 mmol), 
HBTU (5.7 g, 15.0 mmol), HOAt (2.0 g, 15.0 mmol) and DIPEA in DMF (1M, 15 mL) was 
sonicated until clear, and was added to the reactor. The reactor was shaken at room temperature 
for 1.5 h. The resin was washed and deprotected as in the previous step. The coupling and 
deprotection of the amino acids D-Ala and L-Phe were done the same way as the first coupling, 
by using Fmoc-D-Ala-OH (5.9 g, 18.8 mmol) for the second coupling and Fmoc-L-Phe-OH 
(7.3 g, 18.8 mmol) for the third coupling. The introduction of p-aminobenzoyl motif, was 
performed under the same coupling conditions by using Boc-p-aminobenzoic acid instead of 
an Fmoc-amino acid. The peptide was cleaved from the resin by shaking 2 h in the presence of 
a solution of TFA/DCM/H2O/triisopropylsilane (47.5/47.5/2.5/2.5, 100 mL). The solution was 
drained from the reactor, and the solvent was evaporated under air flow. The remaining oil was 
dissolved in a mixture of CH3CN/H2O containing 0.05% of TFA, and purified by reverse-phase 
HPLC (Agilent Technologies, Santa Clara, CA, USA). The HPLC Agilent 1260 Infinity system 
was equipped with a preparative gradient pump (1311B), semi-preparative C-18 column 
(Kinetex, 5 microns, 100 Å, 250 mm x 10 mm, Phenomenex, Torrance, CA, USA), autosampler 
(G1329B), and Photodiode Array detector (G1315C). The following HPLC method was used 
for the purification of the peptide: t = 0–2 min, 25% CH3CN; t = 14 min, 80% CH3CN; 
t = 16 min, 95% CH3CN; t = 17 min, 95% CH3CN. The compound was then freeze-dried to 
yield the corresponding peptide as a white powder. 1H and 19F NMR were used to assess the 
amount of residual TFA− per peptide. Integration of 1H and 19F signals against a reference 
capillary of 1,3,5-trifluorobenzene showed the presence of 2 eq. of TFA− per equivalent of 
peptide. 
1H NMR (400 MHz, 298K, DMSO-d6) δ 8.19 (d, J = 7.5 Hz, 1H, Hd), 8.10 (dd, J = 8.2, 1.8 
Hz, 2H, Hj,m), 7.55 (d, J = 8.8 Hz, 2H, Hc), 7.36 (bs, 2H, Hs), 7.29 – 7.07 (m, 10H, Hg,h,i,p,q,r), 
6.56 (d, J = 8.8 Hz, 2H, Hb), 4.75 (bs, 2H, Ha), 4.52 (ddd, J = 9.1, 7.5, 5.9 Hz, 1H, He), 4.35 
(ddd, J = 10.6, 8.8, 4.1 Hz, 1H, Hn), 4.16 (q, J = 7.3 Hz, 1H, Hk), 3.11 – 2.91 (m, 3H, Hf,o), 
2.75 (dd, J = 13.7, 10.6 Hz, 1H, Ho), 0.91 (d, J = 7.0 Hz, 3H, Hl). 
13C NMR (100 MHz, 298K, 
DMSO-d6) δ 173.4, 172.1, 171.8, 167.7, 151.1, 138.1, 137.5, 129.3, 129.2, 129.1, 128.4, 128.2, 
127.9, 126.6, 126.4, 121.6, 117.3, 113.5, 56.4, 55.0, 48.9, 37.0, 36.7, 16.2. ESI-MS: m/z 
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calculated for M = 501.2, observed positive mode [M + H]+ = 502.2 and negative mode [M - 
H]− = 500.2. HRMS: m/z calculated for [3.C + H+] = 502.2449, observed = 502.2398. 
 
 
Figure 3.20│1H NMR spectrum (400 MHz, 298 K, DMSO-d6) of 3.C 
 
 
Figure 3.21│13C NMR spectrum (101 MHz, 298 K, DMSO-d6) of 3.C. 
 
 
Figure 3.22│19F NMR spectrum (471 MHz, 298 K, CD3CN) of 3.C. 
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Figure 3.23 │ LC trace of 3.C (= 254 nm). Method: t = 0, 95% water (+0.1% CF3COOH) and 5% CH3CN 
(+0.1% CF3COOH); t = 10 min, 5% water (+0.1% CF3COOH) and 95 % CH3CN (+0.1% CF3COOH). Flow: 
0.5 ml/min. (tR= 8.4 min). 
 
Cage 3.1 
5,5',5''-(benzene-1,3,5-triyl)tripicolinaldehyde 3.A (40.0 mg, 
0.1018 mmol, 1.0 eq.) and p-toluidine (32.7 mg, 0.3054 mmol, 
3.0 eq.) were dissolved in CH3CN (10 mL) in a sealed 25 mL 
round bottom flask. The solution was degassed with N2 for 10 
min after which Fe(NTf2)2 (70.0 mg, 0.1018 mmol, 1.0 eq.) 
was added. The solution was degassed for an additional 10 
min. The solution was heated at 50 °C for 18 h. The dark blue 
solution was then cooled and concentrated under a flow of 
nitrogen. Addition of Et2O (80 mL) precipitated the compound as a dark blue solid. The solid 
was separated by centrifugation and washed with Et2O (2 × 80 mL). The solid was then dried 
under a flow of N2. 
1H NMR (500 MHz, 298K, CD3CN) δ 8.95 (s, 12H, Hd), 8.81 (d, J = 8.3, 12H, He), 8.55 (dd, 
J = 8.3, 2.0 Hz, 12H, Hf), 7.43 (s, 12H, Hh), 7.14 (d, J = 8.1 Hz, 24H, Hb), 7.11 (d, J = 2.0 Hz, 
12H, Hg), 5.51 (d, J = 8.0 Hz, 24H, Hc), 2.41 (s, 36H, Ha). 
19F NMR (471 MHz, 298K, CD3CN) 
δ –80.45. LR-ESI-MS [charge, calculated mass]: m/z = 1422.2 [3.1(NTf2)53+, 1422.4], 996.7 
[3.1(NTf2)4
4+, 996.8], 741.3 [3.1(NTf2)3
5+, 741.4], 571.0 [3.1(NTf2)2
6+, 571.2], 449.4 
[3.1(NTf2)
7+, 449.5], 358.2 [3.18+, 358.3]. 
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Figure 3.24│1H NMR spectrum (500 MHz, 298 K, CD3CN) of 3.1. 
 
 
Figure 3.25│19F NMR spectrum (471 MHz, 298 K, CD3CN) of 3.1. 
 
The data was consistent with previously reported data for cage 3.1 with OTf – counterions.[17] 
 
Cage 3.2 
N2,N4,N6-Tris(4-aminophenyl)-N2,N4,N6-trimethyl-1,3,5-triazine-
2,4,6-triamine 3.B (50.0 mg, 0.1133 mmol, 1.0 equiv.) and 2-
picolinaldehyde (32.3 µL, 0.3399 mmol, 3.0 equiv.) were 
dissolved in CH3CN (10 mL) in a sealed 25 mL round bottom 
flask. The solution was degassed with N2 for 10 min after which 
Fe(NTf2)2 (78.0 mg, 0.1133 mmol, 1.0 equiv.) was added. The 
solution was degassed for an additional 10 min. The solution was 
stirred at room temperature for 18 h. The dark purple solution was then concentrated under a 
flow of nitrogen. Addition of Et2O (80 mL) precipitated the compound as a dark blue solid. 
The solid was separated by centrifugation and washed with Et2O (2 × 80 mL). The solid was 
then dried under a flow of nitrogen. 
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1H NMR (500 MHz, 298K, CD3CN) – 3.2: δ 8.84 (s, 12H, He), 8.50 (d, J = 7.7 Hz, 12H, Hd), 
8.39 (t, J = 7.7 Hz, 12H, Hc), 7.75 (t, J = 7.7 Hz, 12H, Hb), 7.43 ‒ 7.35 (bm, 36H, Ha,g), 5.24 ‒ 
4.89 (bm, 24H, Hf), 3.41 (s, 36H, Hh). 
1H NMR (500 MHz, 298K, CD3CN) – NTf2–⊂3.2: δ 
8.80 (s, 12H, He), 8.47 (d, J = 7.7 Hz, 12H, Hd) 8.39 (t, J = 7.7 Hz, 12H, Hc), 7.75 (t, J = 7.7 
Hz, 12H, Hb), 7.43 ‒ 7.35 (bm, 36H, Ha,g), 5.24 ‒ 4.89 (bm, 24H, Hf), 3.41 (s, 36H, Hh). 19F 
NMR (471 MHz, 298K, CD3CN) δ –75.40 (NTf2–⊂3.2), –80.47 (free NTf2–). LR-ESI-MS 
[charge, calculated mass]: m/z = 1486.4 [3.2(NTf2)5
3+, 1486.5], 1044.2 [3.2(NTf2)4
4+, 1044.8], 
779.7 [3.2(NTf2)3
5+, 779.8], 603.1 [3.2(NTf2)2
6+, 603.2], 476.9 [3.2(NTf2)
7+, 477.0], 382.2 
[3.28+, 382.3]. 
 
 
Figure 3.26│1H NMR spectrum (500 MHz, 298 K, CD3CN) of 3.2. 
 
 
Figure 3.27│19F NMR spectrum (471 MHz, 298 K, CD3CN) of 3.2. 
 
The data was consistent with previously reported data for cage 3.2 with OTf – counterions.[15] 
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3.6.2 General preparation for hybrid gels 3.1⊂Gel and 3.2⊂Gel 
For the gels containing 1 mM of cage, a stock solution of 5 mM cage was prepared in CH3CN. 
The peptide was dissolved in CH3CN and added to the required volume of the cage solution to 
get the desired final concentrations of peptide (50 mM) and cage of (1 mM). The sample was 
sonicated for 5 min to promote the formation of the gel.  For the gels containing 5 mM of cage, 
a solution of cage (5 mM) was prepared in CH3CN. The peptide was directly added to the cage 
solution to get the desired final concentrations of peptide (50 mM) and cage (5 mM). The 
sample was sonicated for 10 min to promote formation of the gel. 
All samples used in NMR studies were prepared and sealed in J-Young NMR tubes to prevent 
evaporation of the solvent over time. 
 
3.6.3  Stability of 3.1 and 3.2  
In solution  
KTFA (35 µmol, 20 eq.) dissolved in CD3CN (20 µL) was added to a solution of cage 3.1 or 
FA⊂3.2 in CD3CN (5 mM, 0.35 mL). 
 
Figure 3.28│a) 1H NMR spectra (400 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (376 MHz, 298K, CD3CN) 
of 3.1 in solution before and after addition of KTFA (20 eq.). Time elapsed from addition of KTFA is given on 
the spectra.  
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Figure 3.29│a) 1H NMR spectra (400 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (376 MHz, 298K, CD3CN) 
of FA⊂3.2 in solution before and after addition of KTFA (20 eq.). Time elapsed from addition of KTFA is given 
on the spectra.  
 
In hybrid gels  
3.C (12.5 mg, 17.5 µmol, 10 eq.) was added to a solution of cage 3.1 or FA⊂3.2 in CD3CN (5 
mM, 0.35 mL). The samples were sonicated for 10 min to promote the formation of the gel. 
Figure 3.30│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of 3.1 before addition of 3.C and gelation and of 3.1⊂Gel. Time elapsed from gelation is given on the spectra.  
                                                                                                                                                                    Chapter 3 
 
- 73 - 
 
Figure 3.31│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of FA⊂3.2 before addition of 3.C and gelation and of FA⊂3.2⊂Gel. Time elapsed from gelation is given on the 
spectra. 
 
 
Figure 3.32│LR-ESI-MS of a) 3.1 and b) 3.2 recovered from 3.1⊂Gel and 3.2⊂Gel respectively. 
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3.6.4 Guest uptake in 3.1 and 3.2 
In solution 
KTFA (35 µmol, 20 eq.) dissolved in CD3CN (20 µL) was added to a solution of cage 3.1 or 
3.2 in CD3CN (5 mM, 0.35 mL). After 2 h of equilibration, TBAReO4 or FA (1.75 µmol, 1 eq.) 
CD3CN (20 µL) was added to solutions of 3.1 or 3.2 respectively. 
 
Figure 3.33│a) 1H NMR spectra (400 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (376 MHz, 298K, 
CD3CN) of 3.1 in solution after addition of KTFA (20 eq.) followed by TBAReO4 (1 eq.). Time elapsed from 
guest addition is given on the spectra. 
 
Figure 3.34 │a) 1H NMR spectra (400 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (376 MHz, 298K, 
CD3CN) of 3.2 in solution after addition of KTFA (20 eq.) followed by FA (1 eq.). Time elapsed from guest 
addition is given on the spectra. 
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In hybrid gels 
3.C (12.5 mg, 17.5 µmol, 10 eq.) was added to a solution of cage 3.1 or 3.2 in CD3CN (5 mM, 
0.35 mL). The samples were sonicated for 10 min to promote the formation of the gel. 
After 2 h of equilibration, TBAReO4 or FA (1.75 µmol, 1 eq.) CD3CN (20 µL) was layered on 
top of 3.1⊂Gel or 3.2⊂Gel respectively. 
 
Figure 3.35│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of TFA–⊂3.1⊂Gel before and after addition of TBAReO4 (1 eq.). Time elapsed from guest addition is given on 
the spectra.  
 
Figure 3.36│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of 3.2⊂Gel before and after addition of FA (1 eq.). Time elapsed from guest addition is given on the spectra.  
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3.6.5 Diffusion of compounds in hybrid gels 
FA in 3.1⊂ Gel  
FA (1 eq., 1.75 µmol) in CD3CN (20 µL) was layered on top of ReO4
–⊂3.1⊂Gel. 
 
Figure 3.37│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of ReO4–⊂3.1⊂Gel before and after addition of FA (1eq.). Time elapsed from guest addition is given on the 
spectra.  
 
Cages in 3.1⊂ Gel and 3.2⊂ Gel 
A solution of TFA-⊂3.1 or FA⊂3.2 (1 mM, 0.35 μmol) in CD3CN (50 μL) was layered on top 
of FA⊂3.2⊂Gel or ReO4-⊂3.1⊂Gel respectively.  
 
Figure 3.38│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of 3.2⊂Gel after addition of TFA–⊂3.1. Time elapsed from cage addition is given on the spectra. 
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Figure 3.39│a) 1H NMR spectra (500 MHz, 298 K, CD3CN) and b) 19F NMR spectrum (471 MHz, 298K, CD3CN) 
of 3.1⊂Gel after addition of FA⊂3.2. Time elapsed from cage addition is given on the spectra.  
 
3.6.6 Spatial segregation of cages and guest separation 
The set up for slice selective NMR was similar to the one previously reported.[20]   
Shaped pulse excitation was the Bruker standard gaussian-cascade G4 using: 
NS = 8 
D1 = 1.00 s 
SPW1 = 0.30642 
P11 = 1494 
GPZ1 = 23.5% 
 
1H and 19F NMR 2D mapping of the sample were used to localize the offset corresponding to 
each layer of gel under the conditions (slice width) used for the 1D experiments. Fewer and 
thicker slices were used (approx. 2 mm, 10 slices) than in the initial 2D mapping in order to 
get better intensity of the signals. The mapping was repeated with the following parameters:  
1H NMR: 
 GPZ1 = 6%, SPW1 = 0.30642, P11 = 1494, NS = 8 
19F NMR: 
 GPZ1 = 11.5%, SPW1 = 4.792, P11 = 795.2, NS = 8 
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The optimal slices showing most intense signal in the 1H NMR were identified for each layer 
of gel and the SPOFFS1 were recorded: 
Top layer: SPOFFS1 = 9200  Bottom layer: SPOFFS1 = –9200 
The SPOFFS1 being dependent of the frequency of excitation and the probe used, the SPOFFS1 
for the 19F NMR were identified by matching the slices, giving:  
Top layer: SPOFFS1 = 9200  Bottom layer: SPOFFS1 = –18400 
In order to keep the performance of the 19F NMR experiments similar to those of the 1H NMR 
experiments, a 20 ppm spectral width was acquired and offset selected to observe each region 
of interest. One region of the 1H NMR (0 – 10 ppm, NS = 8) and two regions of the 19F NMR 
(−135 to −115 ppm and −88 to −68 ppm, NS = 256) were monitored. This meant that it was 
not possible to get quantitative data as peaks could not be integrated against a reference in the 
19F spectrum. However, relative values can be obtained by comparing the absolute values of 
the integrals of peaks between different time points as the gain and number of scans were kept 
identical between runs.  
 
Figure 3.40│1H NMR spectra (500 MHz, 298 K, CD3CN) of a) the bottom layer containing 3.1 and b) the top 
layer containing 3.2 over 62 h after addition of a mixture of FA and TBAReO4 (1 eq.). 
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A tripeptide functionalised FeII4L4 
tetrahedral cage undergoes light 
induced reversible gelation 
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4.1 Introduction  
Assembled in living organisms or by chemists to generate peptides or proteins, amino acids are 
the building blocks of life.[1] Differentiated by their specific side chains, they have a general 
chemical structure containing both a carboxylic acid (C-terminus) and an amine (N-terminus) 
functional group. Based on the amino-acid sequence employed, peptides and proteins are able 
to self-organise into higher order structures and materials.[2-5] Peptides are truly versatile 
building blocks, and new properties could emerge from their use in conjunction with 
supramolecular coordination structures.[6-8] 
The bioconjugation of peptides onto coordination cages thus offers a straightforward strategy 
to enhance the properties of the cages. This strategy synergistically combines the characteristics 
of both cages (defined 3D-structure and cavity, host-guest chemistry…) and the peptides used 
as building blocks. For example, we can envision that once grafted with a peptide gelator, a 
cage will form a network of fibrils leading to the gelation of the bulk material, while preserving 
the cage structure. 
Previous results by Li et al. showed that sol-gel transition of a Phe-Phe dipeptide could be 
controlled by light in the presence of a photo-acid generator (PAG).[9] Upon exposure to visible 
light, merocyanine (the protonated form of the PAG), undergoes a ring-closing reaction to form 
the spiropyran, releasing a proton into the environment. The decrease of the pH in bulk solution 
disturbs the packing of the peptide fibrils, leading to the return of the sample to its liquid state. 
Based on this work, we hypothesised that the sol-gel transition of a gel formed from cages 
grafted with peptide gelators could be triggered by an external stimulus in a reversible process. 
This chapter explores the formation of coordination cages which incorporate amino acids or 
short peptides as building blocks. While direct conjugation through the N-terminus was 
unsuccessful, both amino-acids and peptides were appended onto a FeII4L4 tetrahedral cage via 
an aniline linker. Building on results from chapter 3, a gel was formed from the cage grafted 
with the peptide gelator 3.C. Combining this cage with a photoacid generator was predicted to 
lead to the disassembly of the peptide fibrils, while preserving the integrity of the coordination 
cage. The reversible gelation of peptide-cage system could thus be achieved by exposing or 
isolating the sample from light.  
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4.2  Functionalisation of cages with amino acids 
The N-terminus of amino acids and peptides could potentially react with picolinaldehyde to 
form pyridyl-imines, leading to the formation of supramolecular architectures after the addition 
of metal salts. The direct self-assembly of 3.A with various hydrophobic amino acids (glycine, 
alanine, valine, leucine, isoleucine and phenylalanine) and Fe(NTf2)2 was attempted in CH3CN 
(Figure 4.2). Methylated amino acids were also employed to increase the solubility of the 
compounds formed in organic solvents. No discrete supramolecular species could be detected 
by 1H NMR or ESI-MS. Imine condensation occurred between 3.A and the methylated amino 
acids in CH2Cl2, compounds which could be isolated and dissolved in CH3CN. Unfortunately, 
no discrete supramolecular structures were observed by 1H NMR after the addition of 
Fe(NTf2)2 (Figure 4.2 d). In both attempted self-assemblies (direct or with preformation of the 
imine), only the signals for the amino acids were observed in the 1H NMR. Other metals (ZnII 
and CoII) as well as anions (OTf –, BF4
–, ClO4
–) were screened for self-assembly without 
success. 
The MM3-optimised model of the expected tetrahedral capsule showed the close proximity of 
the C-termini of the amino acids (Figure 4.1). We hypothesised that the steric clash between 
the carboxylic acids of the amino acid around the metal vertices was too high and therefore 
prevented self-assembly into a defined 3D architecture. 
 
Figure 4.1│MM3-optimised model of the tetrahedral capsule expected from amino-acids (position residues in 
gold) and 3.A. The space filling highlights the steric clash between carboxylic acids around the metal vertices 
(black arrow). 
Chapter 4 
 
- 84 - 
 
 
Figure 4.2│Top: Synthetic scheme for the formation of a tetrahedral capsule from subcomponent 3.A and amino 
acids (glycine, alanine, valine, leucine, isoleucine and phenylalanine) through a) direct self-assembly or b) via 
preformation of the tri-imine followed by c) transfer into CH3CN and d) addition of Fe(NTf2)2. MM3-optimised 
model of the expected tetrahedral capsule. Bottom: 1H NMR spectra (400 MHz, 298 K, CD3CN (a, c, d) and 
CH2Cl2 (b)) of a) the attempted direct self-assembly of 3.A and phenylalanine methyl ester with Fe(NTf2)2, b) the 
tri-imine formed from 3.A and phenylalanine methyl ester, c) the tri-imine in CD3CN and d) the attempted self-
assembly from the preformed imine after addition of Fe(NTf2)2.  
 
To increase the distance between amino acid residues at the vertices, compounds 4.A – 4.E 
incorporating an aniline were synthesised following Scheme 4.1. The reaction of anilines 4.A 
– 4.E (12 eq.) with 3.A (4 eq.) and Fe(NTf2)2 (4 eq.) in CH3CN led to the formation of FeII4L4 
assemblies 4.1 – 4.5 respectively, after heating for 18 h at 50 °C under N2, as confirmed by 
ESI-MS. The 1H NMR spectra indicated the presence of two sets of signals, each corresponding 
to a highly symmetrical species in solution (Figure 4.3).  
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Scheme 4.1│General synthetic scheme for the synthesis of compounds 4.A – 4.E. 
 
Figure 4.3│a) Synthetic scheme for the formation of tetrahedral capsules 4.1 – 4.5 from subcomponents 3.A, 
anilines 4.A – 4.E (glycine, leucine, phenylalanine and tryptophan) and Fe(NTf2)2 in CH3CN. b) MM3-optimised 
model of tetrahedral capsule formed. c) Aromatic region of the 1H NMR spectra (400 MHz, 298 K, CD3CN) for  
4.1 – 4.5, d) zoom on the imine region of the 1H NMR spectra and e) 19F NMR spectra (376 MHz, 298 K, CD3CN) 
after addition of KTFA (1 eq.) zoomed in the region corresponding to TFA–⊂4.1 – 4.5. 
 
T-symmetric tetrahedra are the only observed symmetry for capsules formed from 3.A, for 
which the ΛΛΛΛ and the ΔΔΔΔ conformation of metal vertices are both present in solution as 
an enantiomeric pair. The splitting observed in the NMR was therefore attributed to the 
formation of diastereisomers (Δ-L and Λ-L) when the chiral aniline was incorporated in 
tetrahedral capsules. Interestingly, depending on the amino acid present on the aniline, the ratio 
of diastereoisomers observed was different (Figure 4.3 c, d) which was inferred to result from 
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the chiral aniline influencing the ratio of ΛΛΛΛ or ΔΔΔΔ isomer of the cage formed. 
Furthermore, upon addition of a fluorinated molecule which can act as a guest for 4.1 – 4.5, 
here TFA–, the signal for the guest was also observed to split (Figure 4.3 e), indicating that the 
chirality of the cage is felt by the guest within the cavity.  
The degree of chiral induction in 4.1 – 4.5 was further probed by circular dichroism (CD). The 
CD response was normalised by the concentration of the cages determined by UV-vis 
spectroscopy so that the response was directly proportional to the enantiomeric excess of the 
compound. Cage 4.1 made from the achiral aniline (glycine methyl ester) showed no CD signal 
whereas 4.2 – 4.5 showed signals of varying intensities (Figure 4.4 a).The bands in the 
500 – 650 nm are characteristic of the MLCT bands of the cages and therefore relate directly 
to the chirality of the metal vertices (Figure 4.4 b). The trend observed for the intensity of the 
CD signal was similar to that observed in the NMR, showing the greater chirality change 
induced by 4.D (L-tryptophan methyl ester) relative to 4.C (L-leucine methyl ester) and 4.B 
(L-phenylalanine methyl ester). Furthermore, the CD response observed for 4.D (L-tryptophan 
methyl ester) and 4.E (D-tryptophan methyl ester) was of opposite sign (Figure 4.4 c). Thus, 
when using amino-acids of opposite chirality induced opposite chiral enrichment of the cages. 
 
Figure 4.4│a) Circular dichroism (CD) spectra of cages 4.1 – 4.5. b) Zoom in the MLCT band of the CD spectra 
for 4.1 – 4.5 showing the range of induction on the cages by different amino acids. c) CD spectra of cages 4.1, 4.4 
and 4.5 showing the opposite response of 4.4 and 4.5. 
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4.3  Functionalisation of coordination cages with a peptide gelator 
Building on the possibility of appending amino acids onto cages via an aniline, it was 
hypothesised that short peptides could also be conjugated to cages using the same approach.  
Subcomponent 3.C ((p-aminobenzoyl)-L-Phe-D-Ala-L-Phe-NH2) introduced in Chapter Three 
was investigated for use as a subcomponent in self-assembly with 3.A. The reaction of 3.C (12 
eq.) with 3.A (4 eq.) and Fe(NTf2)2 (4 eq.) in CH3CN led to the formation of Fe
II
4L4 assemblies 
4.6, after heating for 18 h at 50 °C under N2, as confirmed by NMR and ESI-MS (Figure 4.5 a 
and Figure 4.43). Similarly to 4.1 – 4.5, the 1H NMR spectrum of 4.6 indicated the presence of 
two sets of signals, assigned to the diastereoisomers of the compound (Figure 4.5 c). The 
difference in intensity of these signals was attributed to chiral induction exerted on the cage as 
confirmed by circular dichroism (Figure 4.5 d, e). Due to the presence of residual TFA– with 
peptide 3.C, the cage was always obtained as the host-guest complex with one TFA– 
encapsulated in 4.6. For ease of notation, TFA–⊂4.6 will be simplified to 4.6. 
Based on the ability of 3.C to act as a low molecular weight gelator in CH3CN, the gelling of 
4.6 was tested at different concentrations. Cage 4.6 was obtained as a dark blue powder by 
precipitation of the cage from CH3CN with Et2O. The solid was dissolved at a known 
concentration in CH3CN. Gentle heating was used to solubilise the cage if needed. Sonication 
for 1 h was necessary to promote the formation of a gel. Visible aggregates were observed from 
2 mM. A final concentration above 5 mM was necessary to give a gel-like material which 
remained at the bottom of the sample tube (Figure 4.6).  
Characterisation of the material by cryo-TEM is currently under investigation in collaboration 
with Giorgio Divitini (Materials Science Department, University of Cambridge). The response 
of the material to stress is under investigation by the Marchesan group in Trieste. 
Preliminary TEM results indicated that the gel formed was sensitive to variations of its 
environment. We therefore hypothesised that the sol-gel transition could be triggered by an 
external stimulus leading to potential reversible process.  
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Figure 4.5│a) Synthetic scheme for the formation of tetrahedral capsule 4.6 from subcomponents 3.A, aniline 
3.C and Fe(NTf2)2 in CH3CN. b) MM3-optimised model of tetrahedral capsule 4.6 and a schematic representation 
of the cage. c) 1H NMR spectrum (400 MHz, 298 K, CD3CN) of 4.6. d) CD spectrum of cage 4.6. e) Zoom in the 
MLCT band of the CD spectrum for 4.6 showing the induction on the cages by 3.C. 
 
Figure 4.6│Gel formed from 4.6 at 5 mM in CH3CN after sonication for 1 h. 
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4.4  Probing the compatibility of photoacid generator and cages  
Based on the work by Li et al., MEH was chosen as a PAG based on its metastable character 
which leads to long lived forms of both the SP (spiropyran) and MEH (merocyanine) form. 
(E)-3-(2-(2-Hydroxystyryl)-3,3-dimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate MEH 
was synthesised by Shihao Zang in two steps following a literature procedure (Scheme 4.2).[10]  
 
Scheme 4.2│Synthetic scheme for the synthesis of MEH. 
 
Preliminary solution-phase experiments were conducted using cage 4.3 to verify the 
compatibility of the basic cage scaffold with the PAG. Both the UV-vis (Figure 4.7) and NMR 
spectra (Figure 4.8) of 4.3 and 4.6 were nearly identical, showing the similarity in the chemical 
properties of both cages. The structure of 4.3 is very similar to that of 4.6, with the two cages 
only differing by the two additional amino acids at the periphery of the structure (L-Phe-OMe 
vs L-Phe-D-Ala-L-Phe). We inferred that this difference would not influence the properties of 
the cage framework.  
 
Figure 4.7│a) UV-vis spectrum of 4.3 (green) and 4.6 (blue) showing the similarity between the two cages. The 
insert shows a zoom on the MLCT band of both cages. 
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Figure 4.8│Aromatic region of the 1H NMR spectrum (400 MHz, 298 K, CD3CN) of 4.6 (top) and TFA–⊂4.3 
(bottom) showing the similarity between the two cages. 
 
The PAG was more soluble in CH3CN/H2O mixtures than in pure CH3CN. However, cage 4.3 
was found to be unstable in the presence of as little as 5% H2O in CH3CN. Decomposition of 
the cage was evidenced by the release of aniline 4.C in solution (Figure 4.9). Furthermore the 
formation of the gel from 4.6 was unsuccessful in the presence of water (1% or more), even 
after increasing the concentration of cage to 30 mM. As a consequence, the system was limited 
to pure CH3CN as a solvent. 
 
Figure 4.9│a) 1H NMR spectrum (400 MHz, 298 K, CD3CN:D2O) of 4.3 in mixtures of CD3CN and D2O at 
different ratios (labelled on the left hand-side). The beige boxes highlight the peaks matching the free aniline 4.C. 
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In most reported cases, the PAG was studied in H2O,
[11-13] or mixtures of solvents (including 
H2O, CHCl3, CH3CN, CH3OH and HFIP).
[9, 14-15] Due to the lack of information on the PAG 
in CH3CN only, studies were carried out to establish its behaviour in this solvent. As previously 
reported, the solubility of this compound in CH3CN was very poor.
[16] The maximum solubility 
was determined by UV-vis spectroscopy. Solutions of MEH in CH3CN (13, 26, 33 and 39 µM) 
were prepared. The maximum absorbance at 425 nm were plotted against the concentrations, 
showing a linear relation. 
Using Beer-Lambert’s law, the molar attenuation coefficient for MEH was calculated: 
ɛ = A / l C  = 9802 M-1.cm-1 
A saturated solution of MEH in CH3CN was prepared by sonicating 5 mg of material in 2 mL 
of CH3CN for 1h. The sample was centrifuged and the supernatant was analysed by UV-vis 
spectroscopy, giving the absorbance at 425 nm A = 0.547. The maximum concentration of 
MEH in pure CH3CN was then given by:  
Cmax = A  / (ɛ l) = 55.8 µM 
Due to the poor solubility in CH3CN, 
1H NMR spectra of the PAG were acquired in DMSO-d6 
(Figure 4.10 a). The switching between MEH and SP happened within a few minutes of 
exposure to visible light and the reverse reaction happened within an hour in the dark. This 
observation is however only valid in DMSO as the rate of switching of MEH might differ 
between this solvent and CH3CN. 
Similarly to what was observed in water and solvent mixtures, switching from MEH to SP was 
observed in CH3CN upon irradiation with visible light, as evidenced using UV-visible 
spectroscopy (Figure 4.10 c). When dissolving MEH in CH3CN in the dark, a yellow solution 
was obtained. The UV-vis spectrum of MEH was dominated by a band at 425 nm. Upon 
irradiation for 5 min (blue LED, ν = 470 nm approx.), the PAG switched to the SP form, leading 
to the loss of colour of the solution. The band at 425 nm disappeared and was replaced by a 
band at 301 nm. No bands above 500 nm were observed, indicating the absence of the ME 
transition state and thus the protonation of the PAG (Figure 4.10 c). When isolated from light 
for 18 h, the metastable SP reverted to MEH near quantitatively, which could be observed both 
visually (yellow colour) and by UV-vis spectroscopy.  
The change in acidity was investigated in a mixture of CH3CN and H2O (95:5) as no values for 
the pH of the SP and MEH form can be obtained in pure CH3CN. As expected, the pHCH3CN/H2O 
(readout from a pH electrode in the solvent mixture) was dependent on the concentration of 
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PAG. A drop of pHCH3CN/H2O of 3.2 units caused by the conversion of MEH into SP was 
observed upon light irradiation (Figure 4.10 d). Zhang et al. reported that in organic solvents, 
the acidity of the PAG is comparable to that of CH3SO3H.
[16] Based on the literature and the 
results observed, we inferred that the change of acidity caused by the conversion of MEH to 
SP could be sufficient to impact the gel formation. 
 
Figure 4.10│a) Two forms of the PAG, the open ring form in darkness (MEH) and the closed ring form once 
exposed to visible light (SP). b) 1H NMR spectrum (400 MHz, 298 K, d6-DMSO) of MEH and SP. c) UV-vis 
spectra of MEH (yellow) and SP (red) in CH3CN, showing the typical absorbance bands at 425 nm for MEH and 
301 nm for SP. d) Plot of the pH as a function of the concentration in mM for MEH and SP. 
 
The transition from MEH to SP was fast and the irradiation with blue light for 5 min led to the 
complete conversion of this compound. On the other hand, the kinetic of the reverse process 
was slow. After irradiation of a 0.05 mM solution of MEH in CH3CN, UV-vis spectra were 
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acquired every 15 min for 14 h. The gradual increase of the band at 425 nm was indicative of 
the conversion of SP into MEH (Figure 4.11 a). Plotting the absorbance at 425 nm allowed us 
to access information on the kinetic of conversion of SP into MEH over time. Once fitted to 
an exponential decay, a tau value of τ = 2.87 ± 0.2 h was obtained (Figure 4.11 b). It is 
commonly accepted that after five tau, the function reaches a value less than 1% of its starting 
point and that therefore, the system has reached stability. In this case all of the SP was 
considered to have reverted to MEH after 14.5 h. 
 
Figure 4.11│a) UV-vis spectra of the PAG in CH3CN, taken every hour after irradiation of the compound. b) Plot 
of the absorbance at 425 nm as a function of time for the PAG in CH3CN along with the exponential fitting. 
 
The compatibility of cage 4.3 and the PAG was probed by NMR and UV-vis measurements. 
The excitation of the PAG was possible in the presence of the cage, due to the minimal overlap 
between the absorption bands of the cage (principally the MLCT) and that of the MEH (Figure 
4.12).  
 
Figure 4.12│UV-vis spectra of MEH (0.05 mM) in yellow and 4.3 (0.01 mM) in blue in CH3CN, showing the 
typical absorbance bands at 425 nm for MEH and 590 nm for 4.3. 
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Cage 4.3 (3.7 mg, 0.50 mmol) was dissolved in 0.5 mL of a saturated solution of the PAG in 
CD3CN ([4.3] = 1 mM and [PAG] = 0.05 mM). The sample was kept in the dark for 24 h and 
the 1H NMR spectrum of the mixture was recorded. After 5 min of irradiation with blue light, 
the 1H NMR spectrum of the mixture was acquired again. This cycle was repeated 4 times, 
showing no significant decomposition of the cage (Figure 4.13 b). No signal for the PAG was 
observed as the amount of material present was too small to detect by NMR.  
 
Figure 4.13│a) Composition of the system studied: the PAG (0.05 mM), with its open ring form in the dark 
(MEH) and its closed ring form once exposed to blue light (SP) and the cage 4.3 (1 mM). b) 1H NMR spectra 
(400 MHz, 298 K, CD3CN) of 4.3 and the PAG over 5 cycles alternating darkness and irradiation showing no 
degradation of 4.3. c) Zoom in the 6.8 – 6.5 ppm region of the 1H NMR spectrum (400 MHz, 298 K, CD3CN) 
showing the shift of the free aniline proton peak caused by the change of acidity. 
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The change of acidity induced by the presence of either MEH or SP could be observed via the 
shift of the peak at 6.6 ppm corresponding to a small amount of free aniline 4.C (Figure 4.13 c). 
This experiment showed that the cage framework was not affected by switching of the PAG 
and that the PAG could convert between the two forms in the presence of the cage (20 eq.). 
A solution of  PAG (0.05 mM) and 4.3 (0.01 mM) was used for UV-vis studies. It was necessary 
to limit the concentration of the cage due to its strong absorbance, leading to saturation of the 
UV-vis spectrometer detector. As in the NMR studies, the sample was kept in the dark for 24 h 
and the UV-vis spectrum of the mixture was recorded. After 5 min of irradiation with blue 
light, the UV-vis spectrum of the mixture was acquired again. The cycle was repeated 4 times. 
No changes in the intensity of the MLCT band at 590 nm were observed, indicating that the 
cage was stable in the presence of PAG (5 eq.), while the appearance and disappearance of the 
band at 420 nm confirmed that the PAG can switch in the presence of the cage (Figure 4.14). 
 
Figure 4.14│a) UV-vis spectra of the PAG (0.05 mM) and 4.3 (0.01 mM) in CH3CN over 5 cycles alternating 
darkness (MEH form) and irradiation (SP form) showing the absence of degradation of 4.3 (blue region) and the 
appearance and disappearance of the band for MEH (yellow region), evidencing the switching between forms. b) 
Photos of the solutions containing MEH and 4.3 in the dark (top) or SP and 4.3 after irradiation (bottom). 
Chapter 4 
 
- 96 - 
4.5  Light triggered sol-gel transition of 4.6 
Based on the results obtained in Section 4.4, it was inferred that the photoswitching of the PAG 
in the presence 4.6 should not be impaired and that 4.6 should be stable in the presence of the 
PAG.  
Cage 4.6 (9.2 mg, 0.93 mmol) was dissolved in a saturated solution of PAG (0.056 mM, 100 μl) 
in the dark. The sample was heated at 50 °C to promote the dissolution of the cage and sonicated 
for 1 h after which the mixture became viscous. The sample was left in the dark for 18 h after 
which the gel was formed. The formation of the gel was identified by an inversion test (no 
movement of the material when the tube was inverted 10 times). Upon exposure to blue light, 
the sample reverted to solution state within 2 min. After being kept in the dark for 5 h, the gel 
was formed again. This cycle was performed four times. Significant aggregates were observed 
in the solution phase, but these did not seem to impair the gel-sol-gel transition. The aggregates 
were inferred to result from undissolved cage at such high concentrations (10 mM).  
When a lower concentration of 4.6 was used (5 mM) with the same concentration of PAG 
(0.056 mM), the gel initially formed in the dark within 10 h. The gel-sol transition was achieved 
following 3 min of irradiation and the sol-gel transition happened after 1 h of darkness. The 
cycle was repeated three times, showing no significant aggregates (Figure 4.15).  
 
Figure 4.15│Gel-sol-gel transition of a solution of 4.6 (5 mM) and the PAG (0.056 mM) in CH3CN in the absence 
of light , after irradiation with blue light for 3 min and after being placed in the dark again for 1 h.  
 
Two solutions of 4.6 (5 mM) were prepared in CH3CN with (0.056 mM) or without PAG, 
sonicated for 1 h to promote formation of the gels and kept in the dark for 18 h. Both samples 
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were simultaneously irradiated with blue light for 10 min. No gel-sol transition was observed 
in the absence of the PAG, whereas gel-sol transition was observed within 3 min in the presence 
of the PAG (Figure 4.16). After being placed in the dark for 1 h, the sample underwent sol-gel 
transition. The gel was allowed to set for 18 h before starting the experiment again. Three more 
cycles were performed in the same conditions, giving the same outcome each time, ie. gel-sol 
transition of the sample containing PAG, and absence of changes in the samples without PAG. 
A video taken during the second cycle of gel-sol transitions can be found in the University 
repository. 
 
 
Figure 4.16│Solutions of 4.6 (5 mM) and MEH (0.056 mM) in CH3CN (left) and 4.6 (5 mM) in CH3CN (right) 
a) at the beginning of the irradiation with blue light and b) after 3 min of irradiation. 
 
 
4.6 Conclusions and future work 
In this chapter, we have demonstrated the bioconjugation of amino acids and peptides onto 
metal-organic supramolecular capsules and the changes of properties these can yield on the 
resulting compounds. High levels of steric hindrance around the vertices interfered with the 
coordination between the metal centres and the organic ligands formed by condensation 
between picolinaldehyde and the N-terminus of amino acids, thus preventing the direct 
assembly of cages from basic amino acids. Addition of a p-aminobenzoyl moiety coupled to 
the N-terminus of amino acids or peptide via an amide bond afforded the desired functionalised 
capsules. 
The properties of the biotag (amino acid or peptide) altered the properties of the cage obtained. 
The chirality of the tag influenced the ratio of the stereoisomers the cage formed, with the 
degree of induction varying depending on the tag used. When a short peptide gelator was used 
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to functionalise the cage, the properties of the latter were transferred onto the cage. At high 
concentration (5 mM and above), the bioconjugated cage formed a gel in acetonitrile.  
A spiropyran-based PAG was synthesised and its behaviour in acetonitrile was investigated. 
The presence of the cage did not impair the switching of the PAG. Furthermore, the cage was 
stable to the change in acidity triggered by light irradiation, as evidenced by 1H NMR and 
UV-vis experiments over 5 cycles of switching. When the PAG was added to a solution of the 
peptide-functionalised cage in the dark, a gel was formed. Upon irradiation with light, a gel-sol 
transition was achieved. The process was reversible, and multiple cycles of gelation and 
liquefaction were performed. 
Future work will focus on the use of this system for guest encapsulation and release, playing 
on the difference in kinetics of guest encapsulation in the gel and the solution state. Other 
potential work could involve the creation of a hydrogel based on a similar cage system in 
aqueous media by changing the peptide sequence and potentially the face-capping units. The 
light triggered reversible sol-gel transition of a cage based hydrogel could have potential 
applications in biomedical fields, for example in drug delivery. 
 
4.7 Experimental section 
4.7.1 Synthesis of anilines 4.A – 4.E 
General procedure for the synthesis of the methylated amino acid functionalised aniline 4.A 
– 4.E 
The amino acid methyl ester hydrochloride (2.00 mmol, 1.2 eq.), 4-nitrobenzoic acid (279 mg, 
1.67 mmol, 1.0 eq.), EDC.HCl (0.627 mg, 3.27 mmol, 2 eq.), DIPEA (0.886 mL, 5.10 mmol, 
3 eq.) and HOAt (23 mg, 0.17 mmol, 0.1 eq) were combined in THF (50 mL). The mixture 
were stirred at room temperature for 18 h. The solvents were removed under reduced pressure 
and the resulting materials were dissolved in DCM (50 mL). The solutions were washed with 
water (2 × 50 mL), saturated aqueous NH4Cl (2 × 50 mL) and saturated aqueous NaHCO3 
(2 × 50 mL). The organic phase was dried over MgSO4 and the solvents removed under reduced 
pressure. The resulting solids were purified by silica gel chromatography (DCM) giving the 
desired nitrophenyl compound as a yellow solid. The nitrophenyl compound obtained 
(1.30 mmol) were dissolved in CH3OH and Pd/C (50 mg) was added. The mixture was stirred 
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under an atmosphere of H2 for 3 h. The Pd/C was removed by filtration on celite and the 
solvents removed under reduced pressure to give the desired anilines as solids. 
 
Methyl (4-aminobenzoyl)glycinate 4.A  
Yield over two steps: 77% 
1H NMR (400 MHz, 298K, CD3OD) δ 7.62 (d, J = 8.6 Hz, 2H), 6.67 (d, J = 8.6 Hz, 2H), 4.07 
(s, 2H), 3.74 (s, 3H). 
 
Figure 4.17│1H NMR (400 MHz, 298K, CD3OD) of 4.A. 
This data was consistent with previously reported data.[17] 
 
Methyl (4-aminobenzoyl)leucinate 4.B  
Yield over two steps: 84% 
1H NMR (400 MHz, 298K, CDCl3) δ 7.64 (d, J = 8.5 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 6.41 
(bd, J = 8.3 Hz, 1H), 4.84 (td, J = 8.4, 4.8 Hz, 1H), 3.76 (s, 3H), 1.84 – 1.55 (m, 4H), 0.98 (t, 
J = 6.0 Hz, 6H). 
 
Figure 4.18│1H NMR (400 MHz, 298K, CDCl3) of 4.B. 
This data was consistent with previously reported data.[18]  
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Methyl (4-aminobenzoyl)phenylalaninate 4.C  
Yield over two steps: 89% 
1H NMR (400 MHz, 298K, CDCl3) δ 7.56 (d, J = 8.6 Hz, 2H), 7.32 – 7.20 (m, 3H), 7.17 – 7.04 
(m, 2H), 6.64 (d, J = 8.6 Hz, 2H), 6.40 (bd, J = 7.7 Hz, 1H), 5.14 – 4.93 (m, 1H), 3.95 (bs, 1H), 
3.74 (s, 3H), 3.36 – 3.13 (m, 2H). 
 
Figure 4.19│1H NMR (400 MHz, 298K, CDCl3) of 4.C. 
This data was consistent with previously reported data.[19]  
 
Methyl (4-aminobenzoyl)tryptophanate 4.D and 4.E 
4.D and 4.E are enantiomers and therefore have identical spectra. 
Only 4.D has been fully characterised. 
Yield over two steps: 82% (4.D) and 76% (4.E) 
1H NMR (400 MHz, 298K, CDCl3) δ 8.21 (s, 1H, Ha), 7.55 (d, 
J = 8.4 Hz, 1H, He), 7.51 (d, J = 8.6 Hz, 1H, Hq), 7.34 (d, J = 8.1 Hz, 
1H, Hh), 7.17 (t, J = 7.5 Hz, 1H, Hf), 7.07 (t, J = 7.5 Hz, 1H, Hg), 
6.99 (d, J = 2.4 Hz, 1H, Hb), 6.58 (d, J = 8.6 Hz, 2H, Hr), 6.52 (d, J = 7.7 Hz, 1H, Hn), 
5.17 – 5.08 (m, 1H, Hk), 3.95 (bs, 2H, Ht), 3.70 (s, 3H, Hm), 3.42 (d, J = 5.2 Hz, 2H, Hj). 
13C NMR (101 MHz, 298K, CDCl3) δ 172.3, 166.3, 149.4, 135.8, 128.6, 127.3, 123.0, 122.5, 
121.9, 119.3, 118.4, 113.7, 110.9, 109.9, 52.9, 52.0, 27.4. HRMS: m/z calculated for 
[4.D + Na+] = 360.1324, observed = 360.1292 and for [4.D.HCl] = 373.1193, 
observed = 373.1159 
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Figure 4.20│13C NMR (101 MHz, 298K, CDCl3) of 4.D. 
 
 
Figure 4.21│1H NMR (400 MHz, 298K, CDCl3) of 4.E (top) and 4.D (bottom).The small difference in chemical 
shift for the indole and imine protons of the two compounds was attributed to small changes in water content. 
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Figure 4.22│1H-1H COSY spectrum (400 MHz, 298 K, CDCl3) of 4.D. 
 
Figure 4.23│1H-13C HSQC spectrum (400 MHz, 298 K, CDCl3) of 4.D. 
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4.7.2 Synthesis of PAG  
MEH was synthesized from an adapted literature procedure.[10] 
3-(2,3,3-trimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate 4.F.  
1,3-propane sultone (1.26 g, 10.0 mmol, 1 eq.) was combined with 2,3,3-
trimethylindolenine (1.65 g, 10.0 mmol, 1 eq.) in a round bottom flask under 
N2. The mixture was heated at 90 °C for 4 h. After cooling to room temperature, 
the solid was isolated by filtration, washed with Et2O and dried under vacuum 
to give 3-(2,3,3-trimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate as a purple 
glass-like solid (2.52 g, 9.0 mmol, η = 86.5%). The obtained compound was used without 
further purification. 
1H NMR (400 MHz, 298K, D2O) δ 7.72 (t, J = 6.6, 1H), 7.63 (t, J = 5.8, 1H), 7.56 – 7.49 (m, 
2H), 4.54 (t, J = 7.5, 2H), 3.00 (t, J = 7.5, 2H), 2.35 – 2.21 (m, 2H), 1.46 (s, 6H). 
 
Figure 4.24│1H NMR (400 MHz, 298K, D2O) of 4.F. 
 
(E)-3-(2-(2-hydroxystyryl)-3,3-dimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate MEH.  
3-(2,3,3-trimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate (504 mg, 
1.8 mmol, 1 eq.) was dissolved in 10 mL of EtOH. 2-
Hydroxybenzaldehyde (210 μL, 1.95 mmol, 1.1 eq.) was added to the 
solution and the mixture was refluxed for 18 h under N2. After cooling 
to room temperature, the solid was isolated by filtration, washed with 
Et2O and dried under vacuum to give SP as an orange solid (0.34 g, 0.88 mmol, η = 49 %). 
1H NMR (400 MHz, 298K, DMSO-d6) δ 11.08 (s, 1H), 8.60 (d, J = 16.3 Hz, 1H), 8.26 (d, 
J = 7.4 Hz, 1H), 8.01 (d, J = 7.4 Hz, 1H), 7.91 – 7.80 (m, 2H), 7.67 – 7.57 (m, 2H), 7.47 (t, 
J = 7.9, 1H), 7.06 – 6.92 (m, 2H), 4.79 (t, J = 7.9 Hz, 2H), 2.66 (t, J = 7.1, 2H), 2.21 – 2.14 (m, 
2H), 1.77 (s, 6H). 
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Figure 4.25│1H NMR (400 MHz, 298K, DMSO-d6) of MEH. 
This data was consistent with previously reported data.[10] 
 
4.7.3 Synthesis and characterisation of cages 4.1 – 4.6 
General procedure for the synthesis of cages 4.1 – 4.6. 
5,5',5''-(benzene-1,3,5-triyl)tripicolinaldehyde 3.A (3.6 mg, 0.0092 mmol, 1.0 eq.) and aniline 
4.A − 4.E  or 3.C (0.0275 mmol, 3.0 eq.) were dissolved in 2.0 mL of CH3CN in a sealed 5 mL 
schlenk flask. Oxygen was removed by freeze-pumped-thawing with N2 three times after which 
Fe(NTf2)2 (6.3 mg, 0.0023 mmol, 1.0 eq.) was added. The solution was freeze-pumped-thawed 
an additional two times. The solution was heated at 50 °C for 18 h. The dark blue solution was 
then cooled and concentrated under a flow of nitrogen. Addition of 30 mL of diethyl ether 
precipitated the compound into a dark blue solid. The solid was separated by centrifugation 
and washed with diethyl ether (2 × 30 mL). The solid was then dried under a flow of nitrogen. 
 
Cage 4.1 
1H NMR (400 MHz, 298K, CD3CN) δ 9.11 (s, 12H, He), 8.93 
(d, J = 8.4 Hz, 12H, Hd), 8.61 (d, J = 8.4 Hz, 12H, Hc), 7.83 
(d, J = 8.3 Hz, 24H, Hg), 7.55 (bt, J = 5.7 Hz, 12H, Hh), 7.49 
(s, 12H, Ha), 7.21 (s, 12H, Hb), 5.68 (d, J = 8.3 Hz, 24H, Hf), 
4.15 (d, J = 6.1 Hz, 24H, Hi), 3.74 (s, 36H, Hj). 
13C NMR 
(126 MHz, 298K, CD3CN) δ 176.8, 171.3, 166.8, 159.5, 
153.4, 152.7, 138.9, 137.5, 136.9, 135.4, 133.9, 129.8, 127.0, 
122.7, 122.0, 52.8, 42.2. LR-ESI-MS: [charge, calculated 
mass]: m/z = 1238.5 [4.1Cl(NTf2)3
4+, 1238.5], 934.9 
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[4.1Cl(NTf2)2
5+, 934.8], 732.4 [4.1Cl(NTf2)
6+, 732.3], 587.7[4.1Cl7+, 587.7]. Note: The cage 
picked up a Cl– anion, probably due to the mass spectrometer being dirty. HR-ESI-MS: m/z 
calculated for 4.1(NTf2)3
5+ = 938.9697, observed = 938.9693. 
 
Figure 4.26│1H NMR (400 MHz, 298K, CD3CN) of 4.1. 
 
Figure 4.27│13C NMR (126 MHz, 298K, CD3CN) of 4.1. 
 
Figure 4.28│1H-13C HSQC spectrum (500 MHz, 298 K, CD3CN) of 4.1. 
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Cage 4.2 
1H NMR (400 MHz, 298K, CD3CN) δ 9.10 (s, 12H, He), 
9.10 (s, 12H, He), 8.94 (d, J = 8.4 Hz, 24H, Hd), 8.61 (d, 
J = 8.4 Hz, 24H, Hc), 7.87 – 7.76 (m, 48H, Hg), 7.50 (s, 
24H, Ha), 7.41 – 7.34 (m, 24H, Hb), 7.19 (bs, 24H, Hh), 
5.71 – 5.59 (m, 48H, Hf), 4.73 – 4.68 (m, 24H, Hi), 3.73 (s, 
36H, Hm), 3.72 (s, 36H, Hm), 1.88 – 1.67 (m, 72H, Hk,j), 
1.00 (ddd, J = 9.5, 6.1, 3.3 Hz, 144H, Hl). 
13C NMR 
(126 MHz, 298K, CD3CN) δ 176.8, 174.1, 166.7, 159.5, 
153.3, 152.8, 138.9, 137.5, 136.9, 135.5, 133.8, 130.0, 
127.0, 122.6, 122.1, 53.3 – 51.8 (m), 40.9, 25.8, 23.2, 21.8. 
LR-ESI-MS: [charge, calculated mass]: m/z = 1468.2 [4.2(NTf2)4
4+, 1467.9], 1118.6 
[4.2(NTf2)3
5+, 1118.3], 885.4 [4.2(NTf2)2
6+, 885.3], 718.8 [4.2(NTf2)
7+, 718.8]. HR-ESI-MS: 
m/z calculated for 4.2(NTf2)4
4+ = 1467.3746, observed = 1467.3689. 
 
 
Figure 4.29│1H NMR (400 MHz, 298K, CD3CN) of 4.2. 
 
 
Figure 4.30│13C NMR (126 MHz, 298K, CD3CN) of 4.2. 
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Figure 4.31│1H-13C HSQC spectrum (500 MHz, 298 K, CD3CN) of 4.2. 
 
Cage 4.3 
1H NMR (400 MHz, 298K, CD3CN) δ 9.07 (s, 12H, He), 
9.04 (s, 12H, He), 8.91 (d, J = 4.2 Hz, 12H, Hd), 8.89 (d, 
J = 4.3 Hz, 12H, Hd), 8.58 (d, J = 8.4 Hz, 24H, Hc), 
7.75 – 7.67 (m, 48H, Hg), 7.47 (d, J = 2.4 Hz, 24H, Hh), 
7.44 – 7.14 (m, 180H, Ha,b,k,l,m), 5.58 (d, J = 8.1 Hz, 48H, 
Hf), 5.01 – 4.85 (m, 24H, Hi), 3.73 (s, 72H, Hn), 3.41 – 3.10 
(m, 48H, Hj). 
13C NMR (126 MHz, 298K, CD3CN) 
δ 176.7, 172.9, 166.4, 159.4, 153.3, 152.8, 139.0, 138.1, 
137.4, 136.8, 135.4, 133.8, 130.3, 129.9, 129.5, 127.9, 
127.0, 122.6, 122.1, 55.4, 53.0, 38.0. LR-ESI-MS: 
[charge, calculated mass]: m/z = 1570.3 [4.3(NTf2)4
4+, 1569.9], 1200.2 [4.3(NTf2)3
5+, 1199.9], 
953.5 [4.3(NTf2)2
6+, 953.3], 777.2 [4.3(NTf2)
7+, 777.1]. HR-ESI-MS: m/z calculated for 
4.3(NTf2)3
5+ = 1200.0794, observed = 1200.0829. 
Chapter 4 
 
- 108 - 
 
Figure 4.32│1H NMR (400 MHz, 298K, CD3CN) of 4.3. 
 
Figure 4.33│13C NMR (126 MHz, 298K, CD3CN) of 4.3. 
 
Figure 4.34│1H-13C HSQC spectrum (500 MHz, 298 K, CD3CN) of 4.3. 
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Cage 4.4 
1H NMR (400 MHz, 298K, CD3CN) δ 9.48 (s, 12H, Hl), 
9.41 (s, 12H, Hl), 9.04 (s, 12H, He), 9.01 (s, 12H, He), 8.94 
– 8.83 (m, 24H, Hd), 8.63 – 8.52 (m, 24H, Hc), 7.67 (d, 
J = 8.3 Hz, 24H, Hg), 7.61 (d, J = 7.9 Hz, 24H, Hp), 
7.50 – 7.29 (m, 84H, Ha,b,h,k,m,n,o), 7.22 – 6.98 (m, 84H, 
Ha,b,h,k,m,n,o), 5.63 – 5.42 (m, 48H, Hf), 5.27 – 4.89 (m, 24H, 
Hi), 3.74 (s, 36H, Hq), 3.73 (s, 36H, Hq), 3.56 – 3.32 (m, 
48H, Hj). 
13C NMR (126 MHz, 298K, CD3CN) δ 176.7, 
173.3, 166.6, 159.4, 153.2, 152.8, 138.9, 137.5, 136.8, 
135.4, 133.8, 129.8, 128.4, 127.0, 124.8, 122.6, 122.1, 
120.1, 119.2, 112.6, 110.9, 110.7, 55.0, 53.1, 28.0. 
LR-ESI-MS: [charge, calculated mass]: m/z = 1687.6 [4.4(NTf2)4
4+, 1687.0], 1293.9 
[4.4(NTf2)3
5+, 1293.7], 1031.6 [4.4(NTf2)2
6+, 1031.4], 844.2 [4.4(NTf2)
7+, 844.1], 703.6 [4.48+, 
703.6]. HR-ESI-MS: m/z calculated for 4.4(NTf2)3
5+ = 1293.7062, observed = 1293.7058. 
 
Figure 4.35│1H NMR (400 MHz, 298K, CD3CN) of 4.4. 
 
Figure 4.36│13C NMR (126 MHz, 298K, CD3CN) of 4.4. 
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Figure 4.37│1H-13C HSQC spectrum (500 MHz, 298 K, CD3CN) of 4.4. 
 
Cage 4.5 
The spectra were identical to 4.4. 
 
Cage 4.6 
1H NMR (400 MHz, 298K, CD3CN) δ 8.92 (s, 12H, 
He), 8.87 (s, 12H, He), 8.77 (d, J = 8.3 Hz, 12H, Hd), 
8.72 (d, J = 8.3 Hz, 12H, Hd), 8.48 – 8.41 (m, 24H, 
Hc), 8.29 (s, 24H, Hh), 7.73 (d, J = 8.1 Hz, 24H, Hg), 
7.68 (bd, 24H, Hg), 7.49 – 6.94 (m, 240H, 
Ha,b,k,l,m,n,q,t,u,v), 6.69 (bs, 48H, Hw), 5.50 (bd, 48H, 
Hf), 4.77 – 4.66 (m, 24H, Hi), 4.52 (bs, 24H, Hr), 
4.25 – 4.10 (m, 24H, Ho), 3.29 – 2.94 (m, 96H, Hj,s), 
1.06 (d, J = 6.9 Hz, 36H, Hp), 1.01 (d, J = 6.9 Hz, 
36H, Hp). 
13C NMR (126 MHz, 298K, CD3CN) 
δ 175.3, 174.3, 172.5, 172.2, 166.2, 157.3, 153.6, 
152.4, 137.7, 137.2, 135.5, 135.0, 134.2, 131.9, 
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129.4, 129.3, 128.4, 128.4, 126.8, 126.6, 123.7, 121.5, 121.1, 55.9, 54.6, 49.6, 37.0, 36.9, 
16.5.19F NMR (376 MHz, 298K, CD3CN) δ –79.52, –79.55, –80.29. LR-ESI-MS [charge, 
calculated mass]: m/z = 1654.8 [4.6(TFA)(NTf2)2
5+, 1654.4], 1621.4 [4.6(TFA)2(NTf2)
5+, 
1621.0], 1587.8 [4.6(TFA)3
5+, 1587.6], 1332.0 [4.6(TFA)(NTf2)
6+, 1332.0], 1304.1 
[4.6(TFA)2
6+, 1304.18], 1101.9 [4.6(TFA)7+, 1101.7], 949.4 [4.68+, 949.9]. HR-ESI-MS: m/z 
calculated for 4.6(TFA)(NTf2)2
5+= 1654.5494, observed = 1654.5491. 
 
 
Figure 4.38│1H NMR (400 MHz, 298K, CD3CN) of 4.6. 
 
 
Figure 4.39│13C NMR (126 MHz, 298K, CD3CN) of 4.6. Low concentrations were required to avoid aggregation 
and subsequent gelation of the compound, resulting in low quality of the 13C spectrum. 
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Figure 4.40│1H-1H COSY spectrum (500 MHz, 298 K, CD3CN) of 4.6 
 
 
Figure 4.41│1H-1H NOESY spectrum (500 MHz, 298 K, CD3CN) of 4.6 
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Figure 4.42│1H-13C HSQC spectrum (500 MHz, 298 K, CD3CN) of 4.6 
 
 
Figure 4.43│HR ESI-MS mass spectrum of 4.6 showing the observed z = +6 charge, (bottom left) compared to 
the theoretical isotope pattern (top left) and the observed z = +5 charge, (bottom right) compared to the theoretical 
isotope pattern (top right). 
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5.1  Introduction 
Current work in drug-delivery focuses on improving treatments by increasing both the drug 
uptake in cells and the retention time of the drug in the body. Achieving targeted delivery of 
drug payload represents the next major step towards new medical treatments with higher 
potency and overall lower toxicity towards healthy cells. To do so, the main strategy relies on 
appending cell-targeting or cell-translocating groups, like cyclic-RGD (cyclic peptides 
containing the sequence Arg-Gly-Asp) for example, on the drug delivery vehicle to increase 
its accumulation in the targeted organs or cells. So far, only a few examples of bioconjugated 
coordination cages are reported, despite the advantages they could present in applications such 
as drug delivery (see Chapter 1, sections 1.2.4 and 1.3.3). Amongst those, only one recent 
example was used for drug delivery, and demonstrated only a small enhancement in activity of 
the encapsulated drug.[1]  
The asialoglycoprotein receptor (ASGPR) is a lectin (carbohydrate binding) transmembrane 
protein expressed exclusively at the surface of hepatocytes and is involved in the regulation of 
glycoproteins in the blood. The receptor binds specifically to molecules that contain terminal 
galactose or N-acetylgalactosamine residues, leading to their internalization and subsequent 
removal from blood circulation. Once bound to ASGPR, very large molecules can be 
internalized in the cells via endocytosis. Furthermore, good selectivity can be achieved by 
targeting this receptor, as high numbers are found on the surface of liver cells 
(500,000 ASGPR/hepatocyte) but it is minimally expressed in the rest of the body.[2]  
The spatial geometry of the ligands is crucial in the binding process to ASGPR, with naturally 
occurring highly branched carbohydrates polymers or glycoprotein and glycopeptides being 
particularly successful.[3] Over the years, synthetic multivalent ligands with differing 
branching, hydrophobicity, spatial arrangement and terminating sugars have been screened for 
binding to the receptor.[4] The most successful binders were shown to result from a symmetric 
triangular arrangement of N-acetylgalactosamine (GalNAc) held 19 Å to 32 Å apart (Figure 
5.1 a and b). 
Scrutiny of fac-complexes formed by an octahedral metal and three bidentate pyridyl-imine 
ligands showed that substituents at the 5-position on the pyridine ring (Figure 5.1 c, green 
spheres) are placed in a triangular geometry. It was hypothesized that using a picolinaldehyde 
biotagged with GalNAc as a building block in the self-assembly of tetrahedra displaying 
fac-vertices would result in coordination cages able to bind selectively to ASGPR.  
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Figure 5.1│a) Cartoon representation of ASGPR receptor depicting the transmembrane domain (blue) to which 
three carbohydrate recognition sites (gold) are connected and b) the resulting geometry of the binding sites of 
ASGPR, with the distance between site varying from 19 to 32 Å. c) Cartoon representation of the crystal structure 
of a fac metal complex from an octahedral metal and three bidentate ligands, showing the triangular arrangement 
of the groups at the 5-position of the pyridine. The scale is different between a) and c). Figure a) adapted with 
permission from reference 4. 
 
In this chapter, a new strategy to attach targeting unit on coordination cages was explored, 
using the versatility of sub-components self-assembly. A picolinaldehyde bioconjugated to a 
GalNAc was synthesized and incorporated in water-soluble tetrahedral cages. Similarly, a 
fluorescent dye was conjugated to a picolinaldehyde and incorporated in the coordination cage 
tagged with GalNAcs. The stability of the cages in water and buffer was tested, showing 
stability in PBS down to micromolar concentrations. The binding of the coordination cages to 
hepatocytes via the ASGPR will be tested next.  
 
5.2  Synthesis and design of subcomponents 
5.2.1 Synthesis of the GalNAc biotag 
As mentioned above, previous design of ligands for ASGPR binding identified molecules with 
19 – 32 Å spacing between the sugars as being most efficient.[4] For a triangular arrangement, 
this spacing can be obtained by linkers ranging from 12 to 20 Å (measured between the C-1 of 
the sugar and the connection point of the three arms). Based on these considerations, target 5.J 
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was designed, comprising of a GalNAc for binding to the ASGPR, a 19 Å hydrophobic linker 
and a picolinaldehyde moiety for cage assembly (Figure 5.2). 
 
Figure 5.2│a) Synthetic target 5.J and b) MM3-optimised model of 5.J 
 
Compound 5.F was prepared by a synthesis adapted from an existing patent (Scheme 5.1).[5] 
D-galactosamine pentaacetate 5.A was obtained by reaction of D-galactosamine with acetic 
anhydride in anhydrous pyridine. The hydrolysis of δ-valerolactone in the presence of sodium 
hydroxide yielded compound 5.B. The reaction of benzyl bromide with 5.B in acetone in the 
presence of a phase-transfer catalyst (TBABr) yielded multiple products, which could be 
isolated by silica gel chromatography. The various products were identified by NMR and 
LCMS to be the result of the polymerisation of 5.B and 5.C (up to 4-mer). Despite attempts to 
alter the reaction conditions, no conditions could be found, which decreased the amount of 
polymers, leading to low yield in this step. The reaction of 5.C and 5.A in the presence of 
Sc(OTf)3 proved to have a high anomeric selectivity, forming 95% of the 
β-D-galactopyranoside. However, polymerisation of the benzyl 5-hydroxypentanoate linker 
5.C was observed once more, leading to a library of sugars functionalised with side chains 
containing up to six linkers. The desired compound 5.D was isolated by preparative HPLC in 
low yield. Subsequent deprotection of the carboxylic acid followed by deacetylation of the 
sugar gave compound 5.F in near quantitative yield.  
The reaction of 2-bromoacetic acid with tert-butyl (2-aminoethyl)carbamate in basic media 
yielded compound 5.G. Compound 5.H was obtained by nucleophilic substitution of the 
commercial 5-hydroxypicolinaldehyde with 5.G. Removal of the Boc protecting group with 
HCl (4 M) in dioxane  yielded the target compound 5.I (Scheme 5.1). Finally, amide coupling 
between 5.I and 5.F in the presence of HBTU and DIPEA gave the desired target 5.J in near 
quantitative yield (Scheme 5.3). 
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Scheme 5.1│Synthetic scheme for 5.F. 
 
 
Scheme 5.2│Synthetic scheme for 5.I. 
 
 
Scheme 5.3│Synthetic scheme for the final target compound 5.J. 
 
5.2.2 Synthesis of the fluorescent tag 
Most supramolecular architectures obtained in the Nitschke group have no fluorescent 
properties, and those which do could not be transferred into water successfully. Consequently, 
a novel fluorescent tag was designed for appendage to the cage. The autofluorescence of human 
hepatocytes (HepG2) in the green region of the spectrum[6] prevents the use of common 
fluorophores such as fluorescein, Lucifer yellow or BODIPY.[7] The use of the popular 
commercial dye Alexa FluorTM 647[8] was limited due to its high price, challenging synthesis 
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and high negative charge of three which could reduce the cage’s solubility by lowering the 
overall charge of the structure. The less common cyanine dyes with five and seven carbon 
atoms between the indole moieties (Cy5 and Cy7) have emission wavelengths of 670 nm and 
767 nm respectively and a positive charge which can contribute to the solubility of the cages. 
However, we expect these compounds to be poorly soluble in water and therefore unsuitable 
for our system. 
 
Figure 5.3│Structure of fluorescent dyes and their emission wavelength in water. 
 
Recently, an alternative fluorescent dye (5.L) based on the cyanine structure was developed.[9] 
This new compound has a sulfonated chain instead of the methyl on the indole, which increases 
its water solubility. Dye 5.L was synthesised from an adapted literature procedure (Scheme 
5.4).[10] The synthetic target 5.M was designed based on the same principle as 5.J, comprising 
of both a picolinaldehyde for attachment to the cage and the fluorescent dye 5.L. 
The fluorescence spectrum of 5.M confirmed that the addition of a pyridine moiety did not 
quench the fluorescence. The compound formed appeared to be suitable for use in cell studies 
as both the maximum emission wavelength (671 nm) and maximum excitation (659 nm) in 
water were out of the green channel (Figure 5.4 a). The additional band at 580 nm in the 
excitation spectra was inferred to result from aggregation due to the low solubility of the 
compound in water.  
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Scheme 5.4│a) Synthetic scheme for the alternative fluorescent dye 5.L and synthetic target 5.M. 
 
 
Figure 5.4│a) Fluorescence spectra of 5.M (excitation in black and emission in blue). b) Structure and schematic 
representation of 5.M. 
 
5.3  Formation of supramolecular coordination cages and stability 
in biological media 
To be suitable for cell studies, the coordination cages employed need to be both soluble and 
stable in water. In addition, metals such as CoII or CdII could not be used due to their toxicity 
and FeII was thus favoured. Three trianilines known to readily form cages in water when 
assembled with picolinaldehyde and FeSO4 were tested for self-assembly with 5.J. Neither 3.B 
nor the pararosaniline base assembled into a discrete tetrahedral cage when combined with 5.J, 
with the unreacted subcomponents being the main species observed in the 1H NMR spectra of 
the crude reaction mixture.  
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Figure 5.5│a) Subcomponent self-assembly from i) 5.J (12 eq.), pararosaniline base (4 eq.) or 3.B (4 eq.), FeSO4 
(4 eq.) and NaReO4 (1 eq.) in D2O giving mainly subcomponents, ii) 5.J (12 eq.), 5.N (4 eq.), FeSO4 (4 eq.) and 
NaReO4 (1 eq.) in D2O giving ReO4– ⊂ 5.1 and iii) picolinaldehyde (12 eq.), 5.N (4 eq.), FeSO4 (4 eq.) and NaReO4 
(1 eq.) giving ReO4– ⊂ 5.2 b) MM3-optimised model of ReO4– ⊂ 5.1. The encapsulated ReO4– was omitted for 
clarity. 
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When 5.J (12 eq.) was combined with 5.N (4 eq.), FeSO4 (4 eq.) and NaReO4 (1 eq.) in D2O at 
room temperature for 18 h, ReO4
–⊂5.1 was formed as a discrete species in solution (Figure 5.5 
a). The 1H NMR was similar to the previously reported FeII4L4 tetrahedral cage ReO4
–⊂5.2, 
formed with picolinaldehyde under the same conditions (Figure 5.6).[11] HSQC NMR showed 
the absence of signals matching with aldehyde protons and the presence of a signal matching 
with an imine proton, indicative of the condensation of 5.J and 5.N. No mass spectra 
confirming the stoichiometry of cage ReO4
–⊂5.1 were obtained, a recurring issue with this type 
of water soluble coordination cages.[12] MM3-optimised model showed that the FeII4L4 
tetrahedral cage ReO4
–⊂5.1 could form as expected with no significant strain (Figure 5.5 b).  
 
Figure 5.6│1H NMR spectra (500 MHz, 298K, D2O) of a) ReO4– ⊂ 5.1 with assignment and b) ReO4– ⊂ 5.2, 
showing the similarity between the two complexes. 
 
When the self-assembly was carried in the presence of PF6
− and NTf2
− as templates instead of 
ReO4
−, signals for the encapsulated anions in slow exchange on the NMR time scale were 
observed in the 19F NMR. Free NTf2
− was also observed due to its presence in excess and its 
lower binding affinity than PF6
−. 1H NMR revealed the presence of two cage species, attributed 
to NTf2
−⊂5.1 and PF6−⊂5.1. Both 19F and 1H NMR spectra were consistent with those observed 
for NTf2
−⊂5.2 and PF6−⊂5.2 in the literature.[11]  This was indicative of the formation of a cage 
with a cavity of the appropriate size to encapsulate these anions, likely similar to the FeII4L4 
tetrahedron 5.2 previously reported.  
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Figure 5.7│a) 1H NMR spectrum (400 MHz, 298 K,  D2O) of NTf2− ⊂ 5.1 (red dots) and PF6− ⊂ 5.1 (blue dots) 
and b) 19F NMR spectrum (376 MHz, 298 K,  D2O) of NTf2− ⊂ 5.1 (red dots) and PF6− ⊂ 5.1 (blue dots), showing 
the encapsulated PF6– and encapsulated NTf2– as well as some free NTf2– signals. 
 
Diffusion ordered spectroscopy (DOSY) was further used to probe the formation of a large 
supramolecular assembly. Proton signals for the pyridine, the aniline, the azaphosphatrane 
moiety, the GalNAc and the linkers were observed to diffuse at the same speed (Figure 5.8). 
The diffusion coefficient found for ReO4
– ⊂ 5.1 was D = 1.10 × 10–6 cm2 s–1 from which the 
radius of the cage was calculated using the Stokes-Einstein equation (Equation 5.1). 
Equation 5.1   𝑟 =
𝑘𝐵𝑇
6𝜋𝜂𝐷
=
1.38×10−23×298
6𝜋∗8.9×10−4×1.10×10−10
= 2.23 × 10−9𝑚 
 
Measures on the MM3-optimized model gave an approximate radius of 12 Å for the core of 
the cage (excluding the GalNAc arms), and an overall radius of 20 – 25 Å including the arms, 
which is in accordance with the value from the DOSY experiment.  
Chapter 5 
 
- 125 - 
 
Figure 5.8│DOSY of ReO4–⊂5.1 with coloured peaks corresponding to the aniline and azaphosphatrane 5.N 
(green), pyridine 5.J (red), GalNAc 5.J (blue), and linkers 5.J (yellow). The scatter of the signals was attributed 
to the overlapping signals and the non-ideal shape of the peaks and baseline. 
 
The formation of ReO4
–⊂5.1 was observed to be concentration dependent, with increasing 
amounts of unreacted subcomponents observed when concentrations of ReO4
–⊂5.1 below 
1 mM were tested. This effect was explained by the hydrophilicity of subcomponents 5.J and 
5.N as well as the higher propensity of imine hydrolysis in water. In light of these results, the 
stability of ReO4
–⊂5.1 was tested at low concentrations by UV-vis studies. After formation of 
cage ReO4
–⊂5.1 (2.5 mM), the solution was diluted with water to either 1, 10 or 100 μM and 
the changes in the MLCT band of cage ReO4
–⊂5.1 (maximum absorbance at 546 nm) were 
monitored over time. 
The intensity of the MLCT band decreased over time in all three cases. By normalising the data 
to unity at t = 0, and under the assumption that once completely decomposed no signal for the 
MLCT band remained, the relative intensity of the band was assumed to be proportional to the 
amount of ReO4
–⊂5.1 present in solution. After an initial fast decomposition, the 
decomposition of cage ReO4
–⊂5.1 as a function of time was linear. After 14 h, 57% of cage 
remained for the sample which started at 1 μM, 81% for 10 μM and 90% for 100 μM, showing 
reasonable stability of cage ReO4
–⊂5.1 above 10 μM.  
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Figure 5.9│UV-vis spectra in the 400 – 700 nm region corresponding to the MLCT of ReO4–⊂5.1 at 10 uM, 
showing the changes of the MLCT band over time (one spectrum every hour). b) Plot of the normalised intensity 
at 546 nm over time for starting concentrations of ReO4–⊂5.1 of 1 μM (blue squares), 10 μM (green circles) and 
100 μM (red triangles). 
 
Discrete self-assembled complexes were obtained when 5.J (10 eq.), 5.M (2 eq.), 5.N (4 eq.), 
FeSO4 (4 eq.) and NaReO4 (1 eq.) were combined in D2O/CD3CN (5:1) for 18 h, followed by 
evaporation of the CD3CN (Figure 5.10 a). The formation of a library of cages incorporating 
varying numbers of 5.M was expected in this case. For ease of notation, this library will be 
denoted ReO4
–⊂5.3. The 1H NMR (Figure 5.10 b) and DOSY (Figure 5.11) of the mixture 
revealed the presence of both GalNAc and dye residues on the coordination cages and they 
were very similar to the spectra obtained for ReO4
–⊂5.1. The estimated radius of cages 
ReO4
–
 ⊂5.3 from DOSY was 20.8 Å (D = 1.18 × 10–6 cm2 s–1), which is similar to the value 
obtained for ReO4
–⊂5.1 previously.  
The theoretical amount of 5.M incorporated into cages ReO4
–⊂5.3 was estimated by the 
probability mass function (Equation 5.2). 
Equation 5.2   𝑷 (𝑿 = 𝒌) = (𝒏
𝒌
)𝒑𝒌(𝟏 − 𝒑)(𝒏−𝒌) 
 
With 0 < k < 12, p = 1/6 and n = 12. The calculations indicated that more than 87% of all cages 
formed have fewer than 3 dyes incorporated (Figure 5.12), limiting the probability of self-
quenching as well as the chances of having no metal vertices where three GalNAc are attached.  
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Figure 5.10│a) Subcomponent self-assembly of ReO4–⊂5.3 from 5.J (10 eq.), 5.M (2 eq.), 5.N (4 eq.), FeSO4 (4 
eq.) and NaReO4 (1 eq.) in D2O/CH3CN (5:1). b) 1H NMR (500 MHz, 298 K,  D2O) of ReO4–⊂5.3 with the signals 
for the dye highlighted in blue.  
 
 
Figure 5.11│a) DOSY spectrum of ReO4–⊂5.3 and b) expansion of the aromatic region showing the signals for 
the dye (blue). The scatter of the signals was attributed to the overlapping signals and the non-ideal shape of the 
peaks and baseline. 
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Figure 5.12│Expected distribution of cages ReO4–⊂5.3 as a function of the number of 5.M incorporated in each 
cage.  
 
The UV-vis spectrum of ReO4
–⊂5.3 displayed signals corresponding to an MLCT band 
(maximum absorbance at 552 nm) as well as a band corresponding to dye 5.M (maximum 
absorbance at 651 nm). Both bands were slightly red-shifted compared to those of ReO4
–⊂5.1 
(546 nm) and 5.M (643 nm), which was attributed to the interaction between the dye and the 
cage (Figure 5.13 a). The fluorescence spectrum of ReO4
–⊂5.3 confirmed the presence of a 
fluorophore, with the maximum emission wavelength at 661 nm and maximum excitation at 
644 nm in water (Figure 5.13 b). 
 
 
Figure 5.13│a) UV-vis spectrum of ReO4–⊂5.1, ReO4–⊂5.3 and 5.M, showing the presence of similar bands in 
ReO4–⊂5.3 as in ReO4–⊂5.1 and 5.M. b) Fluorescence spectra of 5.3 (excitation in black and emission in purple). 
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The stability of ReO4
–⊂5.3 was tested in PBS ([Na2HPO4] = 10 mM and [NaCl] = 100 mM) 
using the same method as for ReO4
–⊂5.1 in water. To do so, a stock solution of ReO4–⊂5.3 
(2.5 mM) was diluted with PBS buffer to different concentrations. The results observed at 
0.1 μM, 1 μM and 10 μM were consistent with what was observed for ReO4–⊂5.1 in water, 
with the only difference that the decomposition followed a linear behaviour from t = 0. We 
inferred this difference to result from the more controlled pH in this case compared to water. 
When a higher cage concentration (100 uM) was employed, precipitation of a blue compound, 
assumed to be 5.M, was observed, along with an unexpectedly fast decomposition of the cage. 
This was explained by the low solubility of 5.M in buffer due to the association of this charged 
molecule with the different ions present in PBS solution. As one of the subcomponents was 
coming out of solution, the equilibrium was perturbed, leading to faster decomposition of the 
cage. When the same experiment was carried in water, no precipitation was observed and the 
stability of the cage improved. After 14 h, 60% of cage remained for the sample starting at 0.1 
μM, 65% for 1 μM and 75% for 10 μM, indicating reasonable stability of ReO4–⊂5.3 in buffer 
the range 1 μM – 10 μM.  
 
Figure 5.14│ UV-vis spectra in the 400 – 800 nm region corresponding to the MLCT and dye bands of ReO4– ⊂5.3 
at 10 uM in PBS, showing the changes of the MLCT band (decrease) and dye band (increase) over time (one 
spectrum every hour). b) Plot of the normalised intensity at 552 nm over time for starting concentrations of ReO4– 
⊂ 5.3 of 0.1 μM (yellow diamond), 1 μM  (blue squares), 10 μM  (green circles) and 100 μM (red triangles in 
water and grey triangle in PBS). 
 
5.4  Uptake of cages ReO4–⊂5.3 in hepatocytes 
The interaction of ReO4
–⊂5.3 with hepatocytes is currently under investigation in the 
laboratories of Novo Nordisk, Denmark.  
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5.5 Conclusions and future work 
The importance of ASPGR in biological process led us to target this receptor as a way to 
selectively internalise coordination cages into hepatocytes. Literature precedent showed that 
the receptor binds strongly to GalNAc residues when arranged in a triangular fashion. In this 
chapter, a modified picolinaldehyde subcomponent was therefore synthesised with the aim to 
bioconjugate the GalNac targeting moiety onto self-assembled cages. The design of this 
subcomponent was carefully chosen such that, once self-assembled, each metal vertex of the 
cage would present three targeting units, arranged optimally in space to bind to the ASGPR. 
Self-assembly of the bioconjugated subcomponent was successful and water soluble FeII4L4 
cages were obtained. The coordination cages were further functionalised with a fluorescent tag 
to facilitate their tracking during cell studies. To do so, some of the GalNAc units were replaced 
by an analogue of the Cy5 dye on the coordination cage. The attachment of both the GalNAc 
moieties and the fluorescent tag onto the cage was shown by a combination of NMR, DOSY 
and UV-vis experiments. The stability of the cage formed was tested in biological conditions 
(PBS) and was shown to only slowly decompose to a small extent when the concentration was 
kept between 1 µM and 10 µM. This range of concentrations were found suitable for biological 
testing and the interaction of the cage formed with hepatocytes is being investigated.  
Future work will build upon this proof of concept by extending this strategy of bioconjugation 
to other cages, which display better stability and lower toxicity. The use of different 
coordination motifs such as bipyridine[13] or pyridyl-triazole[14] could be tested instead of the 
pyridyl-imine used in this chapter for example. An obvious next step is the use of the cage 
cavity to carry cargoes into cells. By careful design of the ligands, drugs of interest could be 
encapsulated and delivered selectively to specific cells. Incorporation of responsive groups 
onto the cage could also lead to controlled release of the cargo upon application of stimuli.   
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5.6 Experimental section 
5.6.1 Synthesis of 5.J 
2-Acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 5.A 
D-galactosamine (10.0 g, 55.8 mmol, 1.00 eq.) was suspended in anhydrous 
pyridine (100 mL). Acetic anhydride (60.0 mL, 635 mmol, 11.4 eq.) was 
added dropwise over 1 h. The mixture was stirred at room temperature for 18 h, after which 
the solvents were removed under reduced pressure, giving a syrupy transparent liquid. Addition 
of CH3OH (100 mL) precipitated the product which was collected by filtration and washed 
with CH3OH (200 mL), giving 5.A as a white powder (20.6 g, 53.0 mmol, 95%). 
1H NMR (400 MHz, 298 K, CDCl3) δ 5.70 (d, J = 9.2 Hz, 1H), 5.41 (d, J = 9.2 Hz, 1H), 5.37 
(dd, J = 3.4, 1.2 Hz, 1H), 5.08 (dd, J = 11.3, 3.4 Hz, 1H), 4.45 (dt, J = 11.3, 9.2 Hz, 1H), 4.24 
– 4.05 (m, 2H), 4.02 (td, J = 6.5, 1.2 Hz, 1H), 2.17 (s, 3H), 2.13 (s, 3H), 2.05 (s, 3H), 2.02 (s, 
3H), 1.94 (s, 3H). 
 
Figure 5.15│1H NMR spectrum (400 MHz, 298 K, CDCl3) of 5.A. 
This data was consistent with previously reported data.[15] 
 
Sodium 5-hydroxypentanoate 5.B 
δ-Valerolactone (15.0 g, 150 mmol, 1.00 eq.) and NaOH (6.00 g, 
150 mmol, 1.00 eq.) were dissolved in H2O (150 mL) and stirred at 
70 °C for 18 h. The mixture was cooled to room temperature and the solvents removed under 
reduced pressure to give 5.B as a white solid (20.6 g, 147 mmol, 98%). 
1H NMR (400 MHz, 298 K, D2O) δ 3.62 (t, J = 6.3 Hz, 2H), 2.21 (t, J = 7.2 Hz, 2H), 1.75 – 1.39 
(m, 4H). 
Chapter 5 
 
- 132 - 
 
Figure 5.16│1H NMR spectrum (400 MHz, 298 K, D2O) of 5.B. 
This data was consistent with previously reported data.[16] 
 
Benzyl 5-hydroxypentanoate 5.C 
Sodium 5-hydroxypentanoate (9.50 g, 67.8 mmol, 1.00 eq.) was 
suspended in acetone (70 mL) and sonicated for 3 h. Benzyl 
bromide (9.6 mL, 80.7 mmol, 1.19 eq.) and TBABr (1.10 g, 
3.41 mmol, 0.05 eq.) were added and the mixture was refluxed for 18 h. The solvents was 
removed under reduced pressure and the resulting oil was dissolved in EtOAc (100 mL) and 
washed with an aqueous saturated solution of NaHCO3 (3 × 100 mL) and brine (3 × 100 mL). 
The organic phase was dried with MgSO4 and the solvent was removed under reduced pressure 
to give a light yellow oil. The product was purified by silica gel chromatography (EtOAc in 
heptane, 0 – 50%) to give 5.C as a yellow oil (4.37 g, 21.0 mmol, 31%). 
1H NMR (400 MHz, 298 K, CDCl3) δ 7.43 – 7.29 (m, 5H), 5.12 (s, 2H), 3.64 (t, J = 6.4 Hz, 
2H), 2.41 (t, J = 7.3 Hz, 2H), 1.83 – 1.68 (m, 2H), 1.66 – 1.52 (m, 3H). 
 
Figure 5.17│1H NMR spectrum (400 MHz, 298 K, CDCl3) of 5.C. Peaks for residual heptane were observed. 
This data was consistent with previously reported data.[17] 
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(2R,3R,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-((5-(benzyloxy)-5-
oxopentyl)oxy)tetrahydro-2H-pyran-3,4-diyl diacetate 5.D 
Compound 5.A (1.15 g, 2.95 mmol, 1.00 eq.), benzyl 5-
hydroxypentanoate 5.C (1.22 g, 5.86 mmol, 2.00 eq.) 
and Sc(OTf)3 (0.10 g, 0.20 mmol, 0.07 eq.) were 
combine in DCE (10 mL) and refluxed under nitrogen 
for 3 h. The mixture was cooled to room temperature, diluted with DCM (100 mL) and washed 
with an aqueous saturated solution of NaHCO3 (3 × 100 mL). The organic phase was dried with 
MgSO4 and the solvents were removed under reduced pressure. The product was purified by 
prep-HPLC (C18 column, 0.1% TFA, CH3CN in H2O, 10 – 65%) to give 5.D as a yellow oil 
(0.238 g, 0.442 mmol, 15%). 
1H NMR (400 MHz, 298 K, CDCl3) δ 7.45 – 7.30 (m, 5H), 5.79 (d, J = 8.7 Hz, 1H), 5.36 (dd, 
J = 3.4, 1.1 Hz, 1H), 5.26 (dd, J = 11.2, 3.4 Hz, 1H), 5.13 (s, 2H), 4.64 (d, J = 8.4 Hz, 1H), 
4.24 – 4.08 (m, 2H), 3.98 (dt, J = 11.2, 8.5 Hz, 1H), 3.93 – 3.83 (m, 2H), 3.51 (ddd, J = 9.9, 
6.7, 5.5 Hz, 1H), 2.48 – 2.31 (m, 2H), 2.16 (s, 3H), 2.06 (s, 3H), 2.01 (s, 3H), 1.94 (s, 3H), 1.81 
– 1.67 (m, 2H), 1.68 – 1.54 (m, 2H). 
 
Figure 5.18│1H NMR spectrum (400 MHz, 298 K, CDCl3) of 5.D. 
This data was consistent with previously reported data.[18] 
 
5-(((2R,3R,4R,5R,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-
2-yl)oxy)pentanoic acid 5.E 
Compound 5.D (100 mg, 0.186 mmol) was dissolved in THF 
(20 mL) and Pd/C (10 mg) was added. The mixture was stirred 
under a hydrogen atmosphere for 18 h. The Pd/C was removed 
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by filtration on Celite and the solvent removed under reduced pressure to give the product as 
an off-white solid (79.8 mg, 0.179 mmol, 96%). 
1H NMR (400 MHz, 298 K,   DMSO-d6) δ 7.82 (d, J = 9.2 Hz, 1H), 5.22 (d, J = 3.4 Hz, 1H), 
4.96 (dd, J = 11.2, 3.5 Hz, 1H), 4.49 (d, J = 8.5 Hz, 1H), 4.06 – 3.99 (m, 2H), 3.88 (dt, J = 
11.3, 8.9 Hz, 1H), 3.77 – 3.65 (m, 1H), 2.25 – 2.13 (m, 2H), 2.11 (s, 3H), 2.00 (s, 3H), 1.90 (s, 
3H), 1.77 (s, 3H), 1.58 – 1.42 (m, 4H). The protons marked by the asterisk were inferred to be 
under the water peak.  
 
Figure 5.19│1H NMR spectrum (400 MHz, 298 K, DMSO-d6) of 5.E. Peaks for residual THF were observed. 
 
This data was consistent with previously reported data.[18] 
 
5-(((2R,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-
2-yl)oxy)pentanoic acid 5.F 
Compound 5.E (79.8 mg, 0.179 mmol) was dissolved in a 
solution of sodium methoxide (1 M) in CH3OH (2 mL) and 
stirred at room temperature for 18 h. The solvent was 
removed under reduced pressure. The product 5.F was 
obtained as a white solid (52.9 mg, 0.165 mmol, 92%). 
1H NMR (400 MHz, 298 K, CD3OD) δ 4.34 (d, J = 8.4 Hz, 1H, H1), 3.96 – 3.83 (m, 3H, H6,10), 
3.77 (d, J = 5.8 Hz, 2H, H3), 3.61 – 3.49 (m, 2H, H5,4), 3.46 (t, J = 5.8 Hz, 1H, H2), 2.15 (t, 
J = 7.1 Hz, 2H, H13), 1.98 (s, 3H, H9), 1.69 – 1.53 (m, 4H, H12,11). 13C NMR (101 MHz, 298 K, 
CD3OD) δ 181.0, 172.5, 101.3, 74.7, 71.7, 68.6, 68.4, 60.9, 52.4, 36.9, 28.7, 22.2, 21.3. HRMS: 
m/z calculated for [5.F + H+] = 344.1321, observed = 344.1400. 
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Figure 5.20│1H NMR spectrum (400 MHz, 298 K, CD3OD) of 5.F. Peaks for residual toluene and TBA are also 
observed (4.60, 3.23, 1.41 and 1.01 ppm).  
 
Figure 5.21│13C NMR spectrum (101 MHz, 298 K, CD3OD) of 5.F. Peaks for residual toluene are also observed 
(127-126 and 63 ppm). 
 
Figure 5.22│1H-13C HSQC spectrum (400 MHz, 298 K, CD3OD) of 5.F. 
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Figure 5.23│1H-1H COSY spectrum (400 MHz, 298 K, CD3OD) of 5.F. 
 
tert-Butyl (2-(2-bromoacetamido)ethyl)carbamate 5.G 
2-Bromoacetyl bromide (132 µL, 1.52 mmol, 1.20 eq.) was dissolved 
in DCM (20 mL) and combined with K2CO3 (202 mg, 1.60 mmol, 
1.30 eq.) dissolved in water (20 mL). tert-Butyl 
(2-aminoethyl)carbamate (200 µL, 1.26 mmol, 1.00 eq.) was dissolved in DCM (50 mL) and 
added to the solution. The mixture was stirred at room temperature for 1.5 h after which the 
organic layer was separated, washed with H2O (3 × 50 mL) and brine (3 × 50 mL). The organic 
layer was dried with MgSO4 and the solvent was removed under reduced pressure to give 5.G 
as a white powder (260 mg, 0.925 mmol, 71%). 
1H NMR (400 MHz, 298 K, CDCl3) δ 7.10 (bs, 1H), 4.88 (bs, 1H), 3.86 (s, 2H), 3.39 (q, 
J = 5.5 Hz, 2H), 3.31 (q, J = 5.5 Hz, 2H), 1.45 (s, 9H). 
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Figure 5.24│1H NMR spectrum (400 MHz, 298 K, CDCl3) of 5.G. 
This data was consistent with previously reported data.[19]  
 
tert-Butyl (2-(2-((6-formylpyridin-3-yl)oxy)acetamido)ethyl)carbamate 5.H 
Compound 5.G (240 mg, 0.854 mmol, 1.00 eq.), 
5-hydroxypicolinaldehyde (116 mg, 0.943 mmol, 
1.10 eq.) and DIPEA (163 µL, 0.943 mmol, 1.10 eq.) 
were combined in DMF (2.5 mL) and stirred at 100 °C for 2 h. The mixture was diluted with 
H2O (10 mL), extracted with EtOAc (3 × 20 mL), dried with MgSO4 and the solvents were 
removed under reduced pressure. The product was purified by silica gel chromatography 
(EtOAc in hexane, 60-100%) to give 5.H as a white crystalline solid (179 mg, 0.555 mmol, 
65%). 
1H NMR (400 MHz, 298 K, CDCl3) δ 9.99 (s, 1H, H1), 8.52 (d, J = 2.8 Hz, 1H, H6), 7.98 (d, J 
= 8.6 Hz, 1H, H3), 7.56 (bs, 1H, H9), 7.35 (dd, J = 8.6, 2.8 Hz, 1H, H4), 4.95 (bs, 1H, H12), 4.60 
(s, 2H, H7), 3.55 – 3.39 (m, 2H, H10), 3.41 – 3.26 (m, 2H, H11), 1.41 (s, 9H, H15). 13C NMR 
(101 MHz, 298 K, CDCl3) δ 191.4, 166.7, 156.9, 156.2, 146.9, 138.6, 123.0, 120.6, 79.7, 67.0, 
40.9, 39.5, 27.9. HRMS: m/z calculated for [5.H + H+] = 324.1554, observed = 324.1557  
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Figure 5.25│1H NMR spectrum (400 MHz, 298 K, CDCl3) of 5.H. 
 
Figure 5.26│13C NMR (101 MHz, 298 K, CDCl3) of 5.H. 
 
Figure 5.27│1H-13C HSQC spectrum (400 MHz, 298 K, CDCl3) of 5.H. 
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Figure 5.28│1H-1H COSY spectrum (400 MHz, 298 K, CDCl3) of 5.H. 
 
N-(2-Aminoethyl)-2-((6-formylpyridin-3-yl)oxy)acetamide 5.I 
Compound 5.H (100 mg, 0.309 mmol) was dissolved in 
1,4-dioxane (1.5 mL) and HCl/dioxane (4 M, 2.5 mL) were 
added. The solution was stirred for 5 min after which the solid 
was separated by centrifugation. The solid was washed with 
1,4-dioxane, DCM, EtOAc, hexane and finally Et2O. The hydroscopic solid was freeze-dried 
to give 5.I as an off-white solid (68.2 mg, 0.306 mmol, 99%). 
The compound was hypothesized to be the hydrochloride adduct due to protonation of both 
pyridine and amine moieties. 
1H NMR (400 MHz, 298 K,  DMSO-d6) δ 9.90 (s, 1H, H1), 8.56 (d, J = 2.8 Hz, 1H, H6), 8.51 
(bt, J = 5.8 Hz, 1H, H9), 8.00 (bs, 2H, H12), 7.95 (d, J = 8.7 Hz, 1H, H3), 7.62 (dd, J = 8.7, 2.8 
Hz, 1H, H4), 4.77 (s, 2H, H7), 3.40 (q, J = 6.1 Hz, 2H, H10), 2.90 (q, J = 6.1 Hz, 2H, H11). 
13C 
NMR (101 MHz, 298 K,  DMSO-d6) δ 192.0, 167.5, 157.5, 146.0, 139.0, 123.7, 121.8, 67.1, 
38.5, 36.3. HRMS: m/z calculated for [5.I + H+] = 224.1030, observed = 224.1028.  
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Figure 5.29│1H NMR spectrum (400 MHz, 298 K, DMSO-d6) of 5.I. 
 
Figure 5.30│13C NMR (101 MHz, 298 K, DMSO-d6) of 5.I. 
 
Figure 5.31│1H-13C HSQC spectrum (400 MHz, 298 K, DMSO-d6) of 5.I. 
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Figure 5.32│1H-1H COSY spectrum (400 MHz, 298 K, DMSO-d6) of 5.I. Change in the amide proton shifts was 
attributed to a change in the acidity and water content of the solvent (as evidenced by the shift of the water peak). 
 
5-(((2R,3R,4R,5R,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-
2-yl)oxy)-N-(2-(2-((6-formylpyridin-3-yl)oxy)acetamido)ethyl)pentanamide 5.J 
Compound 5.I (36.9 mg, 0.124 mmol, 
1.00 eq.), compound 5.F (40.0 mg, 
0.124 mmol, 1.00 eq.), HBTU (47.2 mg, 
0.124 mmol, 1.00 eq.) and DIPEA 
(172 µL, 0.992 mmol, 8.00 eq.) were combined in DMF (2 mL) and stirred at room temperature 
for 2 h. The product was precipitated with Et2O (10 mL), collected by centrifugation and 
washed with DCM, EtOAc and finally Et2O, giving 5.J as a white powder (60.7 mg, 
0.115 mmol, 93%). 
1H NMR (400 MHz, 298 K,  DMSO-d6) δ 9.90 (s, 1H, H29), 8.52 (d, J = 2.8 Hz, 1H, H25), 8.27 
(t, J = 6.2 Hz, 1H, H21), 7.95 (d, J = 8.6 Hz, 1H, H27), 7.84 (t, J = 5.6 Hz, 1H, H18), 7.61 (d, J 
= 9.0 Hz, 1H, H7), 7.56 (dd, J = 8.7, 2.9 Hz, 1H, H26), 4.71 (s, 2H, H23), 4.61 – 4.51 (m, 2H, 
H11,12), 4.46 (d, J = 4.3 Hz, 1H, H10), 4.21 (d, J = 8.4 Hz, 1H, H1), 3.75 – 3.60 (m, 2H, H6,4), 
3.60 – 3.45 (m, 2H, H3), 3.43 – 3.39 (m, 1H, H5), 3.29 – 3.24 (m, 1H, H2), 3.22 – 3.10 (m, 4H, 
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H19,20), 2.04 (t, J = 7.2 Hz, 2H, H16), 1.79 (s, 3H, H9), 1.56 – 1.36 (m, 4H, H14,15). H13 was 
found under the water peak (by COSY and HSQC). 13C NMR (101 MHz, 298 K,  DMSO-d6) 
δ 192.1, 172.6, 169.7, 166.9, 157.5, 146.1, 139.1, 123.6, 121.5, 101.5, 75.3, 71.6, 68.0, 67.6, 
60.5, 55.3, 52.2, 38.6, 38.1, 35.2, 28.7, 23.1, 21.9. HRMS: m/z calculated for [5.J + Na+] = 
549.2167, observed = 549.2169. 
 
 
Figure 5.33│1H NMR spectrum (400 MHz, 298 K, DMSO-d6) of 5.J. 
 
 
Figure 5.34│13C NMR (101 MHz, 298 K, DMSO-d6) of 5.J. 
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Figure 5.35│1H-13C HSQC spectrum (400 MHz, 298 K, DMSO-d6) of 5.J. 
 
Figure 5.36│1H-1H COSY spectrum (500 MHz, 298 K, DMSO-d6) of 5.J. 
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5.6.2 Synthesis of 5.M 
Compound 5.K and 5.L were synthesized from an adapted literature procedure.[10] 
1-(5-Carboxypentyl)-2,3,3-trimethyl-3H-indol-1-ium bromide 5.K. 
2,3,3-Trimethyl-3H-indole (2.00 g, 6.30 mmol, 1.00 eq.) and 6-bromohexanoic 
acid (2.45 g, 6.30 mmol, 1.00 eq.) were combined in CH3NO2 (8.0 mL). The 
mixture was stirred at 80 °C for 6 h. Addition of Et2O resulted in the precipitation 
of a dark red paste which was further triturated with Et2O to give 5.K as a dark 
red solid (1.21 g, 3.42 mmol, 27%). 
1H NMR (400 MHz, 298 K,  DMSO-d6) δ 7.96 (dd, J = 6.0, 2.9 Hz, 1H), 7.83 
(dd, J = 6.0, 2.9 Hz, 1H), 7.70 – 7.50 (m, 2H), 4.44 (t, J = 7.8 Hz, 2H), 2.82 (s, 3H), 2.22 (t, 
J = 7.3 Hz, 2H), 1.89 – 1.78 (m, 2H), 1.61 – 1.50 (m, 2H),  1.53 (s, 6H), 1.48 – 1.34 (m, 2H). 
 
Figure 5.37│1H NMR spectrum (400 MHz, 298 K, DMSO-d6) of 5.K. 
 
This data was consistent with previously reported data.[10] 
 
3-((Z)-2-((2E,4E)-5-(1-(5-Carboxypentyl)-3,3-dimethyl-3H-indol-1-ium-2-yl)penta-2,4-
dien-1-ylidene)-3,3-dimethylindolin-1-yl)propane-1-sulfonate 5.L  
Compound 5.K (200 mg, 0.564 mmol, 1.00 eq.) and 
malondialdehyde bis(phenylimine) monohydrochloride (175 mg, 
0.676 mmol, 1.20 eq.) were combined in Ac2O (5m L) and heated 
at 120 °C for 30 min. The solution was cooled to room temperature 
and a solution of 4.F (222 mg, 0.789 mmol, 1.40 eq.) in anhydrous 
pyridine (5 mL) was added. The mixture was stirred at room 
temperature for 18 h. The solvents were removed under reduced 
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pressure. The oily residue was purified by silica gel chromatography (CH3OH in DCM, 0-
20%). The solid obtained was dissolved in DCM and precipitated with hexane to give 5.L as a 
blue microcrystalline powder (274 mg, 0.464 mmol, 82%). Some impurities (> 5%) remained, 
which were removed after the following synthetic step. 
1H NMR (400 MHz, 298 K, CD3OD) δ 8.26 (t, J = 13.1 Hz, 2H, H10,12), 7.48 (dd, J = 7.2, 5.5 
Hz, 2H, H4,18), 7.44 – 7.35 (m, 3H, H5/7/15/17/6/16), 7.33 – 7.22 (m, 3H, H5/7/15/17/6/16), 6.65 (t, 
J = 12.4 Hz, 1H, H11), 6.43 (d, J = 13.7 Hz, 1H, H9/13), 6.28 (d, J = 13.7 Hz, 1H, H9/13), 4.32 (t, 
J = 8.0 Hz, 2H, H3), 4.11 (t, J = 7.6 Hz, 2H, H19), 3.00 (t, J = 6.7 Hz, 2H, H1), 2.32 – 2.19 (m, 
4H, H23,2), 1.88 – 1.78 (m, 2H, H20), 1.72 (d, J = 6.1 Hz, 12H, H8,14), 1.75 – 1.67 (m, 2H, H22), 
1.57 – 1.44 (m, 2H, H21). 13C NMR (126 MHz, 298 K, CD3OD) δ 173.5, 173.0, 154.2, 154.1, 
142.1, 141.4, 141.1, 131.6, 128.4, 128.3, 125.7, 124.9, 124.7, 122.0, 122.0, 114.6, 110.7, 110.5, 
103.2, 103.1, 49.2, 49.1, 47.7, 43.5, 42.4, 35.2 (b), 26.9, 26.6, 26.5, 26.1, 24.2, 22.6. HRMS: 
m/z calculated for [5.L + Na+] = 613.2707, observed = 613.2713. 
 
 
Figure 5.38│1H NMR spectrum (400 MHz, 298 K, CD3OD) of 5.L. 
 
Figure 5.39│13C NMR (126 MHz, 298 K, CD3OD) of 5.L.  
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Figure 5.40│1H-13C HSQC spectrum (400 MHz, 298 K, CD3OD) of 5.L. 
 
Figure 5.41│1H-1H COSY spectrum (400 MHz, 298 K, CD3OD) of 5.L. 
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3-((Z)-2-((2E,4E)-5-(1-(6-((2-(2-((6-Formylpyridin-3-yl)oxy)acetamido)ethyl)amino)-6-
oxohexyl)-3,3-dimethyl-3H-indol-1-ium-2-yl)penta-2,4-dien-1-ylidene)-3,3-
dimethylindolin-1-yl)propane-1-sulfonate 5.M 
Compound 5.L (50 mg, 0.085 mmol, 
1.00 eq.), compound 5.I (25 mg, 
0.085 mmol, 1.00 eq.), HBTU (33 mg, 
0.087 mmol, 1.02 eq.) and DIPEA 
(117 uL, 0.671 mmol, 7.90 eq.) were 
combined in DMF (1.5 mL) and stirred at 
room temperature for 2 h. The product was 
precipitated with Et2O, dissolved in DCM 
(1.0 mL) and precipitated with Et2O. The solid was washed with EtOAc and Et2O. The solid 
was dried under a flow of N2 to give 5.M as a dark blue solid (62 mg, 0.078 mmol, 91%). 
1H NMR (500 MHz, 298 K,  DMSO-d6) δ 9.84 (s, 1H, H32), 8.48 (d, J = 2.7 Hz, 1H, H31), 8.35 
– 8.28 (m, 2H, H10,12), 8.28 (t, J = 5.2 Hz, 1H, H27), 7.90 (d, J = 8.7 Hz, 1H, H30), 7.88 (t, 
J = 5.6 Hz, 1H, H24), 7.61 – 7.55 (m, 2H, H4,18), 7.52 (dd, J = 8.7 Hz, J = 2.7 Hz, 1H, H29), 
7.47 – 7.31 (m, 4H, H5,7,15,17), 7.26 – 7.17 (m, 2H, H6,16), 6.53 (t, J = 12.3 Hz, 1H, H11), 6.42 
(d, J = 13.7 Hz, 1H, H9/13), 6.27 (d, J = 13.7 Hz, 1H, H9/13), 4.69 (s, 2H, H28), 4.25 (t, J = 7.8 Hz, 
2H, H3), 4.04 (t, J = 7.4 Hz, 2H, H19), 3.13 (2t, J = 5.9 Hz, 4H, H26,25), 2.57 (t, J = 6.8 Hz, 2H, 
H1), 2.07 – 1.93 (m, 4H, H23,2), 1.65 (d, J = 3.8 Hz, 14H, H14,8,20), 1.54 – 1.46 (m, 2H, H22), 
1.36 – 1.27 (m, 2H, H21). 13C NMR (126 MHz, 298 K,  DMSO-d6) δ 192.1, 172.9, 172.4, 172.7, 
166.9, 161.0, 157.4, 154.3, 154.1, 151.9, 150.4, 146.1, 142.1, 141.2, 139.1, 128.6, 125.7, 124.8, 
123.6, 122.5, 121.5, 111.2, 111.1, 103.5, 103.2, 67.1, 65.0, 59.8, 49.0, 48.9, 47.9, 43.74, 42.8, 
38.6, 38.1, 35.2, 27.3, 27.2, 26.8, 25.8, 24.9, 23.4. The values in italics were found by 
correlation in HSQC and HMBC spectra. HRMS: m/z calculated for [5.M + Na+] = 818.3558, 
observed = 818.3569.  
 
 
Chapter 5 
 
- 148 - 
 
Figure 5.42│1H NMR spectrum (500 MHz, 298 K, DMSO-d6) of 5.M. 
 
Figure 5.43│13C NMR (126 MHz, 298 K, DMSO-d6) of 5.M. 
 
Figure 5.44│1H-13C HSQC spectrum (500 MHz, 298 K, DMSO-d6) of 5.M. Spectral aliasing for the signal 
corresponding to the aldehyde 13C resonance (actual shift = 192 ppm). 
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Figure 5.45│1H-13C HMBC spectrum (500 MHz, 298 K, DMSO-d6) of 5.M. 
 
Figure 5.46│1H-1H COSY spectrum (500 MHz, 298 K, DMSO-d6) of 5.J. 
Chapter 5 
 
- 150 - 
5.6.3 Synthesis of supramolecular cages 
Synthesis of cage 5.1 
Compound 5.J (6.5 mg, 12.2 µmol, 12.0 eq.), 
compound 5.N (2.2 mg, 4.1 µmol, 4.0 eq.), FeSO4 
(1.1 mg, 4.1 µmol, 4.0 eq.) and NaReO4 (0.3 mg, 
1.0 µM, 1.0 eq.) were combined in D2O (0.5 mL) 
and stirred at room temperature for 18 h. The 
sample was used without further purification. 
1H NMR (500 MHz, 298 K, D2O) δ 8.63 (s, 12H, 
H21), 8.40 (d, J = 8.8 Hz, 12H, H20), 7.79 (d, 
J = 8.8 Hz, 12H, H19), 7.12 – 6.91 (m, 36H, 
H18,23), 6.19 (d, J = 497 Hz, 4H, H27), 4.25 (d, 
J = 8.5 Hz, 12H, H1), 3.81 – 3.31 (m, 120H, 
H2-6,9,24), 3.24 – 3.09 (m, 48H, H14-15), 2.71 – 2.40 (m, 48H, H25-26), 1.83 (s, 36H, H8), 
1.55 – 1.24 (m, 48H, H10-11). H17 and H22 were found under the water peak and H12 under the 
residual acetone peak. 13C NMR (126 MHz, 298 K,  D2O) δ 177.2, 174.6, 172.6, 169.2, 157.4, 
151.5, 149.3, 145.4, 136.6, 131.8, 130.1, 122.5, 101.5, 75.0, 70.9, 69.7, 67.7, 66.8, 60.9, 54.3, 
52.3, 42.5, 38.6, 37.8, 35.3, 33.1, 28.0, 22.2, 21.9. The signal for C22 was assumed too broad 
to be detectable in the 13C NMR spectrum. 
 
 
Figure 5.47│1H NMR spectrum (500 MHz, 298 K, D2O) of 5.1. 
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Figure 5.48│13C NMR (126 MHz, 298 K, D2O) of 5.1. 
 
 
Figure 5.49│1H-13C HSQC spectrum (500 MHz, 298 K, D2O) of 5.1 
Chapter 5 
 
- 152 - 
 
Figure 5.50│1H-1H COSY spectrum (500 MHz, 298 K, D2O) of 5.1. 
 
Synthesis of cage 5.2 
Compound 5.J (8.2 mg, 15.6 µmol, 
10.0 eq.), compound 5.N (3.3 mg, 
6.3 µmol, 4.0 eq.), FeSO4 (1.7 mg, 
6.3 µM, 4.0 eq.) and NaReO4 (0.4 mg, 
1.3 µM, 1.0 eq.) were combined in 
D2O (0.5 mL). Compound 5.M 
(2.5 mg, 3.1 µmol, 2.0 eq.) was 
dissolved in CH3CN (0.1 mL). The 
two solutions were combined and 
stirred at room temperature for 18 h. 
The CH3CN was evaporated under a flow of N2 and the sample was filtered on glass fibre 
before being used. 
1H NMR (500 MHz, 298 K, D2O) δ 8.63 (bs, 12H, H21), 8.39 (bd, J = 8.8 Hz, 12H, H20), 7.95 
(d, J = 8.3 Hz, xH, Hdye), 7.86 (d, J = 8.2 Hz, xH, Hdye), 7.76 (bd, J = 8.8 Hz, 12H, H19), 7.65 
(d, J = 8.3 Hz, xH, Hdye), 7.56 (d, J = 8.7 Hz, xH, Hdye), 7.12 – 6.91 (m, 36H, H18,23), 6.19 (d, 
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J = 497 Hz, 4H, H27), 4.26 (d, J = 8.7 Hz, 12(1-x)H, H1), 3.80 – 3.34 (m, 120(1-x)H, H2-6,9,24), 
3.26 – 3.09 (m, 48(1-x)H, H14-15), 2.67 – 2.35 (m, 48H, H25-26), 2.04 (s, 24(1-x)H, H12), 1.83 (s, 
36(1-x)H, H8), 1.52 – 1.25 (m, 48(1-x)H, H10-11). H17 and H22 were found under the water peak. 
13C NMR (126 MHz, 298 K, D2O) δ 177.2, 174.6, 172.6, 169.2, 157.4, 151.5, 149.3, 145.4, 
136.6, 131.8, 130.1, 122.5, 101.5, 75.0, 70.9, 69.7, 67.7, 66.8, 60.9, 54.3, 52.3, 42.5, 38.6, 37.8, 
35.3, 33.1, 28.0, 22.2, 21.9. The signal for C22 was assumed too broad to be detectable in the 
13C NMR spectrum. The intensity of the signals for the dye were too low to be observed, except 
for a few aromatic protons.  
 
Figure 5.51│1H NMR spectrum (500 MHz, 298 K, D2O) of 5.2. 
 
 
Figure 5.52│13C NMR (126 MHz, 298 K, D2O) of 5.2. 
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Figure 5.53│1H-13C HSQC spectrum (500 MHz, 298 K, D2O) of 5.2. 
 
Figure 5.54│1H-1H COSY spectrum (500 MHz, 298 K, D2O) of 5.2. 
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6.1 Introduction  
The molecular components of biological systems self-sort in different ways to function 
synergically and to avoid interfering with each other. Similarly, in synthetic supramolecular 
coordination cages, molecules can interact in different ways to yield complex self-assembled 
libraries.[1-7] The self-assembly of multiple components can result in the clean formation of 
structurally complex single products,[8-13] as each building block is guided to a specific location 
during thermodynamic equilibration. Understanding the behaviour of dynamic mixtures and the 
driving forces leading to some combinations of components forming discrete entities,[14] while 
others do not is crucial for the future elaboration of more complex systems. In this process, 
rules governing self-assembly are often uncovered[15-16] allowing for the design of increasingly 
complex self-assembling synthetic systems and materials.[17]  
 
Figure 6.1│Representation of the different outcomes when self-assembly is carried using different ligands where 
either a) no sorting, or b and f) self-sorting giving discrete products occurs. Within self-sorting f) a single 
integrative product or b and e) libraries of products can be formed, which range from homoleptic species only (b 
– narcissistic sorting) to various types of social sorting giving both homo- and heteroleptic species (c – near-
narcissistic, d – biased or e – statistical sorting). 
 
In many cases, however, mixtures of different subcomponents produce multiple self-assembled 
products.[18-20] Libraries of structures are formed which generally fall within one of the two 
categories: social self-sorting (Figure 6.1 c-f) or narcissistic self-sorting (Figure 6.1 b). The 
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latter is defined by a complete segregation of the subcomponents in order to form exclusively 
the homoleptic complexes. Within social sorting, where ligands combine to form heteroleptic 
complexes preferentially, different regimes can be adopted. If no energetic bias for any product 
exist, the products will distribute statistically (following the binomial law for two 
subcomponents for example, Figure 6.1 e). When an enthalpic bias is present, the formation of 
a subgroup of all the possible species will be favoured (Figure 6.1 d). For example, if a type of 
geometry is formed preferentially, the sorting can be referred to as geometrically biased sorting. 
The formation of the least favoured species, in reduced proportions, also occurs in these cases. 
Deciphering the self-assembly rules within such systems involves new characterization 
challenges: interconverting, low-symmetry, and sometimes paramagnetic products in the case 
of coordination complexes are difficult to detect by NMR as they lead to multiple broad, 
overlapping signals. Labile species can re-equilibrate after chromatographic separation due to 
their dynamic behaviour.[21] Mass spectrometry could potentially overcome these challenges by 
giving an instantaneous picture of the system, allowing the speciation of components within 
complex mixtures to be gauged.  
This chapter presents, through three case-studies, some of the different types of sorting regimes 
which can be encountered in self-assembly and the potential to analyse mixtures of self-sorted 
assemblies and assess individual outcomes by mass spectrometric techniques. In the first 
system, the relative energies of heteroleptic structures compared to the more stable homoleptic 
were obtained, allowing for the quantification of each ligand’s structural preferences.[22] In a 
second case, quantitative information on both the product distribution, and the proportion of 
ligands incorporated into each species within mixtures was obtained for a complex system of 
self-assembled scalenohedra or pseudo-octahedra using a unique combination of ESI-MS and 
IM-MS.[23] Following a similar approach to the first case, the effect of anion encapsulation on 
a dynamic library of self-assembled tetrahedra was analysed. 
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6.2 Energetic quantification of structural preference between 
tetrahedra and tetragonal prisms 
Elucidation of the structural preferences that favour the formation of mer vertices over fac 
would allow the directed formation of larger structures such as prisms[24-26] as opposed to the 
most commonly observed tetrahedra.[27-30]  With increased knowledge of the rules behind self-
assembly, better control over the rational design of ligands could therefore be achieved. 
 
6.1.1 Chemical system 
Van der Waals surfaces of MM3-optimised models of fac vertices were calculated for 
pyridylimines coordinated around octahedral metal centres (Figure 6.2 a and b). The surfaces 
showed a sterically crowded environment around the aromatic substituent at the 5-position on 
the pyridyl rings. Electrostatic potential maps of mer vertices were also obtained, showing 
greater potential for π-stacking interactions between the electron-rich aniline rings and the 
electron deficient pyridyl rings for mer vertices (Figure 6.2 c). It was therefore postulated that, 
by making the aromatic substituent at the 5-position more sterically demanding and more 
electron withdrawing, the formation of fac vertices might be disfavoured relative to mer. Using 
a 2,3,5,6-tetrafluorobenzene ring appended to the pyridyl ring was hypothesised to fulfil both 
of these requirements due to the larger van der Waals radius of fluorine (1.47 Å) compared to 
hydrogen (1.00 Å), and the electron-withdrawing nature of the fluorine atoms.[31-32]  
Two pyridine based ligands, 2-formyl-5-phenylpyridine 6.A or 2-formyl-5-(2,3,5,6-
tetrafluorophenyl)pyridine 6.B, presenting either a phenyl or a perfluorophenyl ring at the 5-
position of the pyridine were synthesised. Upon self-assembly with p-fluoroaniline and 
Fe(NTf2)2 in acetonitrile, mononuclear complexes 6.1 and 6.2 were formed respectively (Figure 
6.3). ESI-MS results were consistent with the formation of mononuclear complexes of FeIILA3 
or FeIILB3 stoichiometry (where LA and LB represent ligands incorporating subcomponents 6.A 
and 6.B, respectively). The 1H NMR spectrum of 6.1 indicated the presence of both fac and mer 
geometries in the statistical proportion of 1:3. Unlike 6.1, the 1H NMR spectrum of 6.2 indicated 
the presence of mer geometry exclusively (Figure 6.3). These results indicated that 6.A can 
assemble into complexes of both geometries and as a consequence does not show a clear 
preference for either fac or mer coordination. Strikingly, 6.B showed a clear preference to 
undergo mer coordination exclusively.  
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Figure 6.2│a and b) Van der Waals surfaces (green) calculated from optimised geometries by energy minimization 
using the MO-G PM6 method (left) on the software package SCIGRESS 3.1.9 for fac vertices with (6.2) or without 
(6.1) fluorine atoms. c) Electrostatic Potential Map (EPM) of mer-6.2 calculated from the geometry optimised by 
energy minimization using the PM6-D3H4 method with AMPAC 10.1.[33]  
 
 
Figure 6.3│a) Self-assembly of fac and mer mononuclear complexes 6.1 and 6.2. b) 1H NMR spectra (400 MHz, 
298 K, CD3CN) of the imine regions of 6.1 and 6.2. 
 
Dialdehyde subcomponent 6.C is known to self-assemble with p-methoxyaniline 6.E and 
Fe(PF6)2 to form Fe
II
4L
C
6 tetrahedral cage 6.3 in solution, where L
C represent the ligand 
incorporating subcomponent 6.C (Figure 6.4).[34] A similar dialdehyde subcomponent to 6.C, 
which contains a 2,3,5,6-tetrafluorobenzene moiety bridging the two formylpyridine groups 
6.D was synthesised.[22] The self-assembly of 6.D under the same conditions gave rise to a 
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product having the formula FeII8L
D
12 by ESI-MS, where L
D represent the ligand incorporating 
subcomponent 6.D. The 1H NMR spectrum revealed the presence of a predominant species with 
three magnetically distinct ligand environments, consistent with tetragonal prismatic structure 
6.4 with mer coordination at all vertices (Figure 6.4). 
 
Figure 6.4│a) Self-assembly of 6.3 and 6.4 from hydrogenated subcomponent 6.C and fluorinated subcomponent 
6.D, respectively. b and c) Views of the single crystal X-ray structures of 6.3 and 6.4 showing the side view and 
the top views down the main symmetry axis (C3 and C4 respectively), with linkages between FeII centres (blue 
spheres) added in order to highlight the framework. d and e) Zoom on the vertices of 6.3 and 6.4, highlighting the 
differing nature of the vertices geometry, respectively fac or mer only.  f and g) Schematic representation of 6.3, 
6.4. 
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6.1.2 Quantification by mass spectrometry  
As subcomponents 6.C and 6.D formed contrasting structures with exclusively fac (tetrahedron) 
or mer (tetragonal prism) vertices, more information on the factors leading to one or the other 
structure could be obtained by studying the assemblies formed by mixing the two 
subcomponents. Due to the similarity in length and shape of the two ligands, a library of 
heteroleptic assemblies should be formed if neither ligand had a distinct preference for either 
structural type (Figure 6.1 e).  
Preformed tetrahedron 6.3 and tetragonal prism 6.4 were combined in a 2:1 ratio to allow for 
equimolar amounts of LC and LD and were left to equilibrate at 50 °C for three days. The 
1H NMR spectrum of the mixture became significantly more complex during this time. 
Similarly, subcomponents 6.C and 6.D were combined in equimolar amount and reacted with 
6.E and Fe(PF6)2. After equilibration for three days, the same spectra (
1H NMR and ESI-MS) 
as in the first case were obtained. As the non-fluorinated subcomponent 6.C and fluorinated 
subcomponent 6.D were present in a 1:1 ratio and no further changes were observed following 
longer equilibration times (up to two weeks), we inferred that the system had reached 
thermodynamic equilibrium. Furthermore, disassembly of the cages did not appear to have a 
significant energy barrier as both outcomes were identical. 
 
Figure 6.5│Mixing experiment starting from either subcomponents 6.C and 6.D (a) or from the preformed cages 
6.3 and 6.4 (b), giving the same library of tetrahedral (FeII4LC(6-x)LDx) and prismatic (FeII8LD(12-y)LCy) cages after 
equilibration at 50°C for 3 days.  
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The intractability of the 1H NMR spectrum prevented any further analysis via this technique. 
The broadness was inferred to come from the complexity of the library of cages formed, arising 
both from the number of species (up to five tetrahedra and 13 prisms) and the different structural 
arrangements these might adopt.  
ESI-MS was therefore used to study the mixture, where each species formed could be observed 
due to their differing m/z ratio. The ESI-MS spectrum indicated the presence of FeII4L
C
(6-x)L
D
x 
tetrahedra incorporating between zero and four fluorinated ligands 6.D, but no tetrahedra 
incorporating five or six. Peaks corresponding to FeII8L
D
(12-y)L
C
y tetragonal prisms 
incorporating between zero and six non-fluorinated ligands 6.C were also observed, but none 
incorporating more than six (Figure 6.6).  
 
Figure 6.6│LR-ESI-MS of the mixture after equilibration showing the peaks corresponding to the heteroleptic 
species FeII4LC(6-x)LDx and FeII8LD(12-y)LCy formed.  
 
When observing a peak corresponding to a single charge state of either architecture, the 
response factor within a charge state was hypothesised to be independent of the number of 
fluorinated ligands present. The response factors (related to the peak integrals) were therefore 
assumed to be independent of the number of fluorinated ligands present in each tetrahedron or 
prism, or which structural isomer was present. Consequently, the relative concentrations of each 
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of the congeners was assumed to be proportional to the integral of their m/z peaks within clusters 
of peaks corresponding to structures of the same type incorporating different numbers of ligands 
6.C and 6.D. This method had previously provided consistent results in the context of other 
complex metallosupramolecular architectures.[35] However, no assumptions on the proportions 
of one structure type (tetrahedra or prism) compared to the other structure were made based on 
the likeliness of varying ionization between the two structure types.  
Within each charge state, the integrals of the m/z peaks were normalised so that the sum of the 
integrals was equal to one. These integrals were averaged across all observed charge states to 
give the relative amount of each congener in solution. The corresponding statistical distribution 
was obtained by normalising the binomial distribution (Pascal’s triangle with n=6 for the 
tetrahedron and n=12 for the tetragonal prism) so that the sum of the binomial coefficients was 
equal to one. The observed values were plotted alongside the binomial distribution (Figure 6.7).   
Any deviation from the entropically-favoured statistical (binomial) distribution of heteroleptic 
assemblies, even in the absence of complete narcissistic self-sorting, would indicate a 
preference for the ligands to self-sort into their initial structural type.[36-39] Here, a clear 
deviation from the binomial distribution for both tetrahedra and tetragonal prisms was observed 
across both architectures (Figure 6.7). These deviations reflected the energetic preference of 
non-fluorinated subcomponent 6.C to form tetrahedra and fluorinated subcomponent 6.D to 
form tetragonal prisms. 
The energetic preferences could be further quantified by establishing a set of equilibrium 
constants between congeners. Within each series (tetrahedral or prismatic) the ratio between 
the observed proportion of each species and its expected proportion, based upon a binomial 
distribution was calculated. Each congener within a series was identified by the number of 
fluorinated ligands N it possesses. The relative Gibbs energy of each congener was then 
determined from these equilibrium constants using Equation 6.1. 
Equation 6.1   𝜟𝑬𝒓𝑵 =  −𝑹𝑻𝐥𝐧(𝑲𝑵),        𝐰𝐢𝐭𝐡 𝑲𝑵 =
(
𝑰𝑵
𝑰𝒔𝒕𝒂𝒕𝑵
)
𝑰𝟎
 
 
where IN represents the normalised integral of the mass peak for the structure incorporating N 
fluorinated ligands, IstatN the corresponding normalised binomial coefficient (expected 
normalised integral for the structure incorporating N fluorinated ligands if there was no bias), 
and I0 the normalised integral of the mass peak for the original structure (6.3 or 6.4).  
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Figure 6.7│Proportion of each species observed for (a) the family of tetrahedra derived from 6.3 (green) and (b) 
the family of tetragonal prisms derived from 6.4 (blue) compared to the binomial (statistical) distribution (grey). 
Error bars represent the standard deviations of the amounts of each congener measured between the different 
charge states observed in the ESI-MS.  
 
The Gibbs energies followed a linear trend which was fitted to a linear least-squares model. For 
each fluorinated subcomponent 6.D incorporated into the tetrahedral cage, the structure was 
destabilised by an average of 4.1 kJ mol−1 (Figure 6.8 a). For each non-fluorinated 
subcomponent 6.C incorporated into the tetragonal prism, the structure was destabilised by an 
average of 2.7 kJ mol−1 (Figure 6.8 b). These are weighted average energy for all structural 
isomers, as it is impossible to differentiate between structural isomers via ESI-MS. 
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Figure 6.8│Plots of the energy of each species relative to a) tetrahedron 6.3, containing only non-fluorinated 
ligand 6.C, and b) the tetragonal prism 6.4, containing only fluorinated ligand 6.D. Ert and Erp refer to the relative 
energies between congeners respectively in the cases of the tetrahedral series and the prismatic series. α represents 
the energetic destabilization per ligand exchanged. 
 
From these values, it was established that it is more energetically costly to incorporate a 
fluorinated ligand into a tetrahedron than a non-fluorinated ligand into a tetragonal prism. This 
is consistent with the observation made on the mononuclear complexes. Complex 6.1 formed 
as a statistical fac-mer mixture, whereas mer-6.2 formed stereoselectively. Entropy tends to 
favour the formation of structures with the minimum number of components.[40-41] The 
tetrahedron incorporates half the number of building blocks compared to the prism in this study. 
As the non-fluorinated mononuclear complex 6.1 has no preference for fac or mer geometry, 
entropy drives the system towards the formation of the smaller tetrahedron. The fluorinated 
ligands form exclusively vertices of mer-geometry, leading to the formation of larger prismatic 
structures. This suggests that prisms are enthalpically favoured, outweighing the entropic 
preference to form tetrahedra. 
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6.3 Sorting regimes and composition of heteroleptic mixtures  
Given the many uses of self-assembled cages, the ability to gauge the composition of 
heteroleptic mixtures of capsules could be of high value. Understanding the factors (electronics, 
flexibility, size and shape) influencing the incorporation of different ligands into heteroleptic 
species could allow better control over the outcome of the self-assembly process.  
 
6.3.1 Chemical system 
Previously, Rizzuto et al. demonstrated that subcomponent self-assembly of triamines such as 
6.H and 6.I with 2-formylphenanthroline 6.G and either CdII or ZnII formed a series of 
supramolecular MII6L4 pseudo-octahedra.
[42] However, the formation of discrete species was 
not observed when larger triamines such as 6.J and 6.K were employed. CoII has proven useful 
in stabilizing larger and more flexible supramolecular architectures in the past.[43-46] This 
phenomenon can be explained by the slower exchange kinetics and flexible coordination sphere 
of this metal ion. It was thus hypothesised that employing CoII with larger triamines and 6.G 
could stabilise the formation of larger octahedra.  
The self-assembly of 6.G (12 eq.), CoII(OTf)2 (6 eq.) and triamines 6.H – 6.K (4 eq.) carried 
out by Felix Rizzuto resulted in the formation of assemblies 6.5 – 6.8 after heating at 70 °C for 
16 h (Figure 6.9). ESI-MS confirmed the CoII6L4 stoichiometry in all cases. The 
1H NMR 
spectra of 6.5 – 6.7 were highly symmetric, consistent with the threefold symmetry of the 
ligands and the overall T symmetries of the expected octahedra.   
The 1H NMR spectrum of 6.8, was more complex with three sets of ligand signals instead of 
the single one expected for the T symmetric cage. Single crystal X-ray diffraction studies 
carried out by Felix Rizzuto revealed a structure where each of the faces of the polyhedron 
corresponded to a scalene triangle. The alternating metal corners around the equatorial belt are 
forced out of the plane by the ligands, leading to their scalenohedral arrangement. Edge-to-face 
aromatic interactions between the triazine rings of the ligand and adjacent phenanthroline 
moieties was inferred to reinforce the configuration, as seen in the X-ray structure. Furthermore, 
the high electron density of 6.K was hypothesised to contribute to the edge-to-face aromatic 
interactions in 6.8. This would explain the differences in the structures formed by 6.K as 
opposed to 6.J, which possesses similar geometry and size but different electronic properties.  
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Figure 6.9│Formation of supramolecular cages 6.5 – 6.8 (b – schematic representation of the structures) from a) 
subcomponent 6.G, Co(OTf)2 and tiamines 6.H – 6.K, respectively. c) Single crystal X-ray structures of 6.5, and 
6.8 and MM3-optimised models of 6.6 (based on the X-ray structure of the analogue with Cd) and 6.7. Linkages 
between CoII centres (white spheres) added to highlight the framework, hydrogens are omitted for clarity.  
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6.3.2 Quantification by mass spectrometry 
To probe the effect of the ligands’ properties (size, shape, flexibility, electronic properties) on 
self-sorting regimes, triamines 6.H – 6.K were self-assembled two by two with 6.G and 
Co(OTf2)2 and the outcome of the mixing experiment was assessed by NMR and MS.  
Two triamines (1 eq. of each), 2-formylphenanthroline 6.G (6 eq.) and Co(OTf)2 (3 eq.) were 
combined in CH3CN and heated at 70 °C for 18 h. Stock solutions of homoleptic species 6.5, 
6.6, 6.7 and 6.8 were also prepared. The same amount of two homoleptic cage solutions were 
combined and heated at 70 °C for 18 h. 1H NMR and ESI-MS were collected after cooling to 
room temperature. Both methods gave similar spectra that did not change further upon longer  
equilibration times (up to one week). Hence, the system was assumed to be at thermodynamic 
equilibrium in both cases. For ease of preparation and to limit errors due to weighing small 
amounts of material, the method involving stock solutions was used throughout the rest of this 
work.  
 
Figure 6.10│LR-ESI-MS of library of cages of the formulae CoII6LYxLZ4-x obtained by mixing a) 6.5 and 6.6, b) 
6.5 and 6.7, c) 6.5 and 6.8, d) 6.6 and 6.7, e) 6.6 and 6.8 and f) 6.7 and 6.8.  
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ESI-MS was used to probe the effect of each ligand on the outcome of the self-sorting process. 
In most cases, the mixtures containing two different subcomponents were observed to socially 
self-sort into CoII6L
Y
xL
Z
4-x architectures by ESI-MS (where L
Y and LZ represent ligands 
incorporating subcomponents 6.Y and 6.Z, respectively, Figure 6.10). Only the mixture of 6.H 
and 6.K was observed to undergo near-narcissistic sorting where the main species observed 
were the homoleptic 6.5 and 6.8. All other combinations of tiamines (6.H and 6.I, 6.H and 6.J, 
6.I and 6.J as well as 6.J and 6.K) led to the formation of all possible products. Ligands formed 
from 6.J and 6.K are significantly larger than 6.H and 6.I, indicating that ligand geometries and 
size did not have to match closely to form heteroleptic structures. MM3 molecular models of 
the CoII6L
I
xL
J
4-x complexes calculated by Felix Rizzuto indicated that these heteroleptic 
structures did not suffer from significant distortions of the ligands or the coordination 
environments of the CoII ions.[23]  
The ionisation and level of detection in the mass spectrometer is very likely to differ greatly for 
each species. However, information on the product distribution between homoleptic and 
heteroleptic could be obtained for each experiment. To do so, freshly prepared mixtures of 
preformed cages (non-equilibrated) at equal concentration were analysed in parallel to the 
equilibrated ones and compared to each other. For example, a fresh mixture of 6.5 and 6.6 was 
compared against equilibrated CoII6L
H
xL
I
4-x. Peaks corresponding to both homoleptic and 
heteroleptic species were observed in the mass spectra of equilibrated mixtures, whereas no 
peaks matching with heteroleptic species were observed in the freshly combined mixtures. This 
allowed the relative response factor of the heteroleptic species by themselves to be gauged. 
For all mixtures, the +4, +5 and +6 charge states were used for analysis as lower charge states 
were outside the spectral window of the instrument, and higher charge states overlapped with 
too many fragments to be incorporated into the analysis. Each region of the mass spectrum 
(corresponding to either a homoleptic or heteroleptic cage) was integrated for both equilibrated 
and fresh mixtures. To compensate for overlapping peaks for fragments in the heteroleptic 
regions, the integrals for regions corresponding to heteroleptic cages in freshly combined 
mixtures were subtracted from the integrals of the corresponding regions in the spectra of the 
equilibrated mixtures. No free ligand was observed in the NMR spectrum, hence the assumption 
that all homoleptic species consumed are converted into heteroleptic species was made. Under 
this assumption, integrals for each charge state could be normalised to unity to facilitate 
comparison (Figure 6.12). 
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Figure 6.11│Plot of the normalised integrals for either fresh or equilibrated mixtures of a) 6.5 (red) and 6.6 
(yellow), b) 6.5 (red) and 6.7 (green), c) 6.5 (red) and 6.8 (blue), d) 6.6 (yellow) and 6.7 (green), e) 6.6 (yellow) 
and 6.8 (blue), and f) 6.7 (green) and 6.8 (blue). The heteroleptic species CoII6LYxLZ4-x (x = 1, 2 or 3) formed are 
shown in grey. Error bars represent the standard deviations for each species observed in the ESI-mass spectra 
across the different charge states. 
 
No direct comparison between structures incorporating different ratios of ligands could be made 
in this case as the response factors of the homoleptic species were too different, and thus it was 
inferred that the response factors of heteroleptic species will vary as well. However, comparison 
between the overall amounts of homoleptic species in both equilibrated and fresh mixtures can 
be made, as they are structurally identical, and thus exhibit identical ionisation characteristics.  
This method eliminated effects associated with different detection intensities of charged 
complexes with different structures and different ligand configurations. 
The relative decrease in the integral of peaks attributed to homoleptic species was used to 
quantify the amount of each ligand integrated into all heteroleptic species. For example, in a 
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self-sorted mixture of 6.H and 6.I, the percentage of 6.5 and 6.6 remaining in the equilibrated 
mixture, as compared to 6.5 and 6.6 in the fresh mixture, was directly linked to the proportion 
of homoleptic species consumed by the generation of heteroleptic species. The decrease in the 
overall amount of homoleptic species thus relates to the percentage of heteroleptic species 
formed in solution. Likewise, the individual percentage decrease in either 6.5 or 6.6 indicates 
the proportion of subcomponent 6.H or 6.I respectively integrated into heteroleptic cages. 
Hence, the percentage of homoleptic species remaining after equilibration of the mixtures is 
obtained by comparing the normalised integrals of identical homoleptic species in the 
equilibrated (Ix(eq)) and the fresh mixtures (Ix(fresh)). The percentage of each homoleptic species 
(X = 6.5, 6.6, 6.7, or 6.8) remaining in the equilibrated mixtures can be calculated using 
Equation 6.2. 
Equation 6.2     %𝐗(𝐞𝐪)  =
I𝐗(𝐞q)
I𝐗(fresh)
∗ 100 
The values obtained for all mixtures are given in Table 6.1. 
 
Table 6.1│Percentage of homoleptic species remaining after equilibration of the mixtures of homoleptic cages. 
Mixture Percentage of homoleptic species remaining 
6.5 and 6.6 
Percentage of 6.5 Percentage of 6.6 
59 ± 3 40 ± 8 
6.5 and 6.7 
Percentage of 6.5 Percentage of 6.7 
68 ± 8 37 ± 2 
6.5 and 6.8 
Percentage of 6.5 Percentage of 6.8 
89 ± 7 69 ± 11 
6.6 and 6.7 
Percentage of 6.6 Percentage of 6.7 
38 ± 5 46 ± 9 
6.6 and 6.8 
Percentage of 6.6 Percentage of 6.8 
45 ± 5 46 ± 5 
6.7 and 6.8 
Percentage of 6.7 Percentage of 6.8 
81 ± 11 27 ± 4 
 
Chapter 6 
 
- 174 - 
The distribution between heteroleptic and homoleptic species is obtained by measuring the 
overall percentage of homoleptic species remaining after equilibration (Equation 6.3). The 
quantity of heteroleptic species is the reciprocal of this percentage (Equation 6.4). The 
distribution between species in a mixture of cages X and Y is given by:  
Equation 6.3   %𝐻𝑜𝑚𝑜𝑙𝑒𝑝𝑡𝑖𝑐(𝑿, 𝒀) =
%𝑿(𝐞𝐪)+%𝒀(𝐞𝐪)
2
 
Equation 6.4   %𝐻𝑒𝑡𝑒𝑟𝑜𝑙𝑒𝑝𝑡𝑖𝑐(𝑿, 𝒀) = 100 − %𝐻𝑜𝑚𝑜𝑙𝑒𝑝𝑡𝑖𝑐 
The values obtained for all mixtures are given in Table 6.2. 
 
Table 6.2│Distribution between homoleptic and heteroleptic species after equilibration of the mixtures of 
homoleptic cages. 
Mixture 
Percentage of 
homoleptic species  
Percentage of 
heteroleptic species  
6.5 and 6.6 49 ± 6 51 ± 6 
6.5 and 6.7 53 ± 5 47 ± 5 
6.5 and 6.8 79 ± 9 21 ± 9 
6.6 and 6.7 42 ± 7 58 ± 7 
6.6 and 6.8 46 ± 5 54 ± 5 
6.7 and 6.8 54 ± 7 46 ± 7 
 
Under the assumption that all homoleptic species consumed are converted into heteroleptic 
species during equilibration, the percentage of ligand 6.H, 6.I, 6.J or 6.K incorporated into the 
heteroleptic cages of the equilibrated mixtures can thus be quantified. This quantity corresponds 
to the percentage decrease of the corresponding homoleptic species in the equilibrated mixture, 
as compared to that in the fresh mixture. In a mixture of cages X and Y, the percentage of Lx 
incorporated in the heteroleptic species can be calculated using Equation 6.5.  
Equation 6.5  %𝐿𝑥(ℎ𝑒𝑡𝑒𝑟𝑜) =
(100−%𝐗(𝐞𝐪))
(100−%𝐗(𝐞𝐪))+(100−%𝐘(𝐞𝐪))
∗ %𝐻𝑒𝑡𝑒𝑟𝑜𝑙𝑒𝑝𝑡𝑖𝑐(𝑿, 𝒀) 
The ligand composition of heteroleptic cages can be obtained from the percentage of each 
ligand incorporated into heteroleptic species by cross multiplication. In a mixture of X and Y, 
the ligand composition Lx of heteroleptic cages can be calculated using Equation 6.6. 
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Equation 6.6  %𝐿𝑥(𝑐𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛) =  
%𝐗(ℎ𝑒𝑡𝑒𝑟𝑜)
%𝐗(ℎ𝑒𝑡𝑒𝑟𝑜)+%𝐘(ℎ𝑒𝑡𝑒𝑟𝑜)
∗ 100 
The values obtained for all mixtures are given in Table 6.3. 
Table 6.3│Ligand composition of heteroleptic species after equilibration of the mixtures of homoleptic cages. 
Mixture Ligand composition of heteroleptic species 
6.5 and 6.6 
Percentage of 6.H Percentage of 6.I 
41 ± 3 59 ±  8 
6.5 and 6.7 
Percentage of 6.H Percentage of 6.J 
34 ± 8 66 ± 2 
6.5 and 6.8 
Percentage of 6.H Percentage of 6.K 
27 ± 17 73 ± 25 
6.6 and 6.7 
Percentage of 6.I Percentage of 6.J 
53 ± 4 47 ± 7 
6.6 and 6.8 
Percentage of 6.I Percentage of 6.K 
50 ± 5 50 ± 5 
6.7 and 6.8 
Percentage of 6.J Percentage of 6.K 
21 ± 12 79 ± 4 
 
This method thus provided information on both the product distribution within the sorted 
mixtures (i.e., the percentage decrease observed for homoleptic species), as well as the 
proportion of each ligand integrated into the heteroleptic species for each experiment. The 
results are summarised in Figure 6.12.  
If there was no energetic bias for the formation of homoleptic vs heteroleptic structures, a 
socially-sorted mixture would be obtained, consisting of 12.5% of homoleptic species vs. 87.5% 
of heteroleptic species, following a binomial distribution. All sorting experiments were 
observed to deviate substantially from these values (Figure 6.12, left). When heteroleptic 
species were formed (all cases but the combination of 6.5 and 6.8 which followed near-
narcissistic sorting), the makeup was approximately 1:1 homoleptic:heteroleptic. This indicated 
a preference for the formation of homoleptic species, which can be attributed to the strain 
incorporated into mixed-ligand species. Indeed, all ligands have different sizes, leading to 
mismatches when forming heteroleptic structures. Similarly, in the absence of enthalpic bias, 
the ligand composition of the heteroleptic species should be even (1:1).  However, in some 
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cases, higher proportions of one ligand over another were integrated into heteroleptic structures 
(Figure 6.12, right). This indicated that some cage frameworks preferentially incorporated 
specific ligands into their structures.  
 
Figure 6.12│Product distributions determined from ESI-MS experiments: percentage distribution of homo- vs 
heteroleptic products (left) and the ligand make-up of the heteroleptic species (right), compared to the statistical 
binomial distribution (Stat). 
 
In the case of the mixtures CoII6L
H
xL
Y
4-x formed from 6.H and any of the other subcomponents, 
only small amounts of 6.H were incorporated into heteroleptic species, and homoleptic species 
were favoured over heteroleptic. On the other hand, when 6.I was employed with 6.K or 6.J, 
equal amounts of homoleptic and heteroleptic species were formed, which incorporated both 
ligands in similar proportions. This demonstrates that the slight difference of flexibility between 
planar 6.H, and pyramidal 6.I has a considerable impact on the outcome of the sorting. 
Furthermore, the flexibility of the ether linkages in 6.J and amine linkages in 6.K appears to 
enable geometrical diversity, allowing different conformations to be adopted in order to 
accommodate the differently-sized subcomponents. However, in the case of CoII6L
J
xL
K
4-x, 
where the triamines were the same size, a clear bias towards the integration of 6.K over 6.J into 
heteroleptic species was observed.  
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To further explain these observations, the heteroleptic mixtures were studied by IM-MS (ion-
mobility mass spectrometry). Although all structures are of identical stoichiometry, they are not 
isostructural and the difference in size between octahedron and scalenohedron should result in 
different drift times detected by the IM-MS instrument. Indeed, when species with identical 
stoichiometry are ionised, they can be differentiated by the time it takes them to travel through 
a buffer gas under an electric field.[47] Larger structures have a greater number of interactions 
with the buffer gas in the ion-mobility chamber leading to extended or elongated structures 
drifting slower than smaller structures of the same charge.[48-49] The drift time of each 
supramolecular species is thus directly related to its collisional cross section, which in turn 
depends on its geometry. Supramolecular architectures have previously been successfully 
studied with this technique.[50] IM-MS data was acquired and analysed for the mixtures of 6.H 
and 6.K (Figure 6.13), 6.I and 6.K (Figure 6.14) and 6.J and 6.K (Figure 6.15). 
The analysis of CoII6L
H
xL
K
4-x revealed that the m/z regions corresponding to the purely 
homoleptic cages 6.5 and 6.8 had unique drift times (9.6 – 10.4 ms and 10.4 – 11.0 ms, 
respectively) which were each attributed to the octahedral and scalenohedral structures (Figure 
6.13 c and d). Unfortunately, peaks for the heteroleptic species were too weak to examine, due 
to the near-narcissistic sorting of this system.   
When CoII6L
I
xL
K
4-x was analysed by IM-MS, two distinct drift times were observed at 
9.6 – 10.6 ms and 10.6 – 11.2 ms, corresponding to octahedral and scalenohedral geometries 
respectively. The shorter drift time regime included 6.6 and all heteroleptic species of this 
mixture, revealing the octahedral geometry of these structures (Figure 6.14 c). Only homoleptic 
6.8 was scalenohedral (Figure 6.14 d) showing that 6.I promoted the formation of heteroleptic 
octahedra exclusively when combined with 6.K. This situation was inferred to arise from the 
impossibility of rigid 6.I to accommodate the strain necessary to form the scalenohedron, 
whereas more flexible 6.K can adopt the right configuration to form an octahedron.  
The analysis of CoII6L
J
xL
K
4-x likewise revealed two distinct, broad drift time regions at 
10.0 – 10.5 ms and 10.6 – 11.2 ms attributed to octahedra and scalenohedra respectively. When 
each region was examined separately, the octahedra region was revealed to be comprised of 
mainly homoleptic 6.7 and a small proportion of species with higher numbers of 6.J 
incorporated (Figure 6.15 c). In contrast, the scalenohedra range was comprised of 6.8, and 
most of the heteroleptic species which incorporated a higher proportion of 6.K (Figure 6.15 d). 
This data indicated that the scalenohedral geometry is preferred over the octahedral geometry 
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when the ligands are similarly-sized. This bias was attributed to the favourable edge-to-face 
aromatic interactions within congeners of 6.8 incorporating higher numbers of the triamine 6.K.  
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Figure 6.13│IM-MS data for the mixture generated by combining 6.5 and 6.8 showing a) the z = +3 peaks and b) 
the two broad, overlapping drift time regions at 9.6 – 10.4 ms and 10.4 – 11.0 ms. The m/z regions of the purely 
homoleptic cages 6.5 and 6.8 revealed two unique, separate drift times. Peaks attributed to heteroleptic species 
were too weak in to examine, due to the near-narcissistic sorting of this system.   
 
 
 
Figure 6.14│IM-MS data for the mixture generated by combining 6.6 and 6.8 showing a) the z = +3 peaks and b) 
the two distinct, broad drift time regions at 9.6 – 10.6 ms (octahedra) and 10.6 – 11.2 ms (scalenohedra). Separate 
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examination of the two regions showed that species comprising any number of 6.I were octahedral (c) and that 
only 6.8, comprised entirely of 6.K was scalenohedral (d).  
 
 
 
 
Figure 6.15│IM-MS data for the mixture generated by combining 6.7 and 6.8 showing a) the z = +3 peaks and b) 
the two distinct, broad drift time regions at 10.0 – 10.5 ms (octahedra) and 10.6 – 11.2 ms (scalenohedra). Separate 
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examination of the two regions showed that the octahedra region was comprised of species with a higher proportion 
of 6.J (c) and that the scalenohedron range was comprised of species with a higher proportion of 6.K (d).  
 
 
Combining both ESI-MS and IM-MS techniques, the distinct behaviour of each mixture could 
be classified and a sorting regime was attributed to each mixture (Figure 6.16). Depending on 
their size, shape, flexibility, and electronic properties, three distinct sorting regimes were 
achieved. Subcomponents 6.H and 6.K underwent near-narcissistic sorting whereas 6.H and 
6.J, 6.H and 6.I or 6.I and 6.J underwent social self-sorting. Finally, geometrically-biased 
sorting was observed for 6.I and 6.K as well as 6.J and 6.K, towards octahedra or scalenohedra 
respectively. 
 
 
Figure 6.16│Distinct sorting regimes of the mixing experiments on pairs of amines (6.H – 6.K). a) Both homo- 
and heteroleptic species were observed to form from 6.H and 6.J, 6.H and 6.I or 6.I and 6.J. b) Geometrically-
biased sorting where all heteroleptic species formed by 6.I and 6.K were octahedral and only the homoleptic 6.8 
was scalenohedral. c) Geometrically-biased sorting where structures with a greater proportion of 6.K formed the 
scalenohedral shape preferentially for mixtures of 6.J and 6.K. d) Near-narcissistic sorting was observed for 6.H 
and 6.K.  
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6.4 Species amplification by guest binding 
The incorporation of molecules able to interact with congeners within a self-sorted library, such 
as templates, can change the outcome of the sorting process and redistribute the products 
obtained. Being able to quantify the effect of these external trigger molecules on the library 
could allow us to gain better knowledge on the synergy that exist within a self-sorted system. 
 
6.4.1 Chemical system 
Bilbeisi et al. previously reported the formation of FeII4L4 tetrahedral cages from 6.H or 6.I, 
picolinaldehyde and Fe(OTf)2 in CH3CN.
[51] No guest encapsulation was observed for these 
cages, due to the small size of their cavities. The use of CoII had previously proven to increase 
the cage’s cavity when used in self-assemblies instead of smaller coordination sphere metal 
cations.[52-53] Preliminary results by Rana Bilbeisi showed that the self-assembly of 
picolinaldehyde (12 eq.) and Co(NTf2)2 (6 eq.) with either triamine 6.H or 6.I (4 eq.) resulted 
in cages 6.9 and 6.10, respectively, after heating at 70 °C for 18 h (Figure 6.17 a). The 1H NMR 
spectra of 6.9 and 6.10 were consistent with highly symmetric species of overall T-symmetry 
while ESI-MS confirmed the CoII4L4 stoichiometry (Figure 6.17 b and c). Single crystals of 6.9 
and 6.10 suitable for X-ray diffraction were obtained by Rana Bilbeisi. In both cases, the cages 
crystallised with approximate T point-group symmetry with all CoII stereocentres displaying 
the same Δ or Λ stereochemistry (Figure 6.17 a). Both cage enantiomers were present in the 
crystals. Furthermore, the crystal structure of 6.10 contained a central ClO4
− anion bound within 
the cavity (Figure 6.21 a). The average CoII-CoII distances for 6.9 and 6.10 were found to be 
12.0 Å in both cases which is slightly larger than the previously reported values for the FeII 
analogues (11.9 and 11.8 Å respectively).[51]   
The distances between the central atom of the ligand and the plane defined by the three adjacent 
CoII centres varied significantly between 6.9 and 6.10 with values of 1.9 Å in the case of 6.9 
and 2.4 Å in the case of 6.10; evidence of a greater degree of pyramidalisation in the ligand 
incorporated in 6.10 (Figure 6.18). This phenomenon was already observed in the FeII analogues 
of the cages,[51] leading to differences in the cavity size. It was hypothesised that this variation 
in cavity size could subsequently lead to different host-guest properties. 
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Figure 6.17│a) Self-assembly of 6.9 and 6.10 from triamine 6.H or 6.I respectively, picolinaldehyde and 
Co(NTf2)2. Single crystal X-ray structures of 6.9 and 6.10 showing the side view and the top views down the main 
symmetry axes. Linkages between CoII centres (white spheres) have been added to highlight the framework, 
hydrogens are omitted for clarity. b and c) ESI-MS spectra of 6.9 and 6.10 respectively. 
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Figure 6.18│Distances between the central N or C of the ligands and the plane (in yellow) defined by three 
adjacent CoII atoms in the crystal structures of a) 6.9 and b) 6.10. Table summarizing the distances for 6.10 which 
were different due to the compound crystallising in monoclinic space group C2/c with no crystallographic 
symmetry. 6.9 crystallised in cubic space group I222 with crystallographic T-symmetry.  
 
6.4.2 Guest binding  
After addition of either TBABF4, TBAClO4, TBAI or TBABr, no changes in the 
1H NMR 
spectra of 6.9 were observed, indicative of no interaction between 6.9 and these anions. The 
lack of flexibility of 6.H leading to a smaller cavity size was inferred to prevent encapsulation 
of anions in 6.9 (Figure 6.19). 
 
Figure 6.19│a) Schematic representation of 6.9 and b) Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) 
of 6.9 after addition of TBAI, TBABr, TBABF4 or TBAClO4 (equivalents of guests given on the spectra) showing 
no changes and hence no anion binding. 
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In the case of 6.10, the wide sweep 1H NMR spectrum displayed a second set of signals 
consistent with a host-guest complex in solution, which was attributed to encapsulated CH3CN 
or CD3CN. The 
1H NMR spectrum of 6.10 in CH3CN was compared to that of the same cage 
in CD3CN (Figure 6.20).  Solvent suppression (single presaturation at 2.03ppm) was used to 
observe the region close to the solvent peak, however, due to the paramagnetic character of the 
sample, this led to a strong decrease in the proton signals of 6.10 (Figure 6.20 b). Both spectra 
had identical resonances, except for an additional peak at –0.9 ppm in CH3CN which was 
attributed to the encapsulated CH3CN. 
 
Figure 6.20│a) Wide sweep 1H NMR spectra (400 MHz, 298 K) of 6.10 in CD3CN (top) and CH3CN (bottom) 
showing the additional peak at 0.9 ppm in the second spectrum. b) Wide sweep 1H NMR spectrum (400 MHz, 
298 K, CH3CN) after solvent suppression. 
 
Br–, I–, BF4
– and ClO4
– were bound in slow exchange on the NMR timescale in 6.10. The 
subsequent addition of 1 eq. of TBAClO4, TBABF4, TBAI and TBABr to a solution of 6.10 
showed that ClO4
– could be partially displaced by BF4
–, which was in turn mostly displaced by 
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I– and Br– (Figure 6.21). The association strength of the different anions was inversely correlated 
to their size, ie. Br– > I– >> BF4
– > ClO4
–.[54] 
 
Figure 6.21│a) Schematic representation of 6.10 and single crystal X-ray structure of 6.10 highlighting the ClO4– 
anion bound within the cavity. b) Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of 6.10 after addition 
of TBAI, TBABr, TBABF4 or TBAClO4 (1 eq.) showing new sets of peaks for the host-guest complexes. c) Zoom 
into the 250 to 230 ppm and –16 to –36 ppm region of the 1H NMR spectra and assignment of the signals for 6.10 
(red triangle), CD3CN⊂6.10 (inverted grey triangle), ClO4–⊂6.10 (yellow triangle), BF4–⊂6.10 (green circle), 
I–  ⊂6.10 (blue star) and Br–⊂6.10 (black cross). 
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The binding of anions within the cavity of 6.10 did not follow the expected 1:1 binding when 
TBA+ salts of Br–, I–, BF4
– and ClO4
– were titrated into a CD3CN solution of 6.10. For all anions 
tested, the concentration of host-guest complex ([HG], X–⊂6.10) reached a plateau as the 
amount of guest added was increased, indicative of competitive binding from another species 
(Figure 6.23 and Figure 6.24).  
Cage 6.10(BF4)8 was synthesised directly from Co(BF4)2, picolinaldehyde and 6.I and TBABF4 
(8 eq.) was added to 6.10(NTf2)8, giving two different solutions of 6.10, containing equal 
amounts of BF4
– but different amounts of TBANTf2 (respectively 0 eq. and 8 eq.). Close 
examination of their 1H NMR spectra revealed that the amount of encapsulated BF4
– was greater 
in the case where neither TBA+ nor NTf2
– were present (Figure 6.22 a). Furthermore, when 
TBANTf2 (50 eq.) was added to 6.10(BF4)8, a drastic decrease in the encapsulated BF4
– was 
observed (Figure 6.22 b, middle spectrum). When TBABF4 (50 eq.) was added to 6.10(BF4)8, 
the amount of host-guest complex (BF4
–⊂6.10) decreased as well, despite the large increase in 
guest concentration (Figure 6.22, top spectrum). The association of the TBA+ cation with the 
anionic guest was thus inferred to limit the formation of the host-guest complex X–⊂6.10. 
The equations for guest binding were modified to account for the competition of the solvent 
(CH3CN) and the TBA
+ in guest binding, with help from John Thoburn. The changes in the 
concentration of the host-guest complex (X–⊂6.10, abbreviated HG), host-solvent complex 
(CH3CN⊂6.10, abbreviated HS), and empty cage (6.10, abbreviated H) as a function of the 
added guest were described by sets of equations. Based on the different behaviours observed in 
the titrations, two scenario were defined:  
 When the affinity of the guest for cage 6.10 was superior to the affinity of the guest for 
TBA+, the concentration of host-guest complex [HG] converged to unity and the 
concentration of host-solvent [HS] converged to zero. This was observed when strongly 
binding anions (TBABr or TBAI) were titrated into a CD3CN solution of 6.10. In this 
case, the system was described by Equation 6.7 – 6.9.  
 
Equation 6.7  
[𝐻𝐺] =
[𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
− √([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
)
2
− 4[𝐻𝑡][𝐺𝑡]
2
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Equation 6.8  
[𝐻] =
[𝐻𝑡] −
1
2
([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
− √([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
)
2
− 4[𝐻𝑡][𝐺𝑡])
(1 + 𝐾𝐻𝑆[𝑆𝑡])
 
 
Equation 6.9  
[𝐻𝑆] =
𝐾𝑆[𝑆𝑡]
1 + 𝐾𝑆[𝑆𝑡]
([𝐻𝑡] −
1
2
([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
− √([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
)
2
− 4[𝐻𝑡][𝐺𝑡])) 
 
 When the affinity of the guest for cage 6.10 was inferior to the affinity of the guest for 
TBA+, the concentration of host-guest complex [HG] converged to a value inferior to 
one and the concentration of host-solvent [HS] remained constant. In this case, the [HS] 
was fitted to a straight line. A scaling factor (C) was introduced to account for the pairing 
between TBA and X–. This was observed when weakly binding anions (TBABF4 or 
TBAClO4) were titrated into a CD3CN solution of 6.10. The system was described by 
Equation 6.10 – 6.12.  
 
Equation 6.10  
[𝐻𝐺] = 𝐶
[𝐻𝑡] − [𝐻𝑆] + [𝐺𝑡] +
1
𝐾𝐻𝐺
− √([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
)
2
− 4[𝐻𝑡][𝐺𝑡]
2
 
 
Equation 6.11  
[𝐻] = [𝐻𝑡] − [𝐻𝑆] −
𝐶
2
([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
− √([𝐻𝑡] + [𝐺𝑡] +
(1 + 𝐾𝐻𝑆[𝑆𝑡])
𝐾𝐻𝐺
)
2
− 4[𝐻𝑡][𝐺𝑡]) 
 
Equation 6.12  
[𝐻𝑆] = 𝑚[𝐺𝑡] − 𝑏 
 
where [St] represents the total solvent concentration, [Ht] the total host concentration, [Gt] the 
total guest concentration, KHS the equilibrium constant for solvent binding , KHG the equilibrium 
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constant for guest binding and m and b are constants. C represented the scaling factor, which 
was added to account for the contribution of the TBA+ pairing with the different anions.  
 
Figure 6.22│a) Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of 6.10(NTf2)8 to which was added 8 
eq. of TBABF4 (bottom) and 6.10(BF4)8 (top). b) Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of 
6.10(BF4)8 before (bottom) and after addition of either 50 eq. of TBANTf2 (middle) or TBABF4 (top). 
 
Fitting of the NMR titration data to Equation 6.7 – 6.9 or 6.10 – 6.12 simultaneously rather than 
individually was performed using a Mathematica program written by John Thoburn (Figure 
6.23 and Figure 6.24), allowing association constants for the different anions to be calculated. 
More information on the mathematical models is given in Section 6.6.9.  
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Figure 6.23│Plot of the concentration of total host (6.10 total in yellow), free host (6.10 free in red), host-guest 
complex (X–⊂6.10 in blue) and solvent-host complex (CH3CN⊂6.10 in green) as a function of the concentration 
of guest (TBAX) for a) X = Br– and b) I–. The experimental data obtained from titrations is given by the points 
(triangles, circles, squares and diamonds) and the fitting obtained is represented by the dotted lines. 
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Figure 6.24│Plot of the concentration of total host (6.10 total in yellow), free host (6.10 free in red), host-guest 
complex (X–⊂6.10 in blue) and solvent-host complex (CH3CN⊂6.10 in green) as a function of the concentration 
of guest (TBAX) for a) X = BF4– and b) ClO4–. The experimental data obtained from titrations is given by the 
points (triangles, circles, squares and diamonds) and the fitting obtained is represented by the dotted lines. 
 
Due to dilution effects resulting from the addition of the guest solution during titration, the total 
host concentration [Ht] decreased and was modelled as a straight line (Figure 6.23 and Figure 
6.24, yellow line). Thus, the host-guest concentration [HG] increased asymptotically to the 
dilution curve (Figure 6.23 and Figure 6.24, blue line). Furthermore, unity was not reached due 
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to the competition of TBA+ for the guest, which was introduced into the system in the same 
amounts as the guest. The scaling factor C (Equation 6.7 – 6.9) was thus introduced in the 
equations to account for the TBA pairing; C was equal to one in the case of Br– and I– and 
corresponded to the saturation concentration, ie. the asymptote of the [HG] curve for BF4
– and 
ClO4
–
. For large guests (BF4
– and ClO4
–
 ), the concentration of encapsulated solvent [HS], did 
not decrease asymptotically to zero as more guest was added, but remained at 10% occupancy 
and the binding curves for [HS] were thus fitted to a straight line. This was explained by the 
weaker binding affinity of these guests which could not displace the solvent, present in large 
excess. Smaller guests (Br¯ and I¯) with stronger binding could expel the weakly bound solvent. 
The following values for the association constants of the guests in 6.10 in the presence of TBA+ 
were obtained: 
KBr = 16000 ± 1000 M
–1 
KI = 4800 ± 400 M
–1 
KBF4 = 580 ± 50 M
–1 
KClO4 = 1100 ± 100 M
–1 
KCH3CN = 0.0072 ± 0.0004 M
–1 
These values take into account the non-specific interaction of TBA+ and the anion and thus do 
not represent the actual binding affinities of the anion within 6.10. The contribution of each 
phenomenon individually (internal binding and ion pairing) could not be quantified as the 
system was underdetermined.  
 
6.4.3 Quantification by mass spectrometry 
The similarity in sizes of 6.H and 6.I has been used previously to generate a family of 
heteroleptic cages FeIILHxL
I
4-x.
[51] The substitution of FeII for CoII leading to guest encapsulation 
in 6.10 opens prospects for selectively templating specific members of the library. As expected, 
the reaction of 6.H and 6.I (1 eq. each), picolinaldehyde (6 eq.) and Co(NTf2)2 (2 eq.) in CH3CN 
led to the formation of a library (LibNTf2) of cages of formula Co
II
4L
H
xL
I
(4-x) as confirmed by 
ESI-MS (Figure 6.25).  
The same reaction in the presence of sub-stoichiometric amounts of picolinaldehyde (3 eq. 
instead of 6 eq.) at room temperature led to the formation of a different library (LibNTf2SUB). 
ESI-MS revealed the presence of congeners of stoichiometry CoII4L
H
xL
I
(4-x) with 2 ≤ x ≤ 4 
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predominantly (Figure 6.26 a). Three sets of signals containing six, four, and one resonance 
each were observed in the imine region of the 1H NMR (Figure 6.26 b) which were attributed 
to CoII4L
H
4 (T symmetry, one signal per imine proton), Co
II
4L
HLI3 (C3 symmetric, four signals) 
and CoII4L
H
2L
I
2 (C2 symmetric, six signals). Based on this assignment, each signal observed in 
the imine region of the 1H NMR spectrum of LibNTf2 was attributed to one of the congeners 
present (Figure 6.26 c). However, the strong overlap of some signals limited the possibility of 
signal deconvolution, thus no information on the proportion of species present in solution was 
obtained.  
 
Figure 6.25│a) Self-assembly of LibNTf2 from 6.I, 6.H, picolinaldehyde and Co(NTf2)2 into a library of cages of 
the formulae CoII6LHxLI4-x. b) +3 charge peak region of the HR-ESI-MS and c) LR-ESI-MS of LibNTf2 showing 
the isotopic pattern for the cages CoII6LHxLI4-x.  
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Figure 6.26│a) LR-ESI-MS of LibNTf2SUB showing that the predominant species are those incorporating high 
numbers of LH. Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of  b) LibNTf2SUB with the signals assigned 
based on the symmetry of each species and of c) LibNTf2 with all signals attributed in the imine region. Signals for 
CoII4LH4 are marked by a red triangle, CoII4LHLI3 by a green circle, CoII4LH2LI2 by a yellow triangle, CoII4LH3LI by 
a grey inverted triangle and CoII4LI4 by a blue star. 
 
Mass spectrometry, in contrast, allowed the library speciation to be studied in greater detail. 
When 6.9 and 6.10 were combined in equimolar amounts and quickly analysed by ESI-MS 
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before scrambling of the ligands could occur, similar ESI response factors were observed for 
both cages (Figure 6.27). The relative integrals of the peaks for each species did not deviate 
significantly from the expected 1:1 ratio when averaged across the observable charge states of 
+3 to +7. It was therefore hypothesised that the heteroleptic congeners of the library have 
similar response factors and that the integrals of the signals observed for each species are 
proportional to the species concentration in solution.  
 
Figure 6.27│LR-ESI-MS of a freshly combined equimolar mixture of 6.9 and 6.10 and the table summarising the 
integrals of each species for the observed charge states. 
 
In the light of this result, mass spectrometry was used to quantify the amount of congeners 
within libraries formed from 6.H and 6.I. Within each charge state observed in the mass spectra, 
the integrals of the m/z peaks were normalised and the values obtained were averaged across 
the +7 to +3 charge states. Experiments were repeated three times to minimise the error.  
In the case of LibNTf2 (Figure 6.25), the Co
II
4L
H
xL
I
(4-x) species were observed in a 
1:4.1:5.8:3.8:0.8 ratio (Figure 6.25 b). Similarly to Section 6.1.2, a set of equilibrium constants 
between congeners could be calculated. These equilibrium constants were defined by the ratio 
between the observed amount of a species in the library and a binomial distribution. Each 
congener was identified by the number N of ligand LH they possess. The relative energy of each 
could be determined by using the same formula as previously:  
Equation 6.1   𝛥𝐸𝑟𝑁 =  −𝑅𝑇𝑙𝑛(𝐾𝑁),       𝑤𝑖𝑡ℎ 𝐾𝑁 =
(
𝐼𝑁
𝐼𝑠𝑡𝑎𝑡𝑁
)
𝐼0
 
where IN represented the normalised integrals of the mass peak for the structure incorporating 
N LH, IstatN was the corresponding normalised integral for an ideal binomial distribution, and I0 
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was the normalised integral of the mass peak for the most stable structure, here 6.10 (N = 0). 
The average values of the relative energies of each congener were obtained by averaging the 
values across all charge states observed and across three repeats of each experiment. The 
relative Gibbs energies showed no significant deviation from the null hypothesis by Fisher’s 
test as the p-value was above the significance threshold of 0.05 (F = 0.262 and p = 0.660). The 
distribution of congeners within LibNTf2 was thus inferred to not significantly deviate from the 
binomial distribution (Figure 6.33, grey curve). 
Addition of anions X– (2 eq., Br–, I–, BF4
– or ClO4
–) able to bind in the cavity of 6.10 to LibNTf2 
followed by equilibration of the mixtures for 18 h at 70 °C led to changes in the proportion of 
species present in the library (LibX). The ESI-MS spectra displayed clusters of peaks indicative 
of the CoII4L
H
xL
I
(4-x) cages associated with zero, one or more X
– (Figure 6.28 to Figure 6.31). 
The presence of a signal for cages with no X– associated (CoII4L
H
xL
I
4-x
 + mNTf2) along with 
signals for 6.9 (which doesn’t bind X–) associated with X– indicated that X– can either be 
associated externally or internally with the cages. The species within the library LibX which do 
not have an encapsulated X– were defined as belonging to a distribution named DisA(X–, n) 
with n the number of anions X– externally associated (0≤n<8). The species within LibX which 
do have an encapsulated X– were defined as belonging to a distribution named DisB(X–, n) with 
n the overall number of anions X– associated (internally and externally, 1≤n<8). The new library 
LibX thus consists of a distribution of species with: 
 no X– associated ([CoII4L
H
xL
I
4-x
 + mNTf2], 0<m<8) which is referred to as DisA(X
– ,0))  
 X– externally associated ([CoII4L
H
xL
I
4-x + nX
– + (m–n)NTf2], 1≤n<8, n<m<8) which is 
referred to as DisA(X–  ,n  ) 
 X– internally associated ([X–⊂CoII4LHxLI4-x + (n–1)X– + (m–n)NTf2], 1≤n<8, n<m<8) 
which is referred to as DisB(X–,n)) 
Information on the impact of anion X– on the library can be obtained by analyzing the 
distribution of congeners X–⊂CoII4LHxLI4-x of the library LibX which are represented by 
DisB(X–,n). However, the peaks corresponding to DisB(X–,n) overlap with those of DisA(X–  ,n) 
in the mass spectra as they represent complexes of the same m/z ratios (Figure 6.28 to Figure 
6.31, blue triangle and grey star). The integrals of the m/z peaks in the ESI-MS were calculated 
for each congener within each charge state observed for the cluster with zero and one anion 
associated (Figure 6.28 to Figure 6.31, blue triangle and green circle). Due to similarity of the 
response factors for 6.9 and 6.10 across charge states, the integrals of the m/z peaks were 
assumed to be proportional to the concentration of each species in solution. 
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Figure 6.28│LR-ESI-MS of LibClO4 obtained after addition of TBAClO4 (2 eq.) to LibNTf2. Zoom in the +3 region 
of the mass spectra showing the clusters corresponding to cages with no ClO4– associated (DisA(ClO4–,0), green 
circle), cages with one ClO4– associated (DisA(ClO4–,1) + DisB(ClO4–,1), blue triangle) and cages with two ClO4– 
associated (DisA(ClO4–,2) + DisB(ClO4–,2), grey star). 
 
Figure 6.29│LR-ESI-MS of LibBF4 obtained after addition of TBABF4 (2 eq.) to LibNTf2. Zoom in the +3 region 
of the mass spectra showing the clusters corresponding to cages with no BF4– associated (DisA(BF4–,0), green 
circle), cages with one BF4– associated (DisA(BF4–,1) + DisB(BF4–,1), blue triangle) and cages with two BF4– 
associated (DisA(BF4–,2) + DisB(BF4–,2), grey star). 
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Figure 6.30│LR-ESI-MS of LibI obtained after addition of TBAI (2 eq.) to LibNTf2. Zoom in the +3 region of the 
mass spectra showing the clusters corresponding to cages with no I– associated (DisA(I–,0), green circle) and cages 
with no I– associated (DisA(I–,1) + DisB(I–,1), blue triangle). 
 
Figure 6.31│ LR-ESI-MS of LibBr obtained after addition of TBABr (2 eq.) to LibNTf2. Zoom in the +3 region of 
the mass spectra showing the clusters corresponding to cages with no Br– associated (DisA(Br–,0), green circle) 
and cages with one Br– associated (DisA(Br–,1) + DisB(Br–,1), blue triangle). 
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DisA(X–,1) is made of the same cages, as DisA(X–,0) (empty cages CoII4L
H
xL
I
4-x) and only 
differ by the number of anions X– externally associated. The number of externally associated 
anions observed is only dependent on the ionisation of the mass spectrometer. Therefore the 
ratio of congeners within each clusters are identical and the distributions only differ by a scaling 
factor. As 6.9 can not encapsulate any anions (as observed in the NMR, Figure 6.19), the peak 
corresponding to this cage (marked by x=4 on the blue triangle cluster in Figure 6.28 to Figure 
6.31) is representative of DisA(X–,1) exclusively. The scaling factor between DisA(X– ,1) and 
DisA(X– ,0) could thus be obtained by comparing the integrals of the peak for 6.9 in the two 
adjacent cluster (Figure 6.28 to Figure 6.31, blue triangle and green circle). It was thus possible 
to obtain the values of the integrals for the congeners within DisB(X–,1) by subtracting 
DisA(X–  ,1) from the values observed in the cluster incorporating both of these distributions 
(Figure 6.28 to Figure 6.31, blue triangle).  
The values obtained for the congeners within DisB(X–  ,1) were normalized to unity and 
averaged across all charge states observed. The distributions obtained deviated strongly from 
the near binomial distribution observed for LibNTf2 (Figure 6.32). Structures incorporating high 
numbers of LI were favoured for all anions tested, with greater deviations for smaller anions. 
This correlated with the trends observed for binding of the anions in 6.10, ie. 
Br– > I– >> BF4
– > ClO4. 
 
Figure 6.32│Normalised integrals for LibNT2 (gray) and DisB(X–) obtained from LibX (X– = Br–, I–, BF4– and 
ClO4–, respectively in blue, yellow, red and green). Average and standard deviations (error bars) over three repeats 
of the experiment and across all charge states observed. 
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The Gibbs energies were calculated for the congeners of LibX (X– = Br–, I–, BF4– and ClO4–) 
using Equation 6.1 and the ratio between the integrals observed for DisB(X–) and those 
observed for the library in the absence of encapsulated anions (LibNTf2) was determined. The 
values of the relative energies were plotted as a function of the number of LH incorporated in 
the congeners for each anion used. The energetic cost was higher for each LH incorporated, due 
to the reduced size of the cavity of the congeners and hence the decreased binding affinity for 
the anions. Anions which bound strongly within 6.10 imparted greater changes on the libraries, 
leading to higher levels of energetic destabilisation of structures incorporating LH 
predominantly. The relative energy calculated for 6.9 was lower than for the CoII4L
H
3L
I 
congener which was explained by the excess of LI left in the mixture after amplification of the 
congeners incorporating more LH (Figure 6.33). In this case, the ESI-MS analysis enabled 
information to be gained on the binding preference of anions within a library of compounds. 
 
 
Figure 6.33│ Relative energies (kJ mol-1) of the library of cages in the absence of templating anions (NTf2–, grey) 
and of the libraries of cages in the presence of templating anions (Br–, I–, BF4– and ClO4– respectively in blue, 
yellow, red and green). Average over three repeats of the experiment and across all charge states observed. 
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6.5 Conclusion and future work 
In the first example of this chapter, a straightforward analysis based on ESI-MS was used to 
elucidate some of the key factors that led a fluorinated bis-bidentate ligand to form mer rather 
than fac metal vertices. The energetic preference of fluorinated ligands to form mer vertices, 
and therefore prismatic structures, was quantified and compared to the same value for non-
fluorinated ligands. The relative energetic destabilisation was found to be greater for fluorinated 
ligands incorporated into fac vertices and thus tetrahedra than for non-fluorinated ligands 
incorporated into mer vertices and thus prisms. With this key information in hand, the design 
of more complex, larger supramolecular architectures with mer-coordination motifs such as 
icosahedra or dodecahedra could be facilitated. 
In the second case, fine-grained details of self-sorting within complex cage systems could be 
quantified by various MS techniques. A highly accessible analysis based on ESI-MS was used 
to deduce the quantity and composition of metal-organic cages within self-sorted mixtures. In 
addition, the IM-MS study enabled the morphology of heteroleptic species to be determined. 
Combined, these two techniques reported on the distribution of products within self-assembled 
mixtures and the sorting regime they adopted. Rules governing the self-assembly of heteroleptic 
structures based on ligand properties were drawn, which could help with building and 
understanding more complex systems in the future.   
Finally, the subtle effects of guest encapsulation on a statistical library of cages was studied by 
ESI-MS using a similar method as in the first example. The presence of the anion favoured 
structures incorporating more of the flexible ligand. Strongly bound anions lead to an increased 
energetic destabilisation of each congener of the library compared to weaker binding anions, 
allowing for the information on relative binding strength to be gained via MS. Quantitative 
insight into the speciation of complex dynamic libraries of cages in the presence of small guest 
molecules was hence gained.  
Overall, MS has been shown to be a valuable tool for the study of complex dynamic self-sorting 
mixtures. However, the general study of systems by mass spectrometric techniques is still 
limited due to a number of constraining factors such as the variability in the ionisation of each 
structure, the overlap of signals for structural isomers, and fluctuation in detection levels 
between instruments.  
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6.6 Experimental section 
6.6.1 Synthesis of subcomponents 6.A and 6.B 
Synthesis of 5-phenylpicolinaldehyde 6.A 
Phenylboronic acid (98.3 mg, 0.806 mmol, 1.50 eq.), 5-bromopicolinaldehyde (100 mg, 0.538 
mmol, 1.00 eq.) and potassium phosphate (286 mg, 1.35 mmol, 2.50 eq.) were dissolved in 
1,4-dioxane (5 mL) in a round bottom flask and degassed with nitrogen for 15 min. Pd(PPh3)4 
(25 mg, 2.16 mmol, 0.040 eq.) was added and the mixture was degassed for a further 5 min. 
The round bottom flask was equipped with a condenser attached to a nitrogen line and the 
mixture was heated at 100 °C for 24 h, after which TLC analysis indicated the absence of 
starting material in the reaction mixture. The reaction was cooled to room temperature, diluted 
with water (50 mL) and extracted with CH2Cl2 (5 × 25 mL). The combined organic phases were 
dried over MgSO4, filtered and the solvent removed in vacuo to give the crude product as a 
brown solid. Purification by silica gel chromatography (EtOAc in hexane, 10% - 100%) gave 
aldehyde 6.A as a yellow solid (54.2mg, 0.296 mmol, 55% yield). 
1H NMR (400 MHz, 298K, CDCl3) δ 10.14 (s, 1H), 9.02 (s, 1H), 8.10 – 8.01 (m, 2H), 7.65 (d, 
J = 7.1 Hz, 2H), 7.51 (m, 3H). 
This data matches the data reported for the commercial product (CAS RN: 780800-85-3) from 
Acros Organics. 
Synthesis of (2,3,5,6-tetrafluorophenyl)picolinaldehyde 6.B 
 (6-(1,3-Dioxolan-2-yl)pyridin-3-yl)boronic acid[22] (100 mg, 
0.513 mmol, 1.00 eq.), 1-bromo-2,3,5,6-tetrafluorobenzene (176 mg, 
0.770 mmol, 1.50 eq.) and potassium phosphate (272 mg, 1.28 mmol, 
2.50 eq.) were dissolved in 1,4-dioxane/water (3:1 v/v, 6.7 mL) in a 
round bottom flask and degassed with nitrogen for 15 min. Pd(PPh3)4 (23.7 mg, 0.021 mmol, 
0.040 eq.) was added and the mixture was degassed for a further 5 min. The round bottom flask 
was equipped with a condenser attached to a nitrogen line and the mixture was heated at 100 °C 
for 24 h, after which TLC analysis indicated the absence of starting material in the reaction 
mixture. The reaction was cooled to room temperature, diluted with water (50 mL) and 
extracted with CH2Cl2 (3 × 50 mL). The combined organics were dried over MgSO4, filtered, 
and the solvent removed in vacuo. Purification through a plug of silica (EtOAc in hexane, 15% 
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- 100%) afforded a yellow solid, which was used directly in the next step. The solid was 
dissolved in THF/1M HCl(1:1) (30 mL). The reaction was heated at 60 °C for 18 h. The reaction 
was cooled to room temperature and the THF was removed in vacuo. The reaction was 
neutralised by the addition of 15 mL of an aqueous saturated solution of NaHCO3 (15 mL). At 
this point the product precipitated out and was collected via centrifuge. The cream precipitate 
was washed with H2O (2 × 10 mL) before being dried under a flow of nitrogen to furnish 
aldehyde 6.B as a yellow solid (39.9 mg, 0.154 mmol, 30%). 
1H NMR (500 MHz, 298K, CD3CN) δ 10.07 (s, 1H, Hd), 8.92 (d, J = 0.9 Hz, 1H, Ha), 8.13 (dd, 
J = 8.1, 0.9 Hz, 1H, Hb), 8.08 (dd, J = 8.1, 0.9 Hz, 1H, Hc), 7.47 (tt, J = 10.2, 7.6 Hz, 1H, He). 
19F NMR (376 MHz, 298K, CD3CN) δ−140.5 (dd, J = 21.5, 12.8 Hz), −145.0 (dd, J = 21.4, 
12.8 Hz). 13C NMR (126 MHz, 298K, CD3CN) δ 192.7 (s), 152.6 (s), 150.9 (s), 147.8 − 147.4 
(m), 145.3 − 144.8 (m), 142.6 – 142.3 (m),  138.7 (s), 128.2 (s), 121.4 (s), 117.0 (s), 106.8 (s). 
TOF-MS-ES+: Calculated [B+H]+=256.0385 Observed [B+H]+=256.0363 
 
 
Figure 6.34│1H NMR (400 MHz, 298K, CD3CN) of 6.B 
 
 
Figure 6.35│13C NMR (126 MHz, 298K, CD3CN) of 6.B. 
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Figure 6.36│19F NMR (376 MHz, 298K, CD3CN) of 6.B 
 
6.6.2 Synthesis of mononuclear complexes 6.1 and 6.2 
Mononuclear complex 6.1 
5-Phenylpicolinaldehyde 6.A (2.0 mg, 11.0 µmol, 3.0 eq.), 
p-fluoroaniline (1.2 mg, 11.0 µmol, 3.0 eq.) and Fe(NTf2)2.6H2O 
(2.5 mg, 3.60 µmol, 1.0 eq.) were dissolved in CH3CN (2 mL) in a 
sealed 5 mL reaction tube. The solution was heated at 50 °C for 
24 h. The dark purple solution was then cooled and concentrated 
under a flow of nitrogen. The solution was dried under a flow of 
nitrogen and redissolved in CD3CN for analysis.  
Mononuclear complex 6.1 was obtained as a mixture of fac and mer isomers. 
1H NMR (400 MHz, 298K, CD3CN) δ, mer-1 isomer: 9.53 (s, 1H, mer-Hd), 9.41 (s, 1H, 
mer-Hd), 9.16 (s, 1H, mer-Hd), 8.75 (s, 1H, mer-Ha), 8.65 (s, 1H, mer-Hc), 8.63 (s, 1H, mer-Hc), 
8.61 (s, 1H, mer-Ha), 8.44 (s, 1H, mer-Hb), 8.25 (s, 1H, mer-Hb), 8.14 (s, 1Hmer-Hc), 8.09 (s, 
1H, mer-Hb), 8.00 (s, 1H, mer-Ha), 7.63 – 7.45 (m, 30H, 3 mer-Hh + 3 mer-Hi + 3 mer-Hj + 
fac-Hh + fac-Hi  + fac-Hj), 7.22 (s, 2H, mer-Hf), 6.95 (s, 2H, mer-Hf), 6.88 (s, 2H, mer-He), 6.78 
(s, 4H, mer-Hf+mer-He), 6.15 (s, 2H, mer-He). 
1H NMR (400 MHz, 298K, CD3CN) δ, fac-1 
isomer: 9.13 (s, 3H, fac-Hd), 8.60 (s, 3H, fac-Hb),8.12 (s, 3H, fac-Hc), 7.78 (s, 3H, fac-Ha),7.63 
– 7.45 (m, 30H, 3 mer-Hh + 3 mer-Hi +3 mer-Hj + fac-Hh + fac-Hi +fac-Hj),7.07 (t, J = 8.5 Hz, 
6H, fac-Hf),5.65 (dd, J = 8.4, 4.6 Hz, 6H, fac-He). 
13C NMR (126 MHz, 298K, CD3CN) δ 175.7 
(s), 174.9 (s), 173.6 (s), 172.7(s), 157.5 – 155.0 (m), 143.5 (s), 138.5 – 137.7 (m), 136.8 – 135.3 
(m), 133.0 – 131.6 (m), 131.2 – 130.1 (m), 129.1 – 128.1 (m), 126.0 – 124.5 (m), 122.3 – 122.0 
(m), 119.9 – 119.0 (m), 117.6 – 115.7 (m). 19F NMR (376 MHz, 298K, CD3CN) δ −80.60 (s, 
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NTf2
−), −113.47 (s, mer-F + mer-F), −113.91 (s, mer-F), −114.20 (s, fac-F). LR-ESI-MS: 
[charge, calculated mass]: m/z = 442.3 [6.12+, 442.3], 1164.2 [6.1(NTf2)
+, 1164.6]. 
HR-ESI-MS: m/z calculated for 6.12+ = 442.1263, observed = 442.1260. 
 
 
Figure 6.37│Aromatic region of the 1H NMR spectrum (400 MHz, 298K, CD3CN) of a solution of complex 6.1 
 
 
Figure 6.38│19FNMR spectrum (376 MHz, 298K, CD3CN) of a solution of complex 6.1 
Chapter 6 
 
- 206 - 
 
Figure 6.39│Aromatic region of the 1H-1H COSY spectrum (500 MHz, 298K, CD3CN) of a solution of complex 
6.1. 
 
Figure 6.40│Aromatic region of the 1H-13C HSQC spectrum (500 MHz, 298K, CD3CN) of a solution of 
complex 6.1 
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Mononuclear complex 6.2 
(2,3,5,6-Tetrafluorophenyl)picolinaldehyde 6.B (2.0 mg,  
7.80 µmol, 3.0 eq.), p-fluoroaniline (0.87 mg, 7.80 µmol, 
3.0 eq.) and Fe(NTf2)2.6H2O (1.8 mg, 2.60 µmol, 1.0 eq.) 
were dissolved in CH3CN (2 mL) in a sealed 5 mL reaction 
tube. The solution was heated at 50 °C for 24 h. The dark 
purple solution was then cooled and concentrated under a 
flow of nitrogen.  
1H NMR (500 MHz, 298K, CD3CN) δ 9.42 (s, 1H, Hd), 9.20 (s, 1H, Hd), 9.04 (s, 1H, Hd), 8.67 
(d, J = 8.1 Hz, 1H, Hc), 8.65 (s, 1H, Ha), 8.45 (s, 1H, Ha), 8.43 (d, J = 7.5 Hz, 1H, Hb), 8.26 (d, 
J = 7.5 Hz, 1H, Hb), 8.19 (d, J = 8.1 Hz, 1H, Hc), 8.16 (d, J = 8.1 Hz, 1H, Hc), 8.12 (d, 
J = 7.5 Hz, 1H, Hb), 7.88 (s, 1H, Ha), 7.63 – 7.39 (m, 3H, Hj), 7.19 (t, J = 7.5 Hz, 2H, Hf), 7.03 
(t, 2H,J = 7.5 Hz, Hf), 6.86 (underneath p-fluoroaniline peak, 4H, He + Hf), 6.77 (b, 2H, He), 
6.29 (b, 2H, He). 
13C NMR (126 MHz, 298K, CD3CN) δ 175.3 (s), 173.5 (s), 172.3 (s), 
158.6 – 157.1 (m), 156.2 (s), 147.6 – 146.8 (m), 145.9 – 144.5 (m), 143.8 – 142.0 (m), 
141.2 – 139.8 (m), 132.2 – 129.0 (m), 124.9 – 123.3 (m), 121.2 (s), 119.7 – 118.3 (m), 
116.7 – 115.8 (m), 109.2 – 107.6 (m).  LR-ESI-MS: [charge, calculated mass]: m/z = 549.9 
[6.22+, 550.3], 1379.8 [6.2(NTf2)
+, 1380.5] HR-ESI-MS: m/z calculated for 6.22+ = 550.0698, 
observed = 550.0687. 
 
 
Figure 6.41│Aromatic region of the1H NMR spectrum (500 MHz, 298K, CD3CN) of a solution of complex 6.2 
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Figure 6.42│19FNMR spectrum (376 MHz, 298K, CD3CN) of a solution of complex 6.2 
 
 
Figure 6.43│Aromatic region of the 1H-1H COSY spectrum (500 MHz, 298K, CD3CN) of a solution of complex 
6.2 
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Figure 6.44│Aromatic region of the 1H-13C HSQC spectrum (500 MHz, 298K, CD3CN) of a solution of 
complex 6.2. 
 
6.6.3 Synthesis of cages 6.3 and 6.4 
5,5'-(1,4-phenylene)dipicolinaldehyde 6.C or 5,5'-(Perfluoro-1,4-phenylene)dipicolinaldehyde 
6.D (5.50 µmol, 3.0 eq.), p-methoxyaniline (1.4 mg, 11.0 µmol, 6.0 eq.) and Fe(PF6)2.6CH3CN 
(2.2 mg, 3.70 µmol, 2.0 eq.) were dissolved in CH3CN (2 mL) in a sealed 5 mL reaction tube. 
The solution was heated at 50 °C for 24 h. The dark green or blue respectively solutions were 
then cooled and concentrated under a flow of nitrogen. Addition of 10 mL of diethyl ether 
precipitated the cages as a dark green or blue solid. The solid was separated by centrifugation 
and washed with diethyl ether (2×10 mL). The solid was then dried under a flow of nitrogen 
and dissolved in CD3CN. 
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Cage 6.3 
 
1H NMR (400 MHz, 298K, CD3CN) δ 8.83 (s, 12H, Hd), 8.67 (d, J = 
8.1 Hz, 12H, Hb), 8.56 (d, J = 8.2 Hz, 12H, Hc), 7.50 (s, 24H, Hh), 7.45 
(s, 12H, Ha), 6.78 (d, J = 8.8 Hz, 24H, He), 5.71 (d, J = 8.9 Hz, 24H, 
Hf), 3.81 (s, 36H, Hg). These data match those previously reported.
[34] 
 
 
Cage 6.4 
1H NMR (500 MHz, 298K, CD3CN) δ: 9.14 (s, 8H, 
Hd), 8.92 (s, 8H, Hd), 8.87 (s, 8H, Hd), 8.66 (d, 
J = 8.6 Hz, 8H, Hc), 8.35 (s, 8H, Ha), 8.32 (d, 
J = 8.7 Hz, 8H, Hb), 8.28 – 8.20 (m, 16H, 2 × Hb), 
8.13 (d, J = 8.0 Hz, 8H, Hc),8.05 (d, J = 8.0 Hz, 8H, 
Hb), 7.97 (d, J = 8.1 Hz, 8H, Hc), 7.82 (s, 8H, Ha), 
6.86 (d, J = 9.2 Hz, 16H, Hf), 6.76 (d, J = 9.0 Hz, 16H, He), 6.73 – 6.65 (m, 32H, He + Hf), 6.53 
(d, J = 8.8 Hz, 16H, Hf), 6.25 (d, J = 8.8 Hz, 16H, He), 3.73 (s, 24H, Hg), 3.71 (s, 24H, Hg),3.65 
(s, 24H, Hg). 
19F NMR (376 MHz, 298K, CD3CN) δ: −72.72 (d, J = 708.6 Hz, PF6−), −143.70 
(m), −144.23 (s), −144.59 – −145.05 (m). These data match those previously reported.[22] 
 
6.6.4 Sorting experiments for cages 6.3 and 6.4 
Preparation of a mixture of 6.3 and 6.4 from subcomponents. 
5,5'-(1,4-Phenylene)dipicolinaldehyde 6.C (0.80 mg, 2.80 µmol, 3.0 eq.), 5,5'-(perfluoro-1,4-
phenylene)dipicolinaldehyde 6.D (1.0 mg, 2.80 µmol, 3.0 eq.), p-anisidine (1.4 mg, 11.0 µmol, 
12 eq.) and Fe(PF6)2.6CH3CN (2.2 mg, 3.70 µmol, 4.0 eq.) were dissolved in CD3CN (0.7 mL) 
in a sealed J.Young NMR tube. The reaction mixture was kept at 50 °C for 3 days, yielding a 
dark blue/green solution. 
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Figure 6.45│1H NMR (500 MHz, 298K, CD3CN) spectrum of a mixture of 6.3 and 6.4 prepared from 
subcomponents after 3 days at 50 °C. 
 
 
Figure 6.46│ESI-Mass spectrum of a mixture of 6.3 and 6.4 prepared from subcomponents after 3 days at 
50 °C. 
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Figure 6.47│HR-ESI-Mass spectrum and theoretical isotope pattern of [6.3(PF6)4]+4 after exchange of one ligand 
with the prismatic structure. 
 
Figure 6.48│HR-ESI-Mass spectrum and theoretical isotope pattern of [6.3(PF6)2]+6 . 
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Figure 6.49│HR-ESI-Mass and theoretical isotope pattern of [6.4(PF6)6]+10 after exchange of four ligands with 
the tetrahedron. 
 
Figure 6.50│HR-ESI-Mass and theoretical isotope pattern of [6.4(PF6)7]+9 after exchange of four ligands with the 
tetrahedron. 
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Preparation of a mixture of 6.3 and 6.4 from pre-assembled cages. 
6.3 (3.5 mg, 0.82 µmol, 2.0 eq.) and 6.4 (3.9 mg, 0.41 µmol, 1.0 eq.) were dissolved in CD3CN 
(0.7 mL) in a sealed J. Young NMR tube. The reaction mixture was stirred at 50 °C for 1 week, 
yielding a dark blue/green solution.  
 
Figure 6.51│1H NMR (400 MHz, 298K, CD3CN) spectrum of a mixture of 6.3 and 6.4 prepared from pre-
assembled cages after 3 days at 50 °C. 
 
Figure 6.52│ESI-Mass spectrum of a mixture of 6.3 and 6.4 prepared from pre-assembled cages after 3 days at 
50 °C. 
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Figure 6.53│HR-ESI-Mass spectrum and showing the peaks of [6.3(PF6)5]+3 and the structures formed by 
subsequent exchange of ligand with 6.4 and the peaks of [6.4(PF6)10]+6 and the structures formed by subsequent 
exchange of ligand with 6.3. 
 
Figure 6.54│HR-ESI-Mass spectrum and theoretical isotope pattern of [6.3(PF6)3]+5 
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Figure 6.55│HR-ESI-Mass spectrum and theoretical isotope pattern of [6.3(PF6)3]+5 after exchange of one ligand 
with the prismatic structure. 
 
Figure 6.56│HR-ESI-MS spectrum and theoretical isotope pattern of [6.4(PF6)8]+8 after exchange of three ligands 
with the tetrahedron. 
Chapter 6 
 
- 217 - 
 
Figure 6.57│HR-ESI-Mass spectrum and theoretical isotope pattern of [6.4(PF6)8]+8 after exchange of two ligands 
with the tetrahedron. 
 
6.6.5 Synthesis and characterization of cages 6.5 – 6.8 
Cages 6.5 – 6.8 were synthesised and characterised by Felix Rizzuto. All data, including 
crystallographic data, can be found in the literature.[23]  
 
6.6.6 Sorting experiments for cages 6.5 – 6.8  
General procedures 
 Two triamines (1.60 µmol of each triamine, 4 eq. of each triamine), 2-formylphenanthroline 
6.G (2.00 mg, 9.61 µmol, 24 eq.) and Co(OTf)2 (1.71 mg, 4.80 µmol, 12 eq.) were combined 
in CD3CN (0.5 mL) and heated at 70 °C for 18 h after which equilibrium was reached and 
the self-sorted output was formed. 
 Stock solutions of 6.5, 6.6, 6.7 and 6.8 (0.89 mM) were respectively prepared from triamine 
6.H, 6.I, 6.J and 6.K (3.20 µmol, 4 eq.), 2-formylphenanthroline (2.00 mg, 9.61 µmol, 12 
eq.) and Co(OTf)2 (1.72 mg, 4.81 µmol, 6 eq.) and heated at 70 °C for 18 h in CH3CN (0.9 
mL). Once cooled to room temperature, 0.1 mL of two homoleptic cage solutions were 
combined, making solutions of two purely homoleptic complexes: 6.5 and 6.6, 6.5 and 6.7, 
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6.5 and 6.8, 6.6 and 6.7, 6.6 and 6.8 and 6.7 and 6.8. These mixtures were heated at 70 °C 
for 18 h, after which equilibrium was reached and the self-sorted output was formed. 
Note: NMR data of the sorting mixtures was acquired by Felix Rizzuto. IM-MS data was 
acquired by Felix Rizzuto and Marion Kieffer. ESI-MS data was acquired by Marion Kieffer. 
Subcomponents 6.H and 6.I 
 
 
Figure 6.58│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.H and 6.I were used in the self-assembly process. 
 
Figure 6.59│IM-MS data for cages generated when both 6.H and 6.I were used in the self-assembly process, 
showing the z = +3 peaks (top). The assembly resolved a single, broad drift time, indicating similar sizes between 
the sorted species. 
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Subcomponents 6.H and 6.J 
 
 
Figure 6.60│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.H and 6.J were used in the self-assembly process. 
 
Figure 6.61│IM-MS data for cages generated when both 6.H and 6.J were used in the self-assembly process, 
showing the z = +6 peaks (top). The species resolved with broad, asymmetric drift times, indicative of multiple 
species sizes in the assembly for this charge fragment set. 
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Figure 6.62│When only the blue region in the drift time plot in Figure 6.61 was examined (i.e. the species with 
faster drift times), only peaks corresponding to species with a greater proportion of subcomponent 6.H were 
observed. 
 
Subcomponents 6.H and 6.K 
 
 
Figure 6.63│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.H and 6.K were used in the self-assembly process.  
 
IM-MS data for cages generated when both 6.H and 6.K were used in the self-assembly process 
is given in Figure 6.13. 
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Subcomponents 6.I and 6.J 
 
 
Figure 6.64│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.I and 6.J were used in the self-assembly process.  
 
Figure 6.65│IM-MS data for cages generated when both 6.I and 6.J were used in the self-assembly process, 
showing the z = +3 peaks (top). The species resolved with a single broad drift time, indicative of the octahedral 
geometry of all sorted possibilities. 
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Subcomponents 6.I and 6.K 
 
 
Figure 6.66│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.I and 6.K were used in the self-assembly process.  
IM-MS data for cages generated when both 6.I and 6.K were used in the self-assembly process 
is given in Figure 6.14. 
Subcomponents 6.J and 6.K 
 
 
Figure 6.67│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the mixture of cages generated when 
both 6.J and 6.K were used in the self-assembly process.  
IM-MS data for cages generated when both 6.J and 6.K were used in the self-assembly process 
is given in Figure 6.15. 
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6.6.7 Synthesis and characterization of cages 6.9 and 6.10 
Cage 6.9 
Tris(4-aminophenyl)amine 6.H (9.0 mg, 31.1 µmol, 1.0 eq.), 
picolinaldehyde (10.0 mg, 93.3 µmol, 3.0 eq.) and Co(NTf2)2 
(21.5 mg, 31.1 µmol, 1.0 eq.) were combined in CH3CN or 
CD3CN (2.5 mL) in a sealed 5 mL reaction tube. The solution 
was stirred and heated at 70 °C for 18 h. A dark orange stock 
solution of cage 6.9 (3.11 mM) was obtained and was used 
without further purification. 
1H NMR (400 MHz, 298K, CD3CN) δ 234.6 (s, 12H), 87.6 (s, 12H), 71.5 (s, 12H), 51.0 (s, 
12H), 14.8 (s, 12H), –7.7 (s, 24H), –25.1 (s, 24H). 19F NMR (376 MHz, 298K, CD3CN) 
δ – 76.82. LR-ESI-MS [charge, calculated mass]: m/z = 1288.9 [6.9(NTf2)53+, 1288.0], 896.7 
[6.9(NTf2)4
4+, 896.0], 661.3 [6.9(NTf2)3
5+, 660.8], 504.4 [6.9(NTf2)2
6+, 504.1], 392.4 
[6.9(NTf2)
7+, 392.1], 308.4 [6.98+, 308.1]. 
 
Figure 6.68│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of 6.9. 
 
Figure 6.69│LR-ESI-MS mass spectrum of 6.9(NTf2)8. 
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Figure 6.70│HR-ESI-Mass spectrum of 6.9(NTf2)8 showing the observed z = +3 charge, (top) compared to the 
theoretical isotope pattern (bottom). 
 
Cage 6.10 
With Co(NTf2)2 
Pararosaniline 6.I (9.0 mg, 31.1 µmol, 1.0 eq.), picolinaldehyde 
(10.0 mg, 93.3 µmol, 3.0 eq.) and Co(NTf2)2 (21.5 mg, 
31.1 µmol, 1.0 eq.) were combined in CH3CN or CD3CN 
(2.5 mL) in a sealed 5 mL reaction tube. The solution was 
stirred and heated at 70 °C for 18 h. A dark red stock solution 
of cage 6.10 (3.11 mM) was obtained and was used without 
further purification. 
A second minor set of signals was observed in the 1H NMR spectrum which was attributed to 
the host-guest complex CD3CN⊂6.10. 
1H NMR (400 MHz, 298K, CD3CN) δ 240.1 (s, 12H), 236.4 (s, 12H, HG complex), 89.0 (s, 
12H), 87.3 (s, 12H, HG complex), 73.6 (s, 24H), 52.0 (s, 24H), 16.2 (s, 24H), –4.666 (s, 48H), 
–23.8 (s, 48H). 19F NMR (376 MHz, 298K, CD3CN) δ –79.56. LR-ESI-MS [charge, calculated 
mass]: m/z = 1308.9 [6.10(NTf2)5
3+, 1308.1], 911.7 [6.10(NTf2)4
4+, 911.0], 673.3 
[6.10(NTf2)3
5+, 672.8], 514.4 [6.10(NTf2)2
6+, 514.1], 400.9 [6.10(NTf2)
7+, 400.6], 315.9 [6.108+, 
315.6]. 
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Figure 6.71│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of 6.10(NTf2)8. 
 
Figure 6.72│LR-ESI-Mass spectrum of 6.10(NTf2)8. 
 
Figure 6.73│HR-ESI-Mass spectrum of 6.10(NTf2)8 showing the observed z = +3 charge, (top) compared to the 
theoretical isotope pattern (bottom). 
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With Co(BF4)2 
Pararosaniline 6.I (9.0 mg, 31.1 µmol, 1.0 eq.), picolinaldehyde 
(10.0 mg, 93.3 µmol, 3.0 eq.) and Co(BF4)2 (10.6 mg, 31.1 µmol, 
1.0 eq.) were combined in CH3CN or CD3CN (2.5 mL) in a 
sealed 5 mL reaction tube. The solution was stirred and heated at 
70 °C for 18 h. A dark red stock solution of cage 6.10 (3.11 mM) 
was obtained and was used without further purification. 
Three set of signals were observed in the 1H NMR which were 
attributed to the empty cage, the host-guest complex CD3CN⊂6.10 and the host-guest complex 
BF4
−⊂6.10. 
1H NMR (400 MHz, 298K, CD3CN) δ 239.7 (s, 1H, empty cage), 238.5 (s, 1H, BF4−⊂6.10), 
236.1 (s, 1H, CD3CN⊂6.10), 88.6 (bs, 1H, empty cage), 86.7 (bs, 1H, CD3CN⊂6.10), 86.2 (bs, 
1H, BF4
−⊂6.10), 74.0 – 72.9 (m, 3H), 51.8 (s, 3H), 16.4 (s, 3H), –4.5 (s, 6H), –23.6 (bs, 2H, 
empty cage and CD3CN⊂6.10), –25.7 (bs, 2H, BF4−⊂6.10). 19F NMR (376 MHz, 298K, 
CD3CN) δ –143.45 (s, free BF4−), –200.02 (s, BF4−⊂6.10). LR-ESI-MS [charge, calculated 
mass]: m/z = 1523.4 [6.10(BF4)6
2+, 1523.24], 986.7 [6.10(BF4)5
3+, 986.5], 718.3 [6.10(BF4)4
4+, 
718.1], 557.2 [6.10(BF4)3
5+, 557.1], 449.8 [6.10(BF4)2
6+, 449.7], 373.2 [6.10(BF4)
7+, 373.1], 
315.1 [6.108+, 315.6]. 
 
Figure 6.74│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of 6.10(BF4)8. 
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Figure 6.75│LR-ESI-MS mass spectrum of 6.10(BF4)8. 
 
Figure 6.76│HR-ESI-MS mass spectrum of 6.10(BF4)8 showing the observed z = +3 charge, (top) compared to 
the theoretical isotope pattern (bottom). 
 
Crystal structure of 6.9 and 6.10 
Crystals of 6.9 suitable for single crystal X-ray diffraction analysis were obtained by Rana 
Bilbeisi through vapour diffusion of diethyl ether into an acetonitrile solution of 6.9 to which 
TBAClO4 was added. Crystals of 6.10 suitable for single crystal X-ray diffraction analysis were 
obtained by Rana Bilbeisi through vapour diffusion of a solution of 50:50 (v/v) diethyl 
ether:ethyl acetate into an acetonitrile solution of 6.10(ClO4
–)8. Data sets were collected by Jack 
Clegg. 
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6.6.8 Host-guest chemistry in 6.10 
Binding of acetonitrile 
A solution of cage 6.10 (3 mM) was prepared in CH3CN according to the procedure described 
in section 6.6.7. A capillary of CD3CN was added to the NMR tube containing the cage in the 
non-deuterated solvent in order to allow locking and a first 1H NMR spectrum was collected. 
The sample was dried, dissolved in CD3CN and left to equilibrate at 70 °C for 4 days after 
which the 1H NMR spectrum was collected again. 
Binding of ClO4– 
TBAClO4 was titrated into a solution of cage 6.10 (1.0 mM). The samples were left to 
equilibrate for 24 h at 70 °C after each addition of TBAClO4 before collecting the spectrum.  
 
Figure 6.77│Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of cage 6.10 after titration of TBAClO4 
(equivalents of anions labelled on the spectra). 
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Binding of BF4- 
TBABF4 was titrated into a solution of cage 6.10 (1.0 mM). The samples were left to equilibrate 
for 24 h at 70 °C after each addition of TBABF4 before collecting the spectrum.  
 
Figure 6.78│Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of cage 6.10 after titration of TBABF4 
(equivalents of anions labelled on the spectra). 
 
 
Figure 6.79│19F spectrum (376 MHz, 298 K, CD3CN) of cage 6.10 after addition of 50 eq. of TBABF4. 
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Binding of I- 
TBAI was titrated into a solution of cage 6.10 (1.0 mM). The samples were left to equilibrate 
for 24 h at 70 °C after each addition of TBAI before collecting the spectrum.  
 
 
Figure 6.80│Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of cage 6.10 after titration of TBAI 
(equivalents of anions labelled on the spectra) 
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Binding of Br– 
TBABr was titrated into a solution of cage 6.10 (1.0 mM). The samples were left to equilibrate 
for 24 h at 70 °C after each addition of TBABr before collecting the spectrum.  
 
Figure 6.81│Wide sweep 1H NMR spectra (400 MHz, 298 K, CD3CN) of cage 6.10 after titration of TBABr 
(equivalents of anions labelled on the spectra) 
 
6.6.9 Mathematical models for titration curves 
Definition of [HG], [HS] and [H] 
Cage 6.10 was found to undergo 1:1 binding with two types of guests: anions such as Br–, Cl–, 
BF4
–, and ClO4
– and acetonitrile.  
     
Each of these binding events can be expressed by the following equilibrium constants: 
        (Equation 6.10) 
        (Equation 6.11) 
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where [H], [G], [S] are the concentrations of the unbound species and [HG] and [HS] represent 
the bound species. Given that the solvent concentration (~20,000 mM) is orders of magnitude 
greater than that of either the host or guest (~1 mM), the change in concentration upon 
encapsulation of solvent is very small, so that [Sfree] ≈ [Stotal]. 
From mass balance: 
        (Equation 6.12) 
 
(Equation 6.13) 
The free host concentration H is thus: 
        (Equation 6.14) 
Substitution into the equilibrium constant expressions gives: 
    (Equation 6.15) 
Rearranging terms, followed by division with KHG gives the following quadratic equation: 
  (Equation 6.16) 
Solving for the host-guest complex [HG] using the quadratic formula gives the following 
hyperbola: 
 
          (Equation 6.7) 
The root with the negative radical rather than the positive radical was used in order to satisfy 
boundary conditions, namely that at [Gt] = 0, [HG] must equal zero.   
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Likewise, an analytical function can be written for free host [H] as a function of [Gt].  According 
to equation 6.14, H can be expressed in terms of HG.  Substituting the host-guest complex 
concentration defined by equation 6.7 gives: 
(Equation 6.8) 
Likewise, an analytical function can be written for [HS] as a function of [Gt]. Equation 6.13 can 
be rewritten to give bound host-solvent complex as: 
      (Equation 6.17) 
Substituting the definition of [HG] in equation 6.7 gives: 
(Equation 6.9) 
Equation 6.7, 6.8 and 6.9 were used for the case of TBABr and TBAI. A scaling factor C was 
added to Equation 6.7, 6.8 and 6.9 to account for the contribution of TBA+. Furthermore,  giving 
that [HS] did not change required elimination of the terms related to the otherwise competitive 
binding of solvent, namely 1 + KHS [S] term with concomitant addition of the term –[HS] to 
keep the proper mass balance.  Finally, although [HS] is essentially constant throughout the 
titration with larger guests, small variations were modelled as a straight line, giving Equation 
6.10, 6.11 and 6.12 described in Section 6.4.2. 
 
The Merit Function χ2 
The following work was carried out solely by John Thoburn. 
For Gaussian distribution of measurements with individual standard deviations σi, the 
probability that the model parameters fit the N data points is  
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        (Equation 6.18) 
where yi
obs is the range of the ith data point and yi
calc is the range calculated for the corresponding 
ith data point according to equations 6.7, 6.8, and 6.9.  Taking the log of the probability allows 
one to work with sums rather than products, which are computationally more readily handled 
than exponents:  
       (Equation 6.19) 
The quantity to be maximized, ln(P), is equivalent to minimizing –ln(P) 
       (Equation 6.20) 
Thus, a “merit” function, or fitting function, χ2 was defined, which is the function to be 
minimized during the best fit determination of the desired parameters.   
       (Equation 6.21) 
Some data points were more reliable than others and therefore each data point’s contribution to 
the fit was weighted by 1/σi2, where σi2 is the variance.  The term yicalc is a function of the 
variable [Gt] and the binding constants KHG and KHS, which are the parameters to be fitted 
during the minimization process.  Because all three curves are dependent on the parameters KHG 
and KHS, the best fit is obtained by fitting all three functions simultaneously rather than 
individually.  Thus, we define the merit function:  
        (Equation 6.22) 
 
A Mathematica program was written to implement this.  Each data points is to be fitted to only 
one of the equations 6.7, 6.8, or 6.9, that is to only one of the χ2 terms in equation 6.21.  To sort 
the data to the appropriate term, each data point was assigned an index (1, 2, or 3), 
corresponding to equations 6.7, 6.8, or 6.9.  Thus, the N data points to be fitted were represented 
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as an N by 3 matrix, where each row consisted of {indexi, xi, yi}.  Then the Kronecker delta was 
used to associate individual data points to the appropriate fitting function: 
(Equation 6.23) 
where δij = 1 when i = j and δij = 0 when i ≠ j. 
 
Minimization Routine and Error Propagation 
The binding constants were calculated by minimizing merit function (Equation 6.23) with 
respect to the fitted parameters, KHG and KHS: 
         (Equation 6.24a) 
         (Equation 6.24b) 
The roots to equations 6.27 were found numerically using the Newton-Raphson method as 
implemented Mathematica’s built-in NonlinearModelFit function.  In this iterative method a 
new guess at the root xn+1 is derived from an initial guess (xn), the value of the function at xn 
and its derivative: 
        (Equation 6.25) 
In some cases better convergence was achieved with the Levenberg-Marquardt minimization 
procedure.  The standard deviations (“errors”) in the fitted parameters were determined by the 
usual propagation of errors: 
       (Equation 6.26a) 
 
       (Equation 6.26b) 
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where dHG and dHS is the uncertainty of [HG] and [HS], respectively, as estimated from their 
residuals. 
The Mathematica program will be made freely available as supplementary information upon 
publication of this work. 
 
6.6.10 Sorting experiments for cages 6.9 and 6.10 
Untemplated library of heteroleptic cages 
Tris(4-aminophenyl)amine 6.H (4.5 mg, 15.6 µmol, 1.0 eq.), pararosaniline 6.I (4.75 mg, 
15.6 µmol, 1.0 eq.), picolinaldehyde (10.0 mg, 93.3 µmol, 6.0 eq.) and Co(NTf2)2 (21.5 mg, 
31.1 µmol, 2.0 eq.) were combined in CH3CN or CD3CN (2.5 mL) in a sealed 5 mL reaction 
tube. The solution was stirred and heated at 70 °C for 18 h. A dark red stock solution of the 
untemplated library of cages (3.11 mM) was obtained and was used without further purification. 
Templation with Br– or I–  
TBAI or TBABr (2 eq.) were added to a solution of the untemplated mixture (3.11 mM). The 
solutions were stirred and heated at 70 °C for 72 h. A dark red solution of the templated library 
of cages (3.11 mM) was obtained and was used without further purification. 
 
Figure 6.82│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the untemplated library of cages 
(bottom) and the templated library by I– (middle) and Br– (top). The new peaks corresponding to the encapsulated 
guests within the library are marked by blue stars and green stars. The peak corresponding to 6.9 is marked by a 
red triangle.  
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Templation with ClO4– or BF4– 
Tris(4-aminophenyl)amine 6.H (4.5 mg, 15.60 µmol, 1.0 eq.), pararosaniline 6.I (4.75 mg, 
15.60 µmol, 1.0 eq.), picolinaldehyde (10.0 mg, 93.30 µmol, 6.0 eq.), Co(NTf2)2 (21.5 mg, 
31.10 µmol, 2.0 eq.) and TBA ClO4 or TBA BF4 (7.80 µmol, 0.5 eq.) were combined in CH3CN 
or CD3CN (2.5 mL) in a sealed 5 mL reaction tube. The solutions were stirred and heated at 
70 °C for 72 h. A dark red stock solution of the templated library of cages (3.11 mM) was 
obtained and was used without further purification. 
 
Figure 6.83│Wide sweep 1H NMR spectrum (400 MHz, 298 K, CD3CN) of the untemplated library of cages 
(bottom) and the templated library by BF4– (middle) and ClO4– (top). The new peaks corresponding to the 
encapsulated guests within the library are marked by blue stars. The peak corresponding to 6.9 is marked by a red 
triangle. 
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Metal-organic cages are good candidates for applications like drug delivery thanks to their 
ability to selectively encapsulate and stabilise guest molecules.  In particular, the combination 
of coordination cages with biomolecules could facilitate their uptake in the body and progress 
their potential use as drug carriers. This thesis has explored the interactions of self-assembled 
cages with biomolecules and the properties that resulted from the synergy between these 
compounds.  
Chapter Three focused on the incorporation of tetrahedral coordination cages in supramolecular 
gels made from tripeptides through non-covalent linkages. A gel matrix containing 
homogeneously embedded cages was formed when the tripeptide was self-assembled in the 
presence of the cages. While the cages influenced the gel properties at high concentrations, 
their ability to encapsulate chemicals was retained, increasing the gel selectivity for guests. By 
layering gels containing cages with affinities for different guests on top of each other, spatial 
separation of chemicals was achieved within a single solvent system.  
The covalent linkage of biomolecules onto coordination complexes was studied in the 
following chapters. While attachment of amino acids and peptides directly through their N-
termini was unsuccessful, these molecules were tagged to cages via p-aminobenzoyl linkers. 
In Chapter Four, the tripeptide gelator previously used was covalently attached to a tetrahedral 
cage. The gel formed by the biofunctionalised cage was sensitive to changes in acidity and a 
reversible sol-gel transition was light-triggered by the introduction of a long-lived photo-acid 
generator into the system. In Chapter Five, both N-acetylgalactosamine and fluorescent 
moieties were synthesized and conjugated onto a water-soluble cage. The functionalised cage 
was stable at low concentrations in PBS and its ability to be internalised in hepatocytes through 
the asialoglycoprotein receptor will be investigated in the future.  
As more complex synthetic systems are created from self-assembling molecules in order to 
mimic their biological counterparts, the necessity for better characterisation and understanding 
of multicomponent self-sorting is growing. Chapter Six was thus dedicated to the investigation 
of mass spectrometry as a potential tool for the quantitative analysis of self-sorted systems. 
The speciation that occurred in three different chemical libraries was studied and rules 
governing the self-assembly of structures incorporating different types of ligand were drawn. 
The free Gibbs energies of each congener of the libraries were also obtained for two of the 
systems studied.  
